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ABSTRACT OF DISSERTATION

THE INTERPLAY BETWEEN THE EXPRESSION AND FUNCTIONS OF WNT13
ISOFORMS DURING APOPTOSIS IN BOVINE AORTIC ENDOTHELIAL CELLS

Wnt proteins are crucial for development/homeostasis by controlling cell fate
including apoptosis (Moon RT et al. 1997). Three humanWnt13 isoforms were identified:
the secreted Wnt13A, mitochondrial Wnt13B, and nuclear Wnt13C forms; and nuclear
Wnt13 had an increased sensitivity to LPS/TNF-induced apoptosis in primary endothelial
cells (EC); both Wnt13B and C mRNA contain two start codons (AUG+1 and +74), but
the same protein encoded from AUG+74 by Wnt13C was expressed lower than Wnt13B
(Struewing IT et al.2006). We hypothesize that during EC apoptosis, the nuclear Wnt13C
expression is regulated translationally; nuclear Wnt13 favors apoptosis through
regulating the activity/expression of apoptosis-related factors; Wnt13 isoforms may have
differential effects on EC apoptosis and apoptosis-related factors.
1. The protein levels, but not the mRNA levels of Wnt13C were induced by
apoptosis-inducers. And the Myc-tag insertion at the AUG+1 in Wnt13C mRNA
inhibited its expression, indicating the RNA sequences/structures are critical. Therefore,
nuclear Wnt13C is regulated during apoptosis at translational levels.
2. Nuclear Wnt13 increased caspase-3/7 expression with/without LPS, followed
by an increase in LPS-induced caspase-3/7 cleavage; and nuclear Wnt13 upregulated the
pro-apoptotic Bcl-2 family member Bim expression, suggesting that nuclear Wnt13
increased caspase activation through upregulating caspase and Bim expression. Wnt13
isoforms increased EC apoptosis with different strengths: nuclear > mitochondrial >
secreted forms.
3. Both caspase-3 and Bim are FOXO target genes; and nuclear Wnt13 increased
the nuclear localization of FOXOs, suggesting increased FOXO activity. Nuclear Wnt13
also upregulated SOD2, another FOXO target gene related to oxidative stress-resistance.

Nuclear Wnt13 did not increase FOXO activity at the SOD2 promoter, but increased the
SOD2-intron 2 element luciferase activity upon LPS, where a novel putative FOXO site
was found, implying intron 2 may be responsible for enhanced SOD2 transcription by
nuclear Wnt13.
Altogether, our results pinpoint the interplay between the expression and functions of
Wnt13 forms during EC apoptosis, forming a positive cycle further facilitating the
apoptotic program completion, which is important for EC homeostasis.

KEYWORDS: Translational regulation, caspases, FOXOs, SOD2
transcription, EC homeostasis
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CHAPTER 1. INTRODUCTION

1.1 Wnts and Wnt signaling
1.1.1

Overview

1.1.1.1 Brief history
In 1982, Nusse R and Varmus ER firstly identified a mouse proto-oncogene
called Int-1 as a preferential integration site in the host genome for insertional activation
by mouse mammary tumor virus (MMTV) in mammary tumors (Nusse R et al. 1982).
When sequenced, Int-1 was found to encode a novel secreted glycoprotein (van Ooyen A
et al. 1984). The Drosophila homolog of Int-1 (Dint-1) turned out to be identical to a
segment polarity gene, wingless (Wg), which mutation led to the lack of wings and
halteres in adult flies (Sharma RP et al. 1976, Rijsewijk F et al. 1987a). In 1991, Nusse R
et al proposed a new nomenclature to call Int-1 and related genes Wnt, which is an
amalgam of Wingless and Int (Nusse R. 1991).

Wnt1 was shown to induce

morphological transformation in cultured cell lines, including C57MG mammary
epithelial cells (Brown AM et al. 1986; Jue SF et al. 1992), RAC311 mammary cells
(Rijsewijk F et al. 1987b), PC12 pheochromocytoma cells (Bradley RS et al. 1993), and
C3H 10T1/2 fibroblasts (Bradbury JM et al. 1994). Then people extended to all the other
Wnts, and found that different Wnts have distinct ability in transforming activity; hence
the Wnt family members were divided into two groups based on this biological activity:
Wnt1, 3a and 7a are highly transforming members, while Wnt 4, 5a and 11 are nontransforming members (Wong GT et al. 1994). In the late 1980s and early 1990s, many
genes were discovered via screen of Drosophila mutations displaying segment polarity
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defects (Nüsslein-Volhard C et al. 1980; Eberl DF et al. 1988), which helped the
identification of components of the Wnt signaling cascade, such as the cytoplasmatic
Disheveled (Klingensmith J et al. 1994) and nuclear signal transducers Armadillo/βcatenin (Wieschaus E et al. 1987), and then the epistatic relationship between these
molecules was characterized showing that they comprise the Wnt canonical signaling
pathway (Klaus A et al. 2008). So people later on prefer using the terms canonical Wnt
(initiating β-catenin/T cell factor pathway) and non-canonical Wnt (Wnt-Plannar cell
polarity pathway or Wnt- Ca2+ pathway) to classify the Wnt members (Herman M. 2001;
van Amerongen R et al. 2006). Today the Wnt picture has been greatly enriched by the
discovery of new members, receptors, coreceptors, target genes, agonists, antagonists,
biological functions of Wnt signaling, as well as the involvement in human diseases,
which timeline has been reviewed by Klaus A et al (Klaus A et al. 2008).

1.1.1.2 Wnt protein family

Wnt proteins are highly conserved throughout the animal kingdoms, with Wnt
homologs found in genomes of human, mouse, xenopus, chicken, zebrafish, Drosophila,
C. elegans and even Cnidaria (van Amerongen R et al. 2008 and Cadigan KM et al.
1997). There are 19 Wnt proteins in the mammalian genome which can be divided into
12 conserved subfamilies based on evolutionary relationship, and they are expressed in
temporal-spatial patterns during development (Clevers H. 2006).
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Most Wnt proteins have around 350 amino acids in sequence with a molecular
weight of about 40KD (Coudreuse D et al. 2007). Wnts feature a signature Wnt motif (CK-C-H-G-[LIVMT]-S-G-S-C), as well as 23-25 conserved cysteine residues and several
N-glycosylation sites (Zhai L et al. 2004; Coudreuse D et al. 2007). Thus, one posttranslational modification that Wnts undergo is N-glycosylation, and Wnt1, 3a, 3a, 5b, 6
and 7b have been shown to enter the endoplasmic reticulum (ER) and to be Nglycosylated (Smolich BD et al. 1993). Another post-translational modification is lipid
modifications (addition of palmitate at cysteine residues or palmitoleic acid at serine
residues) which contribute to the insolubility of Wnts (Kikuchi A et al. 2007). So far,
Wnt1 (Franch-Marro X et al. 2008), 3a (Willert K et al. 2003) and 5a (Kurayoshi M et al.
2007) have been reported to undergo lipid modifications. And this hydrophobic feature of
Wnts confers a strong affinity for cell membrane; for example, Drosophila Wnt-1 (Wg)
was shown to be converted to a membrane-anchored (more specifically, lipid rafttargeted) protein after lipid modification (Zhai L et al. 2004). Both N-glycosylation and
lipid modification have been shown critical for the secretion and action of Wnt3a
(Komekado H et al. 2007; Takada R et al. 2006; Kurayoshi M et al. 2007). However, for
Wnt5a, palmitoylation is critical for its activity, but N-glycosylation is necessary for only
the secretion (Kurayoshi M et al. 2007). For Drosophila, palmitoylation has been found to
regulate the activity of Wg (Galli LM et al. 2007), but WntD does not require lipid
modification for its secretion and function (Ching W et al. 2008). When Wnt enter into
ER, Wnt undergoes N-glycosylation and then acylation by membrane-bound O-acyl
transferases PORC (Porcupine for Drosophila); subsequently, Wnt is transported into the
Golgi apparatus, where further glycosylations occur, and then Wnt (Wg or XWnt4) is
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routed to plasma membrane accompanied by Wntless (a conserved membrane protein
that is dedicated in Wnt secretion) to be finally secreted from cell surface in a mature and
active form (Zhai L et al. 2004; Bänziger C et al. 2006; Kikuchi A et al. 2007; Kim H et
al. 2009). However, this model does not apply for all the Wnts. For example, not all of
the Wnts are secreted, e.g. Wnt13B and C are intracellular Wnts (Streuwing IT, 2006).

Wnt1, Wnt3a, and Wnt8 are usually believed to be canonical Wnts while Wnt5a
and Wnt11 are usually called non-canonical Wnts, based on which signaling pathways
they initiate, respectively. However, it is difficult to categorize Wnts due to the lack of
clear distinction among all the Wnts by using this classification, and there are increasing
evidence to support that Wnt proteins per se are not intrinsically canonical or
noncanonical but that the pathways that Wnt ligands activate is determined by the context
of receptors (van Amerongen R et al. 2008), and Table 1 demonstrated the details of
individual Wnt that binds which specific frizzled (Fz) receptors and then initiates specific
signaling pathways.

1.1.1.3 Receptors and ligands in Wnt signaling
1.1.1.3.1

Frizzled (Fz) receptors

The interaction between Wnts and their receptors on the cell surface is the first
step in transducing the extracellular signal into intracellular responses, and the first
discovered Wnt receptors were the Fz proteins (Wondarz A et al. 1998). The Fz genes
constitute a big family which belongs to the G-protein-coupled receptors (GPCR)
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superfamily, and they encode seven-pass transmembrane proteins that have high affinity
for secreted Wnt ligands (Kikuchi A et al. 2007; He X et al. 2004). The Fz receptors have
been found in a variety of animal species, and so far there are 10 Fzs reported in humans
(Kikuchi A et al. 2007). The Fz receptors are characterized by the N-terminal cysteinerich domain (CRD), a conserved extracellular region of 120 amino acids, which is
required for Wnt-Fz binding (Clevers H. 2006; Kikuchi A et al. 2007). Knockout mouse
studies have shown that some Fzs are essential for embryonic development (van
Amerongen R et al. 2008).

1.1.1.3.2

Coreceptors

Low density lipoprotein receptor-related proteins (LRP) constitute a subfamily of
LDL receptor family, an ancient family of endocytic receptors (Kikuchi A et al. 2007; He
X et al. 2004). The LRP family is constitutively endocytosed from the membrane and
recycled back to the cell surface (Lillis AP et al. 2005). Unlike LDL receptor which
appears to act solely in lipoprotein metabolism, LRPs seem to have other functions in
protease degradation, activation of lysosomal enzymes, cellular entry of viruses and
toxins,

and neurotransmission as well as vasculature protection by regulating cell

migration and integrin activity (Herz J et al. 2001; Lillis AP et al. 2005). Moreover,
LRP5/6 or Arrow (Drosophila homologue), is a type I single-pass transmembrane
protein, which has been shown to be indispensable for Wnt signaling cascade and appears
to function as Wnt co-receptors (He X et al. 2004). Unlike Fz receptors which are
required for Wnt-β-catenin, Wnt-PCP and Wnt-Ca2+ pathways, LRP5/6 is specifically
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necessary for canonical Wnt-β-catenin pathway, but not for non-canonical pathways
(Kikuchi A et al. 2007; Staal FJ et al. 2008).

1.1.1.3.3

Alternative ligands for Fz/LRP

The finding of alternative ligand for Fz receptors changed the dogma of Wnts
exclusively binding to Fzs (Hendrickx M et al. 2008). Besides Wnts, there are other types
of factors which activate Fz/LRP receptors and serve as alternative ligands of Wnt
signaling. One type is a secreted protein with a cysteine-knot motif called Norrin, which
was found in the Norrie disease, an X-linked congenital blindness due to vascular defect
in the eye (Hendrickx M et al. 2008). Norrin is a specific and high-affinity ligand for Fz4
and play a critical role in vascular development in the eye and the inner ear (Xu Q et al.
2004). Another type of ligand is secreted R-spondin, which is a family of
thrombospondin type I repeat (TSR) domain containing proteins (Clevers H. 2006). Four
related proteins have been found in this family: R-spondin 1-4, and all of them
structurally feature an N-terminal signal peptide, a CRD with 2 furin like domains, a
thrombospondin type1 domain, and a C-terminal region with positively charged amino
acids (Hendrickx M et al. 2008).

In addition, some factors bind LRP5/6, serving as antagonists for Wnt signaling.
One family called Dickkopf (Dkk) which comprises four members (Dkk1-4) and a unique
Dkk-3 related protein named Soggy (Sgy), contain two CRDs separated by a linker
region (Kawano Y et al. 2003). Dkk1 and 2 have been demonstrated to be specifically
bound to LRP6 with high affinity (Mao B et al. 2001). Moreover, another similar secreted
ligand called Wise, consisting of 206 amino acids with a cysteine knot-like domain,
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shares 38% identity with SOST, and the mutation of SOST gene resulting in truncated
product sclerostin has been found responsible for sclerosteosis (a severe and rare bone
disease characterized by a progressive craniotubular hyperostosis) (Itasaki N et al. 2003;
Semënov M et al. 2005; Kim CA et al. 2008), and both Wise and SOST have been shown
to bind LRP5/6 to modulate Wnt pathway (Ellies DL et al. 2006).

1.1.1.3.4

Alternative receptors or coreceptors for Wnt proteins

The discovery of alternative receptors for Wnt proteins confirmed that Wnts are
not exclusively binding to Fzs, but they also interact with some receptor tyrosine kinases
(RTKs). Ryk (related to tyrosine kinase), a newly identified receptor for Wnt, belongs to
the atypical receptor tyrosine kinase family (Lu W et al. 2004). The Ryk family is
composed of a single Ryk gene in mammals and also in C. elegance as well as three Ryk
genes in Drosophila (Bejsovec A. 2005). Ryk contains extracellular Wnt inhibitory factor
(WIF) domain (functionally similar to CRD of Fz receptors), an intracellular PDZbinding domain and a tyrosine kinase domain (Kikuchi A et al. 2007). Unlike regular
RTKs, Ryk family bears unusual kinase domain motifs with mutations in conserved
tyrosine kinase residues, resulting in a lack of catalytic activity (Hovens CM et al. 1992;
Yoshikawa S et al. 2001; Yoshikawa S et al. 2003). Derailed, the Drosophila homolog of
Ryk, was shown to be a receptor for Wnt5 and essential for Wnt5-mediated Drosophila
axon guidance (Yoshikawa S et al. 2003). Mammalian Ryk interacts directly with Wnt1
or 3a via its extracellular WIF domain, and is required for the activity of Wnt-1 or -3a
(Lu W et al. 2004). The extracellular domain of Ryk forms a ternary complex with Fz8
and Wnt, and the intracellular domain of Ryk interacts with Dsh, which is required for
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the TCF activation induced by Wnt3a, suggesting Ryk may be involved in Wnt canonical
signaling (Lu W et al. 2004). Another example is receptor tyrosine kinase-like orphan
receptor (Ror) proteins, which also constitute a conserved family of tyrosine kinase
receptors. Ror receptors are composed of two structurally related proteins, Ror1 and Ror2
(Green JL et al. 2008). Ror-family RTKs feature an extracellular Fz-like CRD, a
membrane proximal kringle (KR) domain, and cytoplasmic tyrosine kinase domains and
proline-rich domain (Forrester WC et al. 1999; Green JL et al. 2008). Ror2 was shown to
interact with Wnt5a its CRD (Oishi I et al. 2003). Unlike Ryk, Ror2 has been recently
demonstrated to require tyrosine kinase activity to mediate the inhibitory canonical
activity by Wnt5a (Mikels A et al. 2009).

1.1.1.4 Wnt signaling

So far, at least three different Wnt signaling pathways have been described: the
canonical Wnt pathway (β-catenin dependent) for cell fate determination, and two noncanonical Wnt pathways (β-catenin independent) including the planar cell polarity (PCP)
pathway for tissue polarity and the Wnt-Ca2+ pathway for cell movement (Staal FJ et al.
2008 and Katoh M et al. 2007).

1.1.1.4.1

Canonical β-catenin pathway

1.1.1.4.1.1 Overview
In the absence of Wnt ligands, the destruction complex of β-catenin is formed,
where Axin, the scaffold protein, interacts with all other components like tumor
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suppressor adenomatours polyposis coli (APC), β-catenin and two kinases, glycogen
synthase kinase (GSK) 3α/β and casein kinase (CK)1; therefore, GSK and CK1
sequentially phosphorylate β-catenin at Ser/Thr residues (Ser45 by CK1, and then Ser33,
37 and Thr41 by GSK), which is then recognized by β-transducin-repeat-containing
protein (βTRCP), a component of an E3 ligase complex, and results in β-catenin
ubiquitination and final degradation by 26S proteasome (Figure 1A). Hence, the levels of
β-catenin in cytoplasm and nucleus stay low without activating signals due to continuous
phosphorylation events, and in the nucleus, the binding of Groucho (a family of nuclear
factors that lack DNA-binding activity but interact with transcription factors resulting in
transcriptional repression) to transcription factors T cell factor (TCF) /lymphoid enhancer
factor (LEF) leads to the inhibition of Wnt-β-catenin signaling target gene transcription
(Clevers H. 2006; Staal FJ et al. 2008; Buscarlet M et al. 2007).

In contrast, in the presence of Wnt ligands, the Fz receptor/LRP coreceptor
complex activates the canonical signaling pathway (Figure 1B). The formation of Fz/LRP
complex through Dvl (mammalian homologue of Drosophila Dishevelled) facilitates the
phosphorylation in the cytoplasmic tail of LRP5/6 by CK1 and GSK3, allowing the
docking of Axin to the LRP phosphorylation sites. Hence, the recruitment of Axin to the
plasma membrane prevents the formation of the destruction complex of β-catenin, and
results in the stabilization of β-catenin. The stabilized β-catenin then translocates to the
nucleus and physically displaces Groucho from TCF/LEF and promotes the expression of
Wnt-β-catenin signaling target genes including cMyc and Cyclin D1 (Clevers H. 2006
and Staal FJ et al. 2008).

9

1.1.1.4.1.2 Glycogen synthase kinase (GSK) 3β and Akt
GSK3β is a Ser/Thr protein kinase, initially described as a key enzyme in
glycogen metabolism, but now known to regulate a diverse array of cell functions,
including development, protein translation, cell cycle, and cytoskeleton dynamics (Cohen
P et al. 2001; Hardt SE et al. 2002). GSK3β has also been shown to promote cell
apoptosis in neuronal cells (Li M et al. 2000), and to activate proinflammatory dendritic
cells (Rodionova E et al. 2007). Direct phosphorylation of a tyrosine residue (Y216) in
the catalytic domain is associated with an increase of its kinase activity, whereas direct
phosphorylation of N-terminal Ser9 is associated with the inhibition of GSK3β activity
(Forde JE et al. 2007). Lithium, a mood stabilizer, not only competitively inhibits Mg2+
leading to the inhibition of Mg2+-ATP-dependent catalytic activity of GSK3β, but also
increases Ser9 phosphorylation of GSK3β, resulting in inhibited GSK3β activity (Wada
A et al. 2009), and thereby activating Wnt/β-catenin signaling through stabilizing βcatenin (Rao AS et al. 2005). In the resting cells, GSK3β is constituively active in the
absence of the extracellular signal. However, in growth factor signaling, the activation of
protein kinase B (PKB)/ Akt leads to the phosphorylation of Ser9 and thereby the
inhibition of GSK3β (Pearl LH et al. 2002).
PI3K-Akt pathway can be activated by a variety of extracellular signals, and have
been involved in cell proliferation, survival and protein synthesis, and tumor growth. The
activation of Akt can inhibit apoptosis through activating pro-survival factors like NF-κB
and inactivating pro-apoptotic factors such as Bad (a Bcl-2 family member), FOXOs,
caspase-9, as well as GSK3β (Jiang BH et al. 2008; Dillon RL et al. 2007). 3T3-L1 cells
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expressing Wnt-1 inhibited cell apoptosis by inducing expression and secretion of IGFs
that activated Akt signaling, and inhibited PI3K partially blocked the effect of Wnt-1 on
cell apoptosis (Longo KA et al. 2002). Almedida M et al reported that Wnt5a required
PI3K/Akt to protect pre-osteoblastic cells from serum withdrawl-induced apoptosis
(Almedida M et al. 2005). Purified Wnt3a also induced phosphoylation and activation of
Akt as well as the phosphorylation of GSK3β at Ser9 to enhance Wnt/β-catenin signaling
in vitro, which was reversed by sFRP-4 (Constantinou T et al. 2008). Also, during
DMSO-induced cardiomyocyte differentiation of P19CL6 cells, Akt inhibition abrogated
Wnt-3a or-8a-induced canonical Wnt/ β-catenin activity, indicating that PI3K/Akt
pathway maintains canonical Wnt cascade during early caridomyogensis (Naito AT et al.
2005). All these studies support that Akt signaling plays a critical role in Wnt cascade.
1.1.1.4.1.3 β-catenin
One of the substrates of GSK3β, β-catenin, display distinct functions in specific
intracellular pools: the membrane bound pool of β-catenin is involved in cell-cell
adhesion while the cytosolic and nuclear pool of β-catenin transduces signals in Wnt
canonical pathway as well as oxidative stress signaling pathway (Dietrich C et al. 2002;
Essers MA et al. 2005). The function and localization of β-catenin depends on the state of
the cell: in human keratinocytes, β-catenin is throughout the cell promoting proliferation
in subconfluent state, while β-catenin translocates to membrane to promote cell adhesion
when cells are confluent (Dietrich C et al. 2002). In endothelial cells, adherens junctions
are composed of vascular endothelial cadherin (VE-cadherin), and several protein
partners including β-catenin to connect VE-cadherin to cytoskeleton, and the dynamic
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opening and closure of adherens junctions regulate endothelial permeability and vascular
integrity (Dejana E et al. 2008). In mouse embryos where β-catenin is endothelial cellspecifically inactivated, vessels display an abnormal lumen and frequent hemorrhage,
indicating the critical role of β-catenin in vascular patterning and permeability (Cattelino
A et al. 2003). The function of β-catenin in Wnt canonical signaling has been described
previously. Additionally, Essers MA discovered a functional interaction between FOXOs
and β-catenin under oxidative stress, and then proposed that upon Wnt signaling which
turns TCF on, or upon insulin signaling that turns FOXOs off, β-catenin prefers
interacting with TCF rather than FOXO to promote cell proliferation; in contrast, under
oxidative stress conditions where FOXO activity is on, β-catenin preferentially binds to
FOXOs to induce apoptosis or quiescence (Essers MA et al. 2005; Bowerman B. 2005).

1.1.1.4.2

Wnt-PCP pathway

Polarity is one of the fundamental properties of many cells, and the tissue
polarity, or planar cell polarity (PCP) is the generation of uniform orientation of a
population of cells within a single plane, which has been demonstrated in organisms from
flies to humans (Fanto M et al. 2004; Montcouguiol M et al. 2006). Drosophila provides
numerous striking examples of PCP in its body, such as uniform organization of hairs on
the wing, and the ommatidial polarity in the eye (Fanto M et al. 2004). One noncanonical
pathway utilizes Fz and Dishvelled (Dvl), as well as many other signaling molecules to
regulate the formation of PCP, which has been proved to be crucial for Drosophila
morphogenesis and vertebrate gastrulation (Kim GH et al. 2005). In one hand, Dvl is in
association with Dishevelled-associated activator of morphogenesis (DAAM) to initiate
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Ras homologue gene-family member A (RhoA) – Rho-associated coiled-coil containing
protein kinase (ROCK) signaling cascade, which regulates cytoskeletal reorganization; in
the other hand, Dvl also activates another small GTPase Rac, both Rac and RhoA can
stimulate stress responsive Jun N-terminal kinase (JNK) signaling to regulate
cytoskeleton dynamic and cell shape (Montcouguiol M et al. 2006; Staal FJ et al. 2008)
(Figure 1.2A). The Wnt-PCP pathway also includes some other components, like protein
tyrosine kinase 7 (PTK7, which recruits Dsh), the four-pass transmembrane protein Van
Gogh (Vang, core factor in PCP pathway via recruiting Dsh), Drosophila
Flamingo/vertebrate Celsr (encoding an atypical proto-cadherine functioning in recruiting
Fz and Vang), and Ror2/Ryk receptors seem to be involved in PCP signaling transduction
(Montcouguiol M et al. 2006; Katoh M et al. 2007; Shnitsar I et al. 2008; Heisenberg CP
et al. 2002; Chen WS et al. 2008).

1.1.1.4.3

Wnt- Ca2+ pathway

The other β-catenin-independent pathway is Wnt-Ca2+ pathway, which utilizes
calcium as a second messenger in this cascade, and has been shown required for body
plan specification during development (Kohn AD et al. 2005). Fz receptors, containing
seven-pass membrane GPCR structure, appear to function in association with G proteins
(Kohn AD et al. 2005; Katanaev VL et al. 2009). When Wnt ligand (e.g. Wnt5a) binds Fz
receptor (e.g. Fz2), phospholipase C (PLC) is activated through heterotrimeric GTP
binding proteins (e.g. Gβγ subunits) and Dvl protein (Slusarski DC et al. 1997). This in
turn causes the cleavage of phosphatidylinositol-4, 5-bisphosphate to inositol
trisphophate (IP3) and diacylglycerol (DAG) (Figure 1.2B). IP3 binds to its receptor
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localized in the endoplasmic reticulum membrane and renders ER-stored calcium release
to cytoplasm,

and the increased

calcium

concentration activates PKC and

calcium/calmodulin kinase II (CamKII), which in turn stimulates Nemo-like kinase
(NLK) and transcription factor nuclear factor of activated T cells (NFAT), resulting in
cell fate regulation and cell movement (Ciani L et al. 2005; Katoh M et al. 2007; Staal FJ
et al. 2008).

1.1.1.4.4

Other Wnt signaling pathways

Ryk and Ror proteins are newly identified receptors for Wnt, which has been
previously described.

1.1.1.4.5

Dishevelled

Notably, Dishevelled (Dsh) is the protein involved in all the Wnt pathways, and
governs a lot of developmental processes of animals ranging from Hydra to humans
(Wallingford JB et al. 2005). Dsh protein contains three conserved elements in structure:
1) N- terminal DIX (Dishevelled/Axin) domain featuring a lot of α-helix; 2) central PDZ
(PSD-95, DLG, ZO1) domain with a hydrophobic cleft responsible for binding to other
proteins; and 3) DEP (Dishevelled, EGL-10, Pleckstrin) domain with a bundle of three αhelices (Wallingford JB et al. 2005). And the unique structure of Dvl proteins provides
docking sites for a diverse set of protein kinases, phosphatases, adaptor proteins, G
proteins and scaffolds, and as a “toolbox” for Wnt signaling, Dsh involves in different
signaling with distinct domains (Malbon CC et al. 2006). In canonical β-catenin pathway,
Dvl-associated proteins include Fz1, Axin, CK1, GSK-binding protein/FRAT (preventing

14

β-catenin phosphorylation), Dapper (promoting Dvl degradation) and IDAX (competing
with Axin for binding Dvl); in Wnt-PCP pathway, Dvl interacting proteins include Fz1,
Go, DAAM, Vang, Diego (sequestering Dsh to Fz/PCP pathway), Prickle, Rac1; in WntCa2+ pathway, the interacting partners of Dvl include Fz2, Go/Gt (Wallingford JB et al.
2005; Malbon CC et al. 2006; van Amerongen R et al. 2005; Gao X et al. 2008; Hino S et
al. 2001; Wu J et al. 2008). In addition, Wnt3a has been shown to induce Dvl
phosphorylation via CKI, and CKI activates Wnt pathway, suggesting that CKI-mediated
Dvl phosphorylation might be capable of transducing Wnt cascade (McKay RM et al.
2001).

1.1.1.4.6 The activation/inhibition of Wnt signaling

Some alternative ligands for Fz/LRP receptors and alternative receptors for Wnts
can activate Wnt cascade and serve as the agonists of Wnt signaling. Norrin-Fz4 pair
activates the canonical Wnt cascade in an LRP5/6-dependent manner (Xu Q et al. 2004).
Other ligands like R-spondin and Ryk receptor, also activate canonical β-catenin/TCF
pathway (Hendrickx M et al. 2008; Lu W et al. 2004). Moreover, Lithium serves as an
activator of canonical β-catenin/TCF signaling through inhibited GSK-3β (Wexler EM et
al. 2008).

However, there are some other alternative ligands/receptors inhibiting Wnt
cascades and they function as antagonists in Wnt signaling. Soluble Frizzled-related
proteins (sFRPs) are the largest family of Wnt antagonists that contain a cysteine-rich
domain (CRD) which resembles the ligand-binding domain of Fzs. sFRPs directly bind to
both Wnts and Fz receptors, and thus might have dual effect: antagonist of Wnt signaling
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but agonist for specific Fz-signaling pathway or Fz-functions, (Clevers H. 2006;
Bovolenta P et al. 2008). The inhibitory function of sFRPs may be caused either by
interaction and sequestration of Wnts from Fzs or formation of nonfunctional complexes
with Fz receptor (Bafico A et al. 1999). But sFRPs was shown to interact with Fz2 and
regulate the growth of retinal ganglion cell axons, implying that sFRPs might activate
canonical Wnt signaling in some cases (Rodriguez et al. 2005).

Unlike sFRPs, there are some Wnt inhibitors functioning through LRPs. Secreted
Dkk-1 blocks activation of the Wnt signaling cascade by interacting with LRP5/6 instead
of Wnts per se, which in turn, crosslinks LRP6 to Kremens, leading to the formation of a
ternary complex including Kremen (Krm), DKK and LRP5/6 and facilitating the
internalization of LRP6 from the cell surface, which in turn, inhibits the downstream βcatenin-TCF signaling the internalization of LRP (Hendrickx M et al. 2008; Nakamura T
et al. 2008). Krm was originally isolated as a novel type I transmembrane protein
containing an extracellular kringle domain which is a homologous triple-disulfide-linked
peptide region (Nakamura T et al. 2008). Both Krm1 and Krm2 were shown to be the
high affinity receptors for secreted Dkk (Mao B et al. 2002). Another example is
SOST/Sclerostin: SOST binds to both LRP5 and LRP6, destroying the formation of FzLRP complex in the presence of Wnt1, hence blocking the Wnt1-β-catenin signaling
(Hendrickx M et al. 2008). In addition, Ror receptors interacts with Wnt5a via its CRD,
and then activates JNK pathway and/or inhibits β-catenin-TCF pathway (Oishi I et al.
2003). Ror also has other ways to signal, such as sequestering Wnt ligands, interacting
with Van Gogh to affect cell polarity, forming dimers to promote osteoblast
differentiation (Green JL et al. 2008).
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However, WISE turned out to activate or inhibit Wnt signaling in a contextdependent manner: Wise activates the Wnt-β-catenin pathway in animal cap; whereas
Wise blocks Wnt8-induced secondary axis formation (Itasaki Net al. 2003).

Also, Wnt ligand is not limited to only one pathway, so one question arises that
how different Wnt ligands preferentially choose these pathways? The specificity may be
achieved by the context of receptors and the availability of coreceptors and/or other
signaling molecules (Kohn AD et al. 2005). For example: Wnt5a interacts with Fz2
preferentially activating Wnt-Ca2+ cascade (Slusarski DC et al. 1997); in association with
LRP5, Wnt5a binds Fz4 to stimulate Wnt- β-catenin pathway (Verkaar F et al. 2009);
however, in the presence of coreceptors like collagen triple helix repeat containing 1
(Cthrc1) and Ror2, Wnt5a bound with Fz5 or 6 can initiate Wnt-PCP signaling pathway
(Yamamoto S et al. 2008). And Table 1 shows more examples of different
Wnt/Fz/coreceptor interaction which specifically induces distinct downstream signaling
cascade.

1.1.2

Functions of Wnts and Wnt signaling

Together with fibroblast growth factor (FGF) pathway, Notch signaling,
transforming growth factor (TGF) β pathway and Hedgehog signaling, Wnt signaling is
recognized as one of the handful powerful pathways that control basic development and
organism homeostasis. (Cadigan KM et al. 1997. Wang J et al. 2007. Clevers H. 2006
and Staal FJ et al. 2008)

17

Wnts and Wnt signaling are involved in virtually every aspect of embryogenesis
and organogenesis, including gastrulation, implantation, the patterning of brain and spin
cord, heart formation, hematopoiesis, and the development of liver, limb, kidney, lung,
skin and gastrointestinal tract. In addition, the non-canonical Wnt pathways such as WntPCP pathway and Wnt-Ca2+ pathway also play a key role in cell polarity and cell
movement, leading to the regulation of tissue polarity establishment and morphogenesis
by Wnts (Wang J et al. 2007). Knockout mouse models have been proved to be a
powerful tool to investigate the role of Wnt signal transduction in mammalian patterning,
physiological conditions and disease development (van Amerongen R et al. 2006).
Table1 summarizes the roles of individual Wnt in embryogenic development and the
phenotypes in available knockout mice. Also, Wnts and Wnt signaling also regulate selfrenewal and repair processes in numerous adult tissues, such as gut, hair follicle, skin,
and bone (Clevers H. 2006).

The roles of Wnts and Wnt signaling in development result from their function in
controlling cell fate, including cell proliferation or self-renewal, differentiation, apoptosis
and senescence, which has been extrapolated to many different systems, such as intestine,
hematopoiesis, CNS, skin, liver, adipogenesis, and bone (Hayward P et al. 2008).

Wnt/β-catenin signaling has been shown the dominant force in controlling cell
fate along the crypt-villus axis in small intestine. In neonatal mice lacking TCF4, the
differentiated villus epithelium appears unaffected, but crypt progenitor compartment is
entirely absent, indicating physiological Wnt signaling maintains the crypt progenitor
compartment (Radtke F et al. 2005). Also, Wnt3a treatment can promote cell
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proliferation, reduce apoptosis, and inhibit osteogenic differentiation of multipotential
adult mesenchymal stem cells (MSCs) (Boland GM et al. 2004). For midbrain
dopaminergic development, Wnt3a can increase the proliferation of precursor cells,
whereas purified Wnt5a induces immature primary precursors into dopaminergic neurons
(Schulte G et al. 2005). Overexpression of constitutively active β-catenin expands the
pool of hematopoietic stem cells (HSCs) in vitro and maintains their immature phenotype
(Reya T et al. 2003).

Wnt signaling is also a critical modulator in adipocyte differentiation. NIH3T3-L1
preadipocytes treated with lithium or infected with Wnt1 or stabilized β-catenin showed
abolished differentiation to adipocytes, which was rescued by PPARγ or C/EBPα
infection; canonical Wnt10b had similar inhibitory effect on adipogenesis in vitro (Ross
SE et al. 2000). Christodoulides C et al gave the first evidence of the possible role of Wnt
signaling in human early adipogenesis: they found DKK1, a Wnt antagonist, had a
transient upregulation in expression during human adipogenesis and ectopic expression of
DKK1 inhibited Wnt-β-catenin activation and promoted preadipocyte differentiation
(Christodoulides C et al. 2006).

Moreover, Wnts and Wnt signaling are also involved in cell senescence and
aging. Wnt/β-catenin signaling was shown to be enhanced in muscle from aged mice and
in myogenic progenitors exposed to aged serum; and the cell fate conversion of myogenic
progenitor by aging was also mediated by Wnt/β-catenin signaling (Brack AS et al.
2007). Increased Wnt/β-catenin signaling induced cell senescence both in vivo and in
vitro, which may be via klotho protein, because klotho is an antagonist of Wnt/β-catenin
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signaling, and mice lacking klotho displayed accelerated aging phenotypes (Liu H et al.
2007). Additionally, Lithium, the inhibitor of GSK-3β was found to induce endothelial
cell senescence via stabilizing p53 and upregulating the expression of matrix
metalloproteinase-1 (Mao CD et al. 2001; Struewing IT et al. 2009).

Besides, Wnts and Wnt signaling are also implicated in cell polarity and
orientation. The uniform orientation of mechanosensory hair cells in the inner ear is a
good example for vertebrate cell polarity (Montcouquiol M et al. 2006). In vivo study
showed that mutation in Vangl2 led to significant defects in the polarization of
stereociliary bundles in mouse cochlea due to the disruptions in the orientation of
movement of the kinocilium in hair cells, indicating Vangl2 is a core Wnt-PCP factor
with a crucial role in the generation of uniform bundle orientation (Montcouquiol M et al.
2003). In the presence of a chemokine gradient, Wnt5a increased the percentage of cells
with the Wnt-mediated receptor-actin-myosin polarity (W-RAMP) structure which was
accumulated asymmetricaly at the cell periphery, triggering membrane contractility and
nuclear movement in the direction of membrane retraction; and this effect by Wnt5a was
found via reciprocal interaction with actin and myosin IIB, as well as the involvement of
small GTPase Rab4 and RhoB (Witze ES et al. 2008). Also, Wnt11 was demonstrated to
play a key role in the oriented elongation of the myocytes during early chick myogenesis
through JNK, because Wnt11 SiRNA showed a failed or mis-oriented enlongation, and
ectopic Wnt11 significantly promoted myocyte orientation (Gros J et al. 2009).

In addition, Wnts and Wnt signaling are also important for cell migration. Wnt5a
was shown upregulated in T cells upon the treatment of CXC chemokine ligand (CXCL)-
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12, and Wnt5a potentiated CXCL-12-stimulated T cell migration through PKC activation
(Ghosh MC et al. 2009). Wnt3a, a canonical Wnt/β-catenin signaling activator, not only
induced HUVEC proliferation, but it also induced HUVEC migration, accompanied with
the upregulation of the target genes such as c-myc, Tie-2 and GJA-1 (Samarzija I et al.
2009). Moreover, intestinal epithelial cells incubated in conditioned media from Wnt11secreting cells were shown to be stimulated in cell proliferation and cell migration, as
well as increased activity of PKC and CAMKII, with abnormal distribution of E-cadherin
(Ouko L et al. 2004).

The role of Wnts in cell apoptosis will be discussed in detail later.

1.1.3

Wnt and diseases
Due to the crucial roles in organism development and postnatal homeostasis,

Wnts and Wnt signaling are highly related to diseases: germline mutations in the Wnt
pathway lead to certain hereditary diseases, and somatic mutations are associated with
cancer and other human disorders (Clevers H. 2006).

1.1.3.1 Cancer
Normally, Wnt/β-catenin signaling tightly controls the proliferation and renewal
of stem cells and progenitors during the development and regeneration of tissues, like
intestinal crypt, hair follicles, and hematopoietic systems. Nonetheless, deregulated Wnt
signaling can cause aberrant expansion of the stem cell pool and constitutive activation of
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stem cell function on progenitor cells, promoting tumor formation in these tissues,
including colon cancer, hair follicle tumors and leukemia (Reya T et al. 2005. Clevers H.
2006). It is noteworthy that without the involvement of some key components of Wnt
signaling, Wnt ligands alone are rarely related to the activation of Wnt pathway during
carcinogenesis (Giles RH et al. 2003).
1.1.3.1.1

Colon cancer

Physiological Wnt signaling appears to be indispensible for the establishment of
crypt stem/progenitor compartment in small intestine epithelium; yet, when APC is
mutated, the stablized β-catenin activates crypt stem/progenitor cell proliferation and
causes tumor formation (Clevers H. 2006). APC was first identified as a tumor
suppressor in human colon cancer, because the germline mutation of APC (mainly
truncation) is responsible for a hereditary cancer called Familiar Adenomatous Polyposis
(FAP), which progresses to colorectal adenomas, and malignant adenocarcinomas, as
well as tumors elsewhere like gastrointestinal tract, brain and thyroid (Polakis P et al.
1997). Not only in FAP, a rare form of cancer, APC mutations are also found in
approximately 85% of somatic colorectal cancer, which is the most common human
neoplasms (Bienz M et al. 2000 and Giles RH et al. 2003). However, recent studies
revealed that loss of APC alone is not sufficient to induce tumor formation in zebrafish,
but contribute to adenoma initiation as the first step, while KRAS-mediated nuclear
localization of β-catenin is required for intestinal cell proliferation as the second step in
promoting adenoma progression to carcinomas (Phelps RA et al. 2009). Besides Wnt
signaling components, Wnt2 was shown upregulated in 74 cases out of 120 colorectal
cancers, and Wnt2 may be associated with the development rather than progression of
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colorectal cancers (Park JK et al. 2009). Moreover, Wnt2 was also shown to be
overexpressed in other digestive neoplasms like gastric cancer and esophageal
carcinomas (Vider BZ et al. 1996). Wnt antagonists were also found to be associated with
colorectal cancer. For sFRP-1, hypermethylation (less transcription) and down-regulated
mRNA levels were identified significantly more often in tumor samples than normal
samples (Caldwell GM et al. 2004). Moreover, DKK-1 was also found hypermethylated
in 17% primary colorectal tumor cases, and the CpG island promoter of DKK-1 was
selectively hypermethylated in advanced Duke’s stages of human colorectal neoplasms
(Aguilera O et al. 2006).
1.1.3.1.2

Skin cancer

Normal Wnt cascade in hair follicles activates epidermal stem cells in bulge area,
promoting the entry into hair lineages, and cell migration to transit-amplifying
germinative matrix, resulting in hair formation (Clevers H. 2006). Both trichofolliculoma
and pilomatricoma are tumors with elements of follicular differentiation, and they both
contain cells undergoing differentiation along hair lineages from epidermal stem cells
that reside in hair follicle (Owens DM et al. 2003). Transgenic mice expressing a
stabilized β-catenin form in the epidermis and hair follicles developed trichofolliculomalike tumors in the mouse skin, and older mice developed pilomatricoma-like lesion (Gat
U et al. 1998). This observation was also seen using tamoxifen-induced stabilized βcatenin transgenic mice which developed tumors resembling trichofolliculomas upon
continuous activation of β-catenin (Lo Celso C. et al. 2004). In addition, most
spontaneous pilomatricomas in humans carry constitutive mutations in β-catenin (Clevers
H. 2006).
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Besides hair follicle tumor, Wnts are also related to other skin cancers. In a study
with 59 primary melanoma cases, cytoplasmic Wnt5a expression is increased with
melanoma progression, and the strong Wnt5a expression is a risk factor for metastasis
and reduced survival (Da Forno PD et al. 2008). And the increased mobility of melanoma
cells by Wnt5a is mediated through the inhibition of metastasis suppressors, such as
KISS-1 (a gene encoding kisspeptin which is a peptide ligand of a GPCR called GPR54
to block chemotaxis) , and is associated with an epithelial to mesenchymal transition
(EMT) in a PKC-dependent manner (Dissanayake SK et al. 2007).
1.1.3.1.3

Leukemia

Hematopoietic stem cells (HSCs), the best studied stem cells in human body, are
controlled by Wnt cascade in their self-renewal and normal growth (Reya T et al. 2005).
Moreover, like stem/progenitor cells in crypt or hair follicles, HSCs can also be the target
of mutational Wnt/β-catenin signaling to cause leukemia (Clevers H. 2006). Wnt5a null
mice showed 35% increase in the proportion of B lineage cells and 55% increase of B
cell number, and Wnt5a heterozygous mice developed B cell lymphomas and chronic
myeloid leukemia, indicating Wnt5a is able to suppress hematopoietic malignancies
(Liang H et al. 2003). Jamieson CH and coworkers reported that the granulocytemacrophage progenitors from patients with chronic myelogenous leukemia (CML)
displayed striking increase of nuclear β-catenin and LEF/TCF activity compared to
normal cells (Jamieson CH et al. 2004). Wnt signaling is also related to acute myeloid
leukemia (AML) since AML fusion proteins induced TCF/LEF target gene transcription
in vitro (Müller-Tidow C et al. 2004). Moreover, some evidences support that abnormal
Wnt signaling is associated with acute lymphoblastic leukemia (ALL); e.g. conditional
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activation of β-catenin by deleting exon3 in mice developed aggressive thymic
lymphomas, and this process was not Notch signaling required, which is the first report
demonstrating that aberrant Wnt/β-catenin cascade alone in the thymus can lead to
leukemia (Guo Z et al. 2007). Similarly, mice transplanted with bone marrow cells
expressing constitutively active mutant of LEF-1 developed B lymphoblastic leukemia
and AML at 12 months, proving the crucial role of LEF-1 activity in normal
lymphopoiesis (Petropoulos K et al. 2008). Besides, DKK1 was found upregulated in the
serum from patients with diagnosed myeloma (Tian E et al. 2003).
1.1.3.1.4

Other cancers

Wnt-1 was found as an oncogene activated by integration with tumor virus
MMTV to induce murine breast cancer (Nusse R et al. 1982). Moreover, Axin mutation
has been found in hepatocellular carcinoma (HCC) cell lines and primary HCCs (Satoh S
et al. 2000), and mice with deletion of APC in liver developed HCC (Colnot S et al.
2004), demonstrating the association of activated Wnt-β-catenin signaling with HCC.
Prostate cancer samples were also shown to carry β-catenin mutations (Gersterin AV et
al. 2002). Additionally, in Wilms Tumor (WT) which is a kidney cancer, genetic
abnormalities were identified, such as mutations in β-catenin and WT gene on the Xchrmosome (WTX), a tumor suppressor preventing β-catenin from translocating to the
nucleus (Nusse R. 2007).
The effect of Wnt5a in tumor development and progression is dependent on the
cancer types: as discussed previously, Wnt5a promotes metastasis in melanoma;
however, Wnt5a transfection can suppress cell proliferation, migration, invasiveness and
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clonogenicity in thyroid tumor cell lines, which is associated with the inhibition of
canonical β-catenin signaling, implying that Wnt5a has tumor suppressor activity in
thyroid carcinoma, which is consistent with the finding in B cell lymphoma
(Kremenevskaja N et al. 2005; Liang H et al. 2003). Furthermore, the up-regulated
expression of Wnt5a is related to the early stages of lip carcinoma (Xavier FC et al.
2009).

1.1.3.2 Alzheimer’s Disease (AD)
Wnt signaling plays an important role not only in the early phases of the nervous
system development during embryogenesis, but also in self-renewal processes, including
maintenance of adult neural stem cells, refinement of neuronal circuits (axon, dendrites,
synapse) and adult hippocampal neurogenesis (Toledo EM et al. 2008; Michaelidis TM et
al. 2008). AD is known as a neurodegenerative disease characterized by diffuse loss of
neurons, protein deposits including neurofibrillary tangoes and amyloid plaques (De
Ferrari GV et al. 2000). The activation of Wnt/β-catenin signaling has shown
neuroprotective roles in AD models. Wnt3a prevented Aβ-induced neurotoxicity in
hippocampal neurons (Alvarez AR et al. 2004). Therapeutic concentrations of lithium
(GSK3β inhibitor) treatment dramatically reduced the production of Aβ peptides in vitro
and in vivo, which was achieved by interfering with the cleavage of amyloid precursor
protein (APP) (Phiel CJ et al. 2003). Furthermore, De Ferrari GV and coworkers reported
that LRP6 single nucleotide polymorphisms (SNPs) were associated with late-onset AD
in both muticenter case-control and family-based series, and Ile1062 --> Val substitution
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which reduced β-catenin activation was also found, showing the involvement of Wnt
signaling components in AD (De Ferrari GV et al. 2007). Furthermore, presenilin 1 (PS1)
is a causative gene product of familial AD, and GSK-3β-mediated phosphorylation of
PS1 inhibited its interaction with N-cadherin, resulting in impaired activation of cell-cell
contact-induced Akt survival pathway, suggesting the possible involvement in reduced
neuronal viability and synaptic plasticity (Uemura K et al. 2007). In the other hand, GSK3β-mediated PS1 phosphorylation induced a structural change of PS1, which in turn
reduced PS1-β-catenin interaction and led to decreased phosphorylation and degradation
of β-catenin, resulting in enhanced β-catenin nuclear signaling (Prager K et al. 2007)

1.1.3.3 Metabolic syndrome
Canonical Wnt signaling activity was observed in pancreatic β cell lines and
mature islets (Welters HJ et al. 2008), and some evidences support that Wnt/β-catenin
signaling may regulate β cell function. Wnt10b transgenic mice showed improved
glucose tolerance and insulin sensitivity (Longo KA. 2004). Additionally, LRP5 deficient
mice displayed impaired glucose-induced insulin secretion under chow diet, which was
restored by the infection with adenovirus encoding LRP5; also LRP5+/+ islets had
increased insulin secretion pretreated with Wnt3a or 5a conditioned media (Fujino T et al.
2003).
Wnt5b was shown to be associated with type II diabetes in Japanese population
(Kanazawa A et al. 2004). And another studies demonstrated the association of
transcription factor 7 like – 2 (TCF7L2, previously TCF4) polymorphism with the risk in
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type 2 diabetes in three Caucasian cohorts. In Grant SF’s study, a microsatellite,
DG10S478, located in the intron 3 of TCF7L2, was found to be related to type 2 diabetes,
and the homozygous carriers of at-risk allele, a DG10S478 composite had around 2.4
times more risk of type 2 diabetes than noncarriers (Grant SF et al. 2006). Then a similar
study was done in Amish population, and the data further indicated that TCF7L2 variants
likely influence insulin sensitivity (Damcott CM et al. 2006).
For in vivo studies, FABP4-Wnt10b transgenic mice showed less adipose tissue
and more resistance to diet-induced obesity (Longo KA. 2004) compared to wildtype
mice; and under ob/ob or agouti background, FABP4-Wnt10b transgenic mice still
displayed reduced body weight, tissue weight and white adipose tissue (Wright WS et al.
2007). All these studies indicate that Wnt signaling inhibit obesity formation in mice.

1.1.3.4 Cardiovascular diseases
Wnt cascade is of significance in normal heart development, and abnormal Wnt
signaling has been shown to be associated with several heart diseases (van de Schans VA
et al. 2008). Using immunohistochemical analysis, coincident expression of both Wnt5a
and TLR-4 was found in murine and human atherosclerotic lesions (Christman MA et al.
2008). Conditional deletion of β-catenin in mouse cardiomyocytes resulted in attenuation
of cardiac hypertrophy induced by pressure, suggesting β-catenin is the regulator of
cardiomyocyte growth (Chen X et al. 2006). Mani A et al characterized a family with
extraordinary prevalence of early coronary artery disease (CAD), also featuring
metabolic syndromes (hyperglycemia, hyperlipidemia, and hypertension). A missense
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mutation (R611C) in LRP6 gene was then identified in most family members through
genotyping studies, linking Wnt signaling to the development of CAD (Mani A et al.
2007).

1.1.3.5 Bone diseases
Bone mass is regulated by the balance between osteoblasts (bone-forming cells)
and osteoclasts (bone-resorbing cells), and osteoporosis comes from the imbalance
between bone resorption and bone formation.

Wnt/β-catenin signaling promotes

osteoblasts expansion and function, playing a particularly important role in bone biology
(Westendoff JJ et al. 2004; Krishnan V et al. 2006). Mutation of human LRP5 was found
to cause an autosomal recessive disorder osteoporosis-pseudoglioma syndrome (OPPG),
featuring low bone mineral density (Gong Y et al. 2001). Also, deletion of sFRP-1 led to
increased trabecular bone formation as well as decreased apoptotic osteoblasts and
osteocytes in adult mice, and to stimulate osteoclastogenesis in vitro (Bodine PV et al.
2004). Similarly, transgenic mice with expression of Wnt10b in marrow also showed
increased bone mass and strength, more resistance to bone loss due to aging or estrogen
deficiency, further suggesting that the involvement of Wnt/β-catenin signaling in bone
mass, and the underlying mechanism could be that Wnt10b inhibits PPARγ –mediated
adipogenic program and shifts the cell fate of bipotential mesenchymal precursors to the
osteoblast lineage (Bennett CN et al. 2005).
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1.1.4

Wnt and vasculature

1.1.4.1 Wnt and vascular biology
Genetic deletions or mutations of Wnt or Wnts signaling components provide the
evidences that Wnt is required for vascular development and function. Wnt2 deficient
mice died perinatally due to the severe placental defects with visible hematomas,
abnormal large maternal blood pools, and reduced number of fetal capillaries, suggesting
Wnt2 is indispensible for the proper vascularization of mouse placenta development
(Monkley SJ et al. 1996). Wnt7b is another example: germline knockout of Wnt7b in
mice led to hemorrhages surrounding the pulmonary vessels caused by defects in the
differentiation (aberrant expression of smooth muscle α-actin) and maintenance of
vascular smooth muscle cells (more apoptosis of vascular smooth muscle cells) (Shu W
et al. 2002). Another study showed that Wnt7b mutant mice failed to drive hyaloids
vessel regression in the developing eye, which is an indication of correlation between
Wnt7b and cell apoptosis required for vasculature (Lobov IB et al. 2005). Moreover, Fz5
conventional knockout mice displayed defective yolk sac and placental vasculature
(Ishikawa T. 2001), further suggesting the regulatory role of Wnt signaling in vessel
development. More recently, Stenman JM et al developed Wnt7a/7b double mutant mice
and showed that these mice had a severe CNS-specific hemorrhaging phenotype due to
endothelial abnormalities, strongly indicating that Wnt7a/7b and canonical Wnt signaling
directly target vascular endothelium to promote vasculature formation in the central
nervous system in mouse embryos and to initiate the development of blood-brain barrier
(Stenman JM et al. 2008).
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1.1.4.2 Wnts and vascular diseases
The discovery of association between Wnt/β-catenin signaling and human
vascular disease was with Fz4 mutations in familial exudative vitreoretinopathy (FEVR),
a hereditary ocular disorder characterized by excessive vascular branching due to failure
of vessel regression, retina detachments and leaky vasculature (Miyakubo H et al. 1982;
Robitaille J et al. 2002; Masckauchán TN et al. 2006). Another type of disease related to
Fz4 is Norrie disease, which is a sex-linked, congenital disorder with fibrous and vascular
changes of the retina causing visual impairment (Zerlin M et al. 2008). Xu Q et al also
reported that Fz4 null mice displayed intraretinal vascular defects in adulthood (Xu Q et
al. 2004), indicating the critical role of Fz4 in retina vasculature. Furthermore, unlike Fz5
whole-body knockout mice described before, Fz5 retina-specific knockout mice
developed phenotypes similar to human eye disease persistent hyperplastic primary
vitreous (PHPV), characterized by accumulation of retrolental tissue, failure of vessel
regression, and abnormal retina morphogenesis (Zhang J et al. 2008), also proving that
abnormalities in Wnts and Wnt//β-catenin signaling are responsible for vascular
pathogenesis.
In zebrafish, Wnt13 (Wnt2bb) was detected in posterior lateral plate mesoderm
(LPM) during somitogenesis, predominantly in cells who are committed to endothelial

and hematopoietic lineages, and expressed in the developing vasculature, endocardium,
atrioventricular valve in the clater stages (Ober EA et al. 2006). Additionally, all three
isoforms of Wnt13 have been found in differentiated endothelial cells, (Struewing IT et
al. 2006), and the differential function of Wnt13 isoforms in endothelial cells will be
discussed in following chapters.
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Figure 1.1.1 Wnt/β-catenin canonical pathways. A) In the absence of Wnts (e.g. Wnt1,
3a), the scaffold Axin assembles the destruction complex of β-catenin which contains
APC, GSK3, CK1 and β-catenin. In this complex, β-catenin is sequentially
phosphorylated by CK1 and GSK3, and then recognized by β-TrCP, a component of E3
ligase which conjugates β-catenin with ubiquitin, resulting in the degradation of β-catenin
by proteasome. In the nucleus, the binding of transcription repressor Groucho to
transcription factors T cell factor (TCF) /lymphoid enhancer factor (LEF) leads to the
inhibition of Wnt-β-catenin signaling target gene transcription. B) In the presence of
Wnts (e.g. Wnt1, 3a), Axin is recruited to cell surface through LRP5/6 phosphorylation.
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Without the formation of destructive complex, the phosphorylation and degradation of βcatenin is thereby inhibited, so β-catenin is stabilized and accumulated in the cytosol, and
then translocates to the nucleus to displace Grouncho and activate TCF transcription
factor to initiate Wnt target gene transcription (He X et al. 2004).
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Figure 1.1.2 Noncanonical Wnt pathways. A) Wnt-PCP pathway activates RhoA and Rac
through Dvl and DAAM. Subsequently ROCK and JNK signaling are initiated to regulate
cytoskeletal remodeling, cell adhesion and mobility. B) Wnt-Ca2+ pathway is mediated
via heterotrimeric G protein and Dvl, which in turn activates PLC to produce IP3 and
DAG, leading to Ca2+ release from ER and the activation of PKC, CAMKII, and
phosphatase Calcineurin, leading to the regulation of cell fate and the change of cell
movement (Staal FJ et al. 2008).
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Table 1 The receptors/coreceptors, signaling pathways, phenotypes of knockout mice and
other features of individual Wnts

Wnt1
(Wg)

Wnt2

Wnt3

Bound receptors
(coreceptors) and
signaling
Fz1, 2, 5 (LRP6):
canonical/β-catenin
(Cong F et al.2004)
Fz9 (Wang YK et al.
1997)
Fz4, 7, 8 (Bhabot P
et al.1996)
Fz1, 4, 5, 9:
canonical/β-catenin
(Gazit A et al. 1999;
Ishikawa T et al.
2001; Karasawa T
et al. 2002; Klein D
et al. 2008)

Secreted

Fz1, 7: canonical/βcatenin (Gazit A et
al. 1999; Kim M et
al. 2008)

Yes
(Kobune
M et al.
2007)

Isoforms

Phenotypes of
Knockout mice

Yes
Not reported yet
(Smolich
BD et al.
1993)

Prenatal lethality or
antaxia if survival
(deficiency in midbrain
and
cerebellum)
(Thomas KR et al.
1990)

Yes
3
different
(Klein D isoforms: variant
et
al. 1 and variant 2
2008)
differ in Nterminus, while
variant 3 only
contains partial
mRNA
with
exon1 and 2
(Genebank)

Perinatal lethality or
reduced
birthweight
due to placental defects
with
visible
hematomas, abnormal
large maternal blood
pools, and reduced
number
of
fetal
capillaries (Monkley SJ
et al. 1996); severe
lung hypoplasia with
dilated
vascular
endothelial
plexus
(Goss AM et al. 2009)
Embryonic lethality
with no primitive streak
formation (sign of
anterior-posterior axis)
before gastrulation (Liu
P et al. 1999)
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Not reported yet

Table 1 (continued)

Wnt3a

Wnt4

Bound receptors
(coreceptors) and
signaling
Fz1, 2: canonical/βcatenin (Gazit A et
al. 1999; Verkaar F
et al. 2009)
Fz1: Go activation
(Katanaev VL et al.
2009)
Fz5,
6
[protein
collagen triple helix
repeat containing 1
(Cthrc1),
Ror2]:
Wnt-PCP
(Yamamoto S et al.
2008)
Fz8 (LRP6) (Cong F
et al.2004)
Fz1, 2: canonical/βcatenin (Harris KE.
2007)
Fz6: non-canonical
(Lyons JP et al.
2004)
Fz3: (Lyuksyutova
AI et al. 2003)
( Four jointed, Fj):
Wnt-PCP (Lim J et
al.2005)

Secreted

Isoforms

Phenotypes of
Knockout mice

Yes(Smoli Wnt3a variant 1
ch BD et and
Wnt3a
al. 1993)
variant
2
(chicken): differ
in
N-terminus
(exon 1). Wnt3a
variant 2 induces
β-catenin
activity. (Narita
T. 2007)

Embryonic
lethality
due to axial truncation
as well as defective
development of dorsal
mesoderm and CNS
morphogenesis (Takada
S et al. 1994)

Yes
Not reported yet
(Smolich
BD et al.
1993;
Stark K et
al. 1994)

Perinatal lethality with
failure
in
Kidney
tubulogenesis (Stark K
et al. 1994);
Loss
of
female
productive
duct
formation (Vainio S et
al. 1999);
Defect
in
testis
differentiation (JeaysWard K. 2004)
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Table 1 (continued)

Wnt5a

Wnt5b

Wnt6

Bound receptors
(coreceptors) and
signaling
Fz1:
unknown
(Gazit A et al. 1999)
Fz1,6,7:
Go
activation (Katanaev
VL et al. 2009)
Fz2: Wnt-Ca2+ via
Gβγ (Slusarski DC
et al. 1997)
Fz4
(LRP5):
canonical/β-catenin
(Verkaar F et al.
2009)
Fz5:
canonical/βcatenin (He X et al.
1997)
Fz5, 6 (Cthrc1,
Ror2):
Wnt-PCP
(Yamamoto S et al.
2008)
Fz1: Go activation
(Katanaev VL et al.
2009)
Fz7:
Myogenesis
(Linker C et al.
2003)
Unknown: Wnt-PCP
(Carreira-Barbosa F
et al. 2003)
Fz7:
canonical/βcatenin? (Linker C et
al. 2005)
Fz8
(LRP5):
canonical/β-catenin
(Semenov MV et al.
2006)

Secreted

Isoforms

Yes(Smoli Not reported yet
ch BD et
al. 1993)

Yes
(Smolich
BD et al.
1993)

Neonatal
lethality;
defective outgrowth of
limbs, face, ears and
genitors
due
to
disability of anteriorposterior (A-P) axis
extension in embryos
(Yamaguchi TP et al.
1999);
Abnormal
lung
morphogenesis (Li C et
al. 2002);
Impaired
pituitary
gland shape (Cha KB et
al. 2004)

Human Wnt5b Viable
(van
variant 1 and 2: Amerongen R et al.
differ in 5’-UTR 2006)
at mRNA level,
encoding
the
same
protein
(pubmed)

Yes
Not reported yet
(Smolich
BD et al.
1993)
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Phenotypes of
Knockout mice

Viable
(van
Amerongen R et al.
2006)

Table 1 (continued)

Wnt7a

Wnt7b

Bound receptors
(coreceptors) and
signaling
Fz1,6: Go activation
(Katanaev VL et al.
2009)
Fz5,
10:
canonical/β-catenin
(Carmon KS et al.
2008b; Kawakami Y
et al. 2000)
Fz10: Wnt-PCP (
Carmon KS et al.
2008a)

Secreted

Fz1, 10 (LRP5):
canonical/β-catenin
(Wang Z et al. 2005)
Fz4:
canonical/βcatenin (Lobov IB et
al. 2005)

Yes
(Smolich
BD et al.
1993)

Isoforms

Yes
Not reported yet
(Smolich
BD et al.
1993)
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Wnt7b-1
and
Wnt7b-2 (mouse
and
chicken):
differ in Nterminus (exon
1) (Rajagopal J
et al. 2008 and
Fokina VM et al.
2006)

Phenotypes of
Knockout mice
Lack
of
anteriorposterior and dorsalvertral axis patterning
of limb (Parr BA et
al.1995);
Female mice were
sterile
due
to
posteriorized
productive
tracts
(Miller C et al. 1998);
Delayed morphological
maturation
in
cerebellum (Hall AC et
al. 2000)
Embryonic
lethality
due
to
placental
abnormalities (exon 3
deletion) (Parr BA et
al. 2001)
Perinatal lethality due
to respiratory failure
(defects
in
mesenchymal
proliferation and vessel
development) (exon 1
deletion) (Shu W et al.
2002)
Some neonatal lethality
while viable mice
showing fertile and
failure of hyaloids
vessel regression (exon
1 deletion) (Lobov IB
et al. 2005)

Table 1 (continued)

Wnt8a

Wnt8b

Wnt9a
(Wnt14)

Bound receptors
(coreceptors) and
signaling
Fz1:
canonical/βcatenin
(YangSnyder J. 1996)
Fz4,5,7
(LRP6):
canonical/β-catenin
(Holmen SL et al.
2002)
Fz2,8 (Hsieh JC.
1999a)
Fz8a: canonical/βcatenin (Kim SH et
al. 2002; Cavodeassi
F et al. 2005)
Fz4,
7,
9:
canonical/β-catenin
(Matsumoto K et al.
2008)

Secreted

Isoforms

Yes
Not
(Hsieh JC. yet
1999b)

Phenotypes of
Knockout mice

reported Viable
(van
Amerongen R et al.
2006)

Yes
Not
reported
(Katoh M yet
et
al.
2005)
Yes
( Not reported yet
Matsumot
o K et al.
2008)

Viable
(van
Amerongen R et al.
2006)
Neonatal
lethality;
skeletal defects and
chrondroid metaplasia
in some joints (Später D
et al. 2006)

Wnt9b
(Wnt15)

Fz5 (LRP6), Fz8:
canonical/β-catenin
(Liu C et al. 2008)

Wnt10a

Not
yet
Fz8
(LRP5): Yes (Ouji 2
isoforms:
canonical/β-catenin
Y et al. differ in a central
(Semenov MV et al. 2006)
region
Exon
2006)
3(Wang J et al.
Fz5:
canonical/β1996)
catenin (Ishikawa T
et al. 2001)

Wnt10b
(Wnt12)

Not
yet

39

reported Neonatal lethality with
defective
urogenital
system (Carroll TJ et
al. 2005)
reported Unknown
More
myogenic
differentiation
of
myoblasts
and
increased activation of
adipogenic program in
muscle injury (Vertino
AM et al. 2005);
Reduced
bone
formation rate (Bennett
CN et al. 2007)

Table 1 (continued)

Wnt11

Wnt13
(Wnt2b)

Wnt16

Bound receptors
(coreceptors) and
signaling
Fz5
(LRP6):
canonical/β-catenin
(Holmen SL et al.
2002)
Fz5:
antagonize
canonical/β-catenin
(Cavodeassi F et al.
2005)
Fz7 (Ryk): Wnt-PCP
(Djiane A et al.
2000; Kim GH et al.
2008)
Fz7(receptor
for
Wnt13A): unknown
(Struewing IT et al.
2007)

Secreted

Isoforms

Yes
Not
(Kikuchi
yet
A et al.
2007)

Yes
(Wnt13A)
(Struewin
g IT et al.
2006)

Unknow receptors:
canonical/β-catenin
(Mazieres J et al.
2005)
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Phenotypes of
Knockout mice

reported Perinatal lethality with
smaller size of kidney
due
to
defective
ureteric
branching
patterning (Majumdar
A et al. 2003)

Wnt13A, Wnt13B
and
Wnt13C
(human): differ in
N-terminus
(Katoh
M
et
al.2000
and
Struewing IT et
al. 2006)
Wnt16a, Wnt16b
(human): differ in
N-terminus (exon
1) (Fear MW et
al. 2000)

Viable
(van
Amerongen R et al.
2006)
Wnt2/Wnt2b
double
knockout
mice:
complete lung agenesis
(Goss AM et al. 2009)
Viable
(van
Amerongen R et al.
2006)

1.2 Wnt13
1.2.1

General background
The original human Wnt13B (Wnt2b1) cDNA was firstly isolated and

characterized from human gastric cancer mRNAs by Katoh M et al in 1996. However, the
sequence of the human Wnt13B (Wnt2b1) was different than that of the Wnt13/Wnt2b
identified in mouse, chicken and xenopus; and in 2000, the mouse Wnt13/Wnt2b was
found equivalent to human Wnt13A/Wnt2b2 (Katoh M. et al. 2000). Besides Wnt13A
and Wnt13B, the human Wnt13C was also identified from endothelial cells in 2006
(Struewing IT et al. 2006).
One of the distinguished features of a few Wnts compared to most of Wnts is that
they have different isoforms which differ 1) either in N-terminus due to alternative
splicing, resulting in distinct subcellular localizations, such as Wnt3a (Narita T et al.
2007), 7b (Fokina VM et al. 2006 and Rajagopal J et al. 2008), 13(Katoh M. et al. 2000;
Struewing IT et al. 2006), and 16 (Fear MW et al. 2000); 2) or in the central region, such
as Wnt10b. Therefore Wnt13 is one of the few Wnt members with isoforms.
The Wnt13B gene is located in human chromosome 1p13 (Katoh M et al. 1996).
Due to the difference in the first or second exons, the mRNAs of Wnt13A and Wnt13B
differ in the 5’-UTR and N-terminal coding region (Katoh M. et al. 2000). Wnt13B
contains exon 1-2, 4-7, which encodes the protein of 372 amino acids including the Nterminal hydrophobic domain; while Wnt13A contains exon 3-7, encoding 391 amino
aids without this N-terminal hydrophobic domain (Katoh M. et al. 2000). The Wnt13B
mRNA was detected in heart, brain, placenta, lung, prostate, testis, ovary, small intestine,
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kidney, and colon (Katoh M et al. 1996). The Wnt13A mRNA was also detected in fetal
brain, fetal lung, fetal kidney, caudate nucleus, testis, while Wnt13B expression level was
relatively higher in fetal brain and fetal lung than in other tissues (Katoh M. et al. 2000).
Besides the discovery of human Wnt13, the Wnt13 cDNAs were also identified in
Xenopus (Wolda, SL et al. 1992), mouse (Zakin LD et al. 1998) , chicken (Jasoni C et al.
1999), zebrafish (Ng JK et al. 2002), rat (Ricken A. et al. 2002) and bovine (Struewing IT
et al. 2006; Goodwin AM et al. 2006). Indeed, the Wnt13 found in all these animal
species refers to Wnt13A, so it seems that the isoform pattern of Wnt13 only exist in
higher class of animals.
Among Wnt family, Wnt2b and Wnt2 are under the same subfamily since the
alignment of Wnt sequences shows that Wnt2 has more homology to Wnt2b (72.5%
amino acid identity) than other Wnts (Katoh M. et al. 2000), and the evolutionary
relationship between Wnt2 and Wnt2b is contributed by duplication of an ancient gene
cluster (Katoh M. et al. 2002; Gariock RJ et al. 2007).

1.2.2

Human Wnt13 isoforms
Katoh M. et al firstly described two Wnt13 isoforms derived from the same gene

due to alternative splicing. They isolated a novel Wnt13 isoform (Wnt2b2/Wnt13A) in
addition to the original Wnt13 isoform (Wnt2b1/Wnt13B). Wnt13A and Wnt13B share
the Wnt core domain but differ in the 5’-UTR and N-terminus, resulting in 87.0% amino
acid homology between Wnt13A and Wnt13B. Also as shown in Figure 1.2A, Wnt13B

42

mRNA contains exons 1, 2 and 4-7, whereas Wnt13A contains mRNA contains exons 37, and their expression pattern differs too (Katoh M. et al. 2000).
Our laboratory demonstrated that various human cell types, such as differentiated
endothelial cells and hematopoietic cells, express three different Wnt13 isoforms:
Wnt13A, Wnt13B and a new form Wnt13C (Struewing IT et al. 2006; Bunaciu RP et al.
2008). Wnt13C mRNA consists of exons 1 and 4-7 with the entire exon 2 skipped during
an alternative splicing (see Figure 1.2A). Also, Wnt13A was shown transcribed from the
P2 promoter, while mRNAs of Wnt13B and Wnt13C were generated using P1 promoter
(Figure 1.2A, Struewing IT et al. 2006).
Two translational start codons were found in Wnt13B and C mRNAs: Met1 and
Met74, so Wnt13B mRNA gave rise to a long form and a short form at protein levels,
resulting in the detection of a protein doublet by western blotting, in contrast to Wnt13A
with one single band of 41KD in size. This result was confirmed by site mutagenesis:
mutant M1L-Wnt13B, where Met1 was replaced by leucine1, only generated the short
form of Wnt13B (S-Wnt13B); however, mutant M74L-Wnt13B, where Met74 was
replaced by Leucine74, only generated the long form (L-Wnt13B). Compared to Wnt13B
mRNA, Wnt13C sequence had a deletion of 71 nucleotides corresponding to exon 2,
leading to a change in the open reading frame of exon 4 and formation of a stop codon
(Figure 1.2 B). Consequently, Wnt13C encoded the same protein as S-Wnt13B from the
second translational start site (Met74), plus a very short peptide of 30 amino acids in
length from the first start site (Met1), but only S-Wnt13B band was able to be seen by
immunoblots (Struewing IT et al. 2006; Tang T et al. 2008).
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The three Wnt13 isoforms displayed different subcellular localizations: Wnt13A,
like most of other secreted Wnt members, was mainly retained in endoplasmic reticulum
(ER), and underwent N-glycosylation during post-translational processing. In contrast,
Wnt13B was not secreted but associated with intracellular fractions. Moreover, LWnt13B and S-Wnt13B were shown targeted to mitochondria and to the nucleus,
respectively. Thus Wnt13 forms with S-Wnt13B alone, including Wnt13C and M1LWnt13B were localized in nucleus; however, Wnt13 forms with L-Wnt13B alone, like
M74L-Wnt13B was localized in mitochondria due to N-terminus containing
mitochondrial targeting sequences. Wnt13B, which had both long and short forms, was
tightly associated with mitochondrial membranes and was able to induce the changes of
mitochondrial morphology (from reticular to fragmented morphology) (Struewing IT et
al. 2006).

1.2.3

Wnt13 expression and function

1.2.3.1 In humans
1.2.3.1.1

Human hematopoiesis

Wnt13 transcripts were detected by RT-PCR in thymus in human fetus and
different hematopoeitic cell lines, including B-cell lines (Daudi, Raji, and Ramos), a Tcell line (Jurkat), myeloid cell lines (KG-1 and KG-1a), and erythroid cell lines (HEL and
TF1), but not primitive stem/progenitor cells (CD34+Lin-), implying Wnt13 was likely
expressed in committed progenitor cells and /or mature cells (Van Den Berg DJ et al.
1998). However, the Wnt13 primers used for PCR amplification can not distinguish the
Wnt13 isoforms in this report, so the Wnt13 expression reflected the total levels of
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Wnt13 isoforms. Also, Wnt13A-transduced CV-1 cells were used to test the biological
activity: Wnt13 was shown to increase greatly the numbers of mixed colony-forming
units (CFU-MIX), colony-forming units-granulocyte macrophage (CFU-GM), and burst
forming units–erythoroid (BFU-E), indicating Wnt13 gene may be a new group of
hematopoietic factors (Van Den Berg DJ et al. 1998).

Moreover, our laboratory further proved that all three Wnt13 isoforms were
expressed in different human hematopoeitic cells including monoblastic U937 cells,
erythroblastic K562 cells, and monocytic THP1 cells, with Wnt13C level being the
highest compared to Wnt13A and B, by using specific primers for Wnt13A, Wnt13B and
Wnt13C in realtime PCR reactions. In U937 cell line, Wnt13B and Wnt13C mRNAs
were up-regulated while Wnt13A was down-regulated during cell differentiation towards
monocyte/macrophages; however, in K562 cell line, the mRNA levels of all three Wnt13
forms were increased with cell differentiation to megakaryocytes. And the expression of
Wnt13B and C, not Wnt13A were correlated to transcription factor MAF-B level in both
U937 and K562 systems (Bunaciu RP et al. 2008). This finding demonstrated differential
regulation of Wnt13 forms and Wnt13 isoform switch during U937 cell differentiation,
further suggesting that Wnt13 forms may be new players in leukemic differentiation
process towards monocyte/macrophages.

1.2.3.1.2

Human cancers

The Wnt13B mRNA was found in some cancer cell lines, such as Hela (cervical
cancer), MKN28 and MKN74 (gastric cancer) (Katoh M et al. 1996). The Wnt13
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expression was also detected by RT-PCR in human mammary epithelial cells, and breast
cancer cell lines (BT-20, T-47-D, BT-474, MCF-7, MDA-MB-468, MDA-MB-453) as
well (Benhaj K. et al. 2006). Besides, Wnt13 was shown to be expressed in 2
glioblastoma cell lines, 10 head and neck squamous cell carcinomas (HNSCC) cell lines,
and 2 B cell tumor cell lines by using RT-PCR (Rhee C. et al. 2002). Wnt13 transcripts
were detected in 4 cases out of 12 acute lymphoblastic leukaemia (ALL) cases using RTPCR (Khan NI et al. 2007), and Wnt13 isoforms are also expressed in leukemic cell lines
(Bunaciu RP et al.2008). In addition, Wnt13 transcripts were found in rat ovarian surface
epithelium using in situ hybridization as well as in human ovarian cancer lines (SKOV-3,
HEY, CAOV-3. OVCAR, SW626) using RT-PCR (Ricken A. et al. 2002). Although all
these results imply the association between the levels of Wnt13 protein expression and
human carcinogenesis, one limitation that most of these studies share is that the
methodology they used could not distinguish the isoforms of Wnt13.
However, some other studies did specify the differential Wnt13 isoforms. The
Wnt13 mRNA was shown up-regulated in 2 of 8 cases of primary gastric cancer by using
matched tumor/normal expression array analysis where Wnt13 probe could detect both
Wnt13A and B; in adult gastric epithelial cells, Wnt13A mRNA was the only form to be
shown preferentially up-regulated in a case of primary gastric cancer by RT-PCR, and
injection of synthetic mRNA of Wnt13A instead of Wnt13B was able to induce axis
duplication in Xenopus embryos, suggesting that the Wnt13A may be positive regulator
of Wnt/β-catenin pathway and its up-regulation may be related to tumor formation in
gastric cancer (Katoh M et al. 2001). However, the activated effect on canonical signaling
of Wnt13A is cell type specific, since Wnt13A failed to increase β-catenin/TCF activity
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in HEK293 cells (Struewing IT et al. 2006). In addition, another report from Katoh has
showed that Wnt13A mRNA, but not Wnt13B mRNA, was expressed in MCF-7 cells
(breast cancer), NT2 cells (teratocarcinoma) and MKN45 cells (gastric cancer), further
proved that differential expression of Wnt13 forms in carcinogenesis (Katoh M. 2001).
Our laboratory also illustrated the differential expression and regulation of Wnt13
isoforms during leukemic cell differentiation: in U937 cell line, Wnt13B and Wnt13C
mRNAs were up-regulated while Wnt13A was down-regulated during cell differentiation
towards monocyte/macrophages (Bunaciu RP et al. 2008).

1.2.3.1.3

Human type II diabetes:

In 2008, Lee SH et al reported that using immune-histochemistry approach
(Wnt13 antibody: AF3900, from R&D), Wnt13 and other canonical Wnt signaling
members (such as TCF3) were absent from islets of nondiabetic individuals, but were
greatly up-regulated in islets from type II diabetic patients, and Wnt13 was robustly
expressed in both β-cells and α-cells of diabetics (Lee SH et al. 2008).

1.2.3.1.4

Inflammation in gastrointestinal tract

You J et al examined the expression of Wnt pathway-related genes in patients
with ulcerative colitis (UC) by Wnt-specific microarray analysis, and they found that
Wnt13 expression in colonic mucosa from patients with inflammatory bowel disease
(IBD) was around six fold higher than normal colonic mucosa (You J et al. 2008), but
this finding was not confirmed by RT-PCR using specific primers.
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Moreover, Tanaka A et al took advantage of suppressive subtractive hybridization (a
technique combining suppressive PCR and subtractive hybridization) to compare mRNA
populations from biliary epithelial cells (BEC) isolated from patients with primary biliary
cirrhosis (PBC) to BECs from normal samples, and they identified that one of 71 cDNA
clones which have higher transcription levels in PBC patients, has 98% homology to
human Wnt13 gene, but the paper did not specify Wnt13 isoform and the detail of the
increase by Wnt13 (Tanaka A et al. 2001).

1.2.3.1.5

Others

Bisgaard AM et al described a case of deletion in chromosome 1(1p13.1 and
1p21.1) with breakpoints: the patient was a 13-year-old girl with severe mental
retardation, short stature, dysmorphic appearance, and iris coloboma. The authors
hypothesized that this phenotype in eyes might be contributed by Wnt13, as Wnt13 maps
to 1p13.2 and Wnt13 is expressed in the optic vesicles during eye development (Bisgaard
AM et al. 2006), but no evidence was given to support this hypothesis in the paper.
The Wnt13 mRNA was also detected by RT-PCR in human bone marrow stromal
cells (hMSCs), also known as bone marrow-derived mesenchymal stem cells, which have
the potential to differentiate into various types of cells such as osteoblasts and adipocytes
(Shen L et al. 2009). Due to the lack of the information about Wnt13 primers in this
paper, it is unknown whether the Wnt13 mRNA the authors detected represented the total
Wnt13 or a specific isoform. In this study, there was no significant gender difference in
Wnt13 expression; however, the Wnt13 mRNA demonstrated a trend of higher levels in
young group, and for the hMSCs from women, the mRNA expression of Wnt13 was
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inversely correlated with age, suggesting that Wnt13 gene expression may be affected by
age (Shen L et al. 2009).

1.2.3.2 In animals
Wnt13 functions as the stem cell factor for neural or retinal progenitor cells
during embryogenesis (Zakin LD et al. 1998; Nakagawa et al. 2003; Kubo F. et al. 2003).
Unlike in humans, Wnt13 isoforms have not been specified in animals, so Wnt13 in
animal studies are usually referred to ortholog of human Wnt13A.

1.2.3.2.1

Embryogenesis and organogenesis

During embryogenesis in mice, xenopus, chicken, and zebrafish, the Wnt13
expression is similarly characterized by a dynamic pattern at different developing stages
(Zakin LD et al. 1998; Jasoni C et al. 1999; Ng JK et al. 2002).
For mice, Wnt13A expression was detectable in the mouse embryonic mesoderm
during gastrulation by using in situ hybridization. At later stages, robust expression of
Wnt13A transcripts was found in neuroepithelium of the developing brain (as a narrow
line of the dorsal midline of the diencephalon and mesencephalon), the heart primordia,
the periphery of the lung bud and the otic and optic vesicles, suggesting Wnt13A may
partially overlap with other Wnt genes in controlling mesoderm specification and
embryonic patterning of brain, heart, or lung (Zakin LD et al. 1998).
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1.2.3.2.2

Retinal development and degeneration

According to Jasoni C et al, chicken Wnt13 was shown to be expressed in the
developing eye with a two-phase pattern using in situ hybridization: the earlier expression
was restricted within the pigment epithelium, and the later expression was confined to the
lens and ciliary margin. Also strikingly, whole-mount hybridization experiment showed
that cWnt13 was restricted to the proliferating lens epithelium and absent from the
quiescent, differentiating annular pad, and in vitro BrdU incorporation studies indicated
the correlation between cell division and Wnt13 expression in the lens (Jasoni C et al.
1999), but the authors did not give specific information of the RNA probe for cWnt13 in
this paper. Later, a study showed that dissociated retina cells formed the correctly
laminated layer in Wnt13A-conditioned media, suggesting that Wnt13A may play a role
in the formation of laminar structure in the retina (Nakagawa et al. 2003). Kubo F et al
revealed that Wnt13A was visible in the marginal retina by in situ hybridization, and
overexpressing Wnt13A by in ovo electroporation in central retina inhibited neuronal
differentiation (Kubo F. et al. 2003). Also, the retina progenitor cells (RPC) in chicken
ciliary marginal zone (CMZ) showed prolonged proliferation in Wnt13A-conditioned
media in vitro, suggesting Wnt13A serves as a stem cell factor in the retina (Kubo F. et
al. 2003). In contrast, in vivo studies by Cho SH et al showed another case: canonical
Wnt signaling reduced RPC proliferation in vivo, and viral infection of Wnt13A
interfered with the maintenance of retinal progenitor gene (RPG) expression, resulting in
the conversion of retina cells into the peripheral fates of the ciliary body and iris (Cho SH
et al. 2006). A recent report showed that Wnt13A induced the formation of both CMZ
and iris/ciliary epithelium, which was mediated by Hairy1, a Notch signaling effector
50

(Kubo F et al. 2009). All these data demonstrate that Wnt13A plays a crucial role in
controlling retina cell fate.
In addition to eye development, Wnt13 has been also shown to be involved in
retina degeneration and regeneration. Wnt13 transcripts were detected during rod and
cone photoreceptor death in mice by quantitative PCR (primer for Wnt13 was unable to
distinguish Wnt13 isoforms), implying that Wnt13 might be a potential mediator in retina
degeneration (Yi H. et al. 2007). Also, Wnt13 transcripts were found clearly expressed in
the newt lens-regenerating iris tissue by RT-PCR, and local Wnt13 activation by lens
removal or FGF-2 injection was restricted to the dorsal iris, indicating dorsal-specific
activation of Wnt13 determines the dorsal iris-limited step during lens regeneration in the
newt eye (Hayashi T et al. 2006).

1.2.3.2.3

Limb initiation

Kawakami Y. et al reported that Wnt13A-infected fibroblasts were able to induce
Fgf-10 expression in lateral plate mesoderm, and to generate an ectopic limb when
implanted in the flank of chicken embryo, which was mediated by stabilizing cytosolic
and membrane β-catenin (Kawakami Y. et al. 2001). Similarly, in zebrafish embryos,
Wnt13(Wnt2ba, which has 76% homology to human Wnt13A) loss-of-function
experiments were performed by injection of Wnt13 morpholino oligonucleotides, and
resulted in 75% embryos lacking pectoral fins, and this paper also showed Wnt13 was the
upstream of Tbx5 and Fgf 10 to initiate limb outgrowth (Ng JK et al. 2002).
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1.2.3.2.4

Liver specification

Ober EA et al found that prometheus (prt) gene mutation caused an absence or
remarkable reduction in liver formation during the early stages of zebrafish development,
which was a transient but dramatic phenotype. Indeed, prt gene encodes Wnt2bb, which
is another Wnt13 ortholog in zebrafish (89% identical to Wnt2ba, and 77% homology to
human Wnt13A and B), and knock-down of wnt2bb function by injecting morpholino
antisense oligonucleotides resulted in a complete absence of liver, indicating a positive
role for Wnt13 in zebrafish liver specification (Ober EA et al. 2006).

1.2.3.2.5

Kidney development

The Wnt13 gene was also detected in the kidney of murine embryos using in situ
hybridization (Lin Y et al. 2001). And isolated kidney mesenchyme which was placed on
the monolayer of cells expressing secreted Wnt13A, failed to induce tubulogenesis, but
ureteric bud cultured with Wnt13A-expressing cells showed promoted growth, branching
and kidney reconstitution (Lin Y et al. 2001). Another report showed that canonical Wnt
signaling was detected in branching ureteric bud tips and emerging S-shaped bodies in
TCF-LacZ transgenic mouse kidney, and Wnt13A transfection increased Topflash
activity greatly in MK4 cells (murine mesenchyme), which suggests that Wnt13 might be
involved in the branching nephrogenesis in fetal kidney (Iglesias DM et al. 2007).

1.2.3.2.6

Vasculature

During organogenesis, zebrafish Wnt2bb was detected using in situ hybridization
at the onset of somitogenesis in the posterior lateral plate mesoderm (LPM),
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predominantly in cells fated to give rise to the endothelial and blood lineages, and
expressed in the developing vasculature, endocardium, atrioventricular valve in the later
stages (Ober EA et al. 2006).

1.2.3.2.7

Other organ development

In xenopus, knockdown of Wnt13 by injecting different morpholino
oligonucleotides resulted in a hypoplastic stomach as well as in hypoplasia of the
pancreas, suggesting a positive role of Wnt13 in controlling proliferation of stomach and
pancreas (Damianitsch K et al. 2009). In skeletal development, Wnt13 mRNA levels
were decreased by 60% in human dermal fibroblasts exposed to demineralized bone
powder (DBP) for 3 days, which is the first evidence that Wnt2b may influence post-natal
chrondrocyte differentiation induced by DBP (Yates KE et al. 2004).
It was reported that the conventional Wnt13 knock-out mice did not show obvious
phenotype (van Amerongen R et al. 2006), but this information was gained through their
personal communication with Yamaguchi T without any description of how these knockout mice were generated. Based on this result, either the role of Wnt13 might be not
critical for development, or the deficiency of Wnt13 functions might be compensated by
other Wnts.
Goss AM et al generated Wnt2 null mice, Wnt2b null mice, and Wnt2/Wnt2b
double knockout mice to study the function of Wnt2 and Wnt13 in the development of
the anterior foregut (Goss AM et al. 2009). In this study, Wnt2b null mice were viable
without showing obvious phenotypes, which is consistent with the result discussed in van
Amerongen R’s review (van Amerongen R et al. 2006). Yet, most Wnt2 null mice were
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cyanotic at birth and died perinatally; histological analysis in these mice showed
remarkable lung hypoplasia, with poor development of the lung mesenchyme which
resulted in dilated and abnormal vascular endothelial plexus by birth; these mice also
displayed reduced cell growth in epithelial and mesenchyme cells and low levels of
transcription factor important for lung development. Compared to Monkley SJ’s finding
showing placental defects with visible hematomas, abnormal large maternal blood pools,
and reduced number of fetal capillaries in Wnt2 knockout mice (Monkley SJ et al. 1996),
this new paper discovered the novel function of Wnt2 in lung development. Moreover,
the Wnt2/Wnt2b double knockout mutants in this paper revealed complete failure of lung
and tracheal development due to specific loss of lung progenitor specification in the
foregut endoderm. The findings described above suggest the positive role of both Wnt2
and Wnt2b in specifying lung progenitors in the mouse foregut; yet, the difference
between Wnt2 and Wnt2b is that the function of Wnt2 is not redundant whereas the role
of Wnt2b may be, at least partially, compensated by Wnt2. In contrast, other organs
derived from the foregut endoderm, including the thyroid, liver, pancreas and kidney,
were unaffected by Wnt2/Wnt2b double knockout. This result seems to be contradictory
to the findings by Ober EA et al: mutation in Wnt2bb gene caused a transient absence of
liver formation in zebrafish development (Ober EA et al. 2006), which may be explained
by the differential effects of Wnt2b in distinct species. Also, the phenotype of Wnt2bb
knockout in zebrafish was transient, which implies that Wnt2bb deficiency may cause
dramatic defects in liver specification at the early stage, but this deficiency might be
compensated by other Wnts like Wnt2 in the later stage.
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A)

B)

Figure 1.2 Three Wnt13 isoforms are generated via alternative promoter, alternative
splicing, and alternative translational start codons. (A) The schematic human Wnt13
gene is shown, and Wnt13A, B and C mRNAs are produced through different
promoters and alternative splicing sites. (B) N terminal sequences of Wnt13B,
Wnt13C forms as well as M1L-Wnt13B, M74L-Wnt13B mutants, showing a long
form and a short form at protein level can be generated via alternative translational
start sites (modified from Struewing IT et al. 2006).
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1.3 Cell apoptosis
1.3.1 Definition and features
Cell death is a programmed event during development and tissue turn over, or the
ultimate consequence of the cell upon toxic or pathologic insults (Leist M et al. 1997). So
far, at least three major types of cell death have been described: autophagy, a process
characterized by portion of cytoplasm (including organelles) which is enwrapped in
double-membrane vacuoles and targeted for lysosomal degradation; necrosis is a passive,
pathological, catabolic process, which results from cell response to extreme challenges or
toxic stimuli; and apoptosis, a form of programmed cell death, is an active process in
need of energy, which can occur under both physiological and pathological circumstances
(Renvoizé C et al. 1998; Galluzzi L et al. 2008). Besides, there are other forms of
programmed cell death which are caspase-independent, such as Wallerian degeneration
(nervous system), excitotoxicity (neurons), erythropoiesis, and cornification (epidermis)
(Melino G et al. 2005; Kroemer G et al. 2009).
“Apoptosis” is a Greek word, originally meaning falling-off leaves from the tree
in autumn. This term was anciently used by Hippocrates of Cos back in the 4th century
BC, and reused by Kerr JF et al to describe a morphologically distinct form of cell death
(Diamantis A et al. 2008; Kerr JF et al. 1972).
The striking morphological changes make apoptosis easy to be identified in vitro.
In nearly all cell types, apoptosis occurs in scattered, single cells or small cell clusters in
a tissue which is actively regulating its own homeostasis. Once the cell is committed to
suicide, chromatin condenses into dark crescentic masses adjacent to nuclear envelops,
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leading to pyknosis, one of the most typical features in apoptosis. At the same time, the
cell shrinks abruptly due to the loss of fluid, possibly because of blocked Na+-K+-Clcotransporter system, and with cell shrinkage, the cytoplasm thereby becomes dense and
the organelles are more tightly packed. Convolutions of plasma and nuclear membranes
take place progressively with chromatin condensation, leading to a bubbling or extensive
blebbing surface. Minor modification of cytoplasmic organelles is found, and the cell is
segregated into apoptotic bodies which contain cytoplasm and cytoplasmic organelles
with or without nuclear fragments, and the integrity of plasma membrane is remained.
Subsequently, these apoptotic bodies are soon phagocytosed by professional phagocytes
such as macrophages and dendritic cells, or by amateur phagocytes in the neighboring
tissue such as epithelial cells and mesangial cells, and eventually degraded within
lysosomes (Maderna P et al. 2003; Monks J et al. 2003). Interestingly, no inflammatory
reaction is found during the process of apoptosis and phagocytosis of apoptotic bodies,
since apoptotic cells keep plasma membrane intact so that no cellular components leak
into surrounding tissue, and they are quickly engulfed by other cells which are not
releasing inflammatory mediators (Allen RT et al. 1997; Elmore S. 2007)
In contrast to apoptosis, autophagy and necrosis have distinct morphological
characteristics. Autophagy is featured by intracellular accumulation of autophagic
vacuoles; however, necrosis is characterized by cellular swelling, lysed nucleus, rapid
loss of cellular membrane integrity and diffuse inflammation (Allen RT et al. 1997; Loos
B et al. 2009).
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1.3.2

Apoptotic pathways and mechanisms
The mechanisms of apoptosis are complex and sophisticated, involving a lot of

highly-regulated molecular events. So far two main apoptotic pathways, intrinsic pathway
and extrinsic pathway, have been described in eukaryotic cells (Blank M et al. 2007;
Elmore S. 2007), which are illustrated in Figure 1.3.1.
1.3.2.1 Intrinsic pathway
1.3.2.1.1

Overview

The intrinsic apoptotic signaling requires a variety of non-receptor stimuli that
emanate intracellular signals converging at the mitochondria (Blank M et al. 2007).
Mitochondria play a crucial role in cell apoptosis in mammals, because 1) the induction
of mitochondrial outer membrane permeabilization (MOMP) is the pivotal event in the
process of apoptosis; 2) the release of apoptogenic proteins, such as cytochrome c, from
the mitochondrial intermembrane space to cytoplasm results in downstream execution
phase apoptosis (Tsujimoto Y et al. 2000; Spierings D et al. 2005).
Two nonexclusive models may explain the induction of MOMP: 1) as shown in
Figure 1.3.1, the pro-apoptotic Bax or Bak, assemble by homo-oligomerization and then
create pore-like structures in the outer membrane (OM) without affecting the function of
the inner membrane (IM) and the matrix. The Bax and Bak are members of Bcl-2 family,
which is described in 1.3.2.3.1. 2) Some signals, like Ca2+ overload and increased ROS,
induce the opening of permeability transition pore complex (PTPC) which consists of
voltage-dependent anion channel (VDAC) in the OM and adenine nucleotide translocator
(ANT) in the IM, and osmotic forces drive water into the matrix, resulting in swelling
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and the ultimate rupture of both membranes (Spierings D et al. 2005; Garrido C et al.
2006).
Once MOMP occurs, the mitochondria undergo the loss of the membrane
potential and release a variety of pro-apoptotic proteins to the cytosol. One of the
apoptotic proteins is cytochrome c, which functions as an electron shuttle between
complex III and complex IV of the respiratory chain. And in mitochondria, most of
cytochrome c (85%) is trapped within the cristae and associated with cardiolipin while
the rest is free in the intermembrane space (IMS) or loosely attached to IM (Garrido C et
al. 2006; Schug ZT et al. 2009). As shown in Figure 1.3.1, upon MOMP, cytochrome c is
released into the cytoplasm, where it binds and activates the apoptotic protease-activating
factor (Apaf)-1, leading to the formation of a heptameric caspase-activating complex with
deoxyadenosine triphosphate (dATP) and procaspase-9, termed the apoptosome. Each
apoptosome recruits seven dimers of procaspase-9, and provides a platform that
efficiently cleaves and activates caspase-9. In turn, activated caspase-9 induces the
cleavage of executioner caspase-3, 6 and 7, which results in later-on execution phase of
apoptosis (Wang Z et al. 2005; Jin Z et al. 2005).
Besides, the induction of MOMP also leads to the release of another type of
apoptogenic factors including apoptotic inducing factor (AIF), endonuclease G (endoG)
and Omi/HtrA2 to promote caspase-independent cell death (CICD) (Blank M et al. 2007).
AIF, a mitochondrial flavoprotein, normally resides in IMS; however, upon apoptotic
stimuli, AIF translocates from the mitochondria to the nucleus and induces peripheral
chromatin condensation and large-scale DNA fragmentation (stage 1) (Donovan M et al.
2004). Likewise, endoG, a mitochondrial enzyme, also translocates from IMS to the
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nucleus to cause oligonucleosomal DNA fragmentation (DNA laddering; stage 2)
secondary to the first stage caused by AIF (Donovan M et al. 2004). Mammalian
Omi/HtrA2, a serine protease with homology to the bacterial high temperature
requirement A (HtrA) heat shock protease, can also induce CICD but the mechanism
remains unclear (Donovan M et al. 2004).

1.3.2.1.2

Inducers of intrinsic pathways

The signals to induce the intrinsic apoptotic pathway include, but not limited to,
oxidative stress, DNA damage, endoplasmic reticulum (ER) stress, cytoskeletal damage,
hypoxia, loss of cell adhesion, toxins, macromolecular synthesis inhibition, viral
infection, as well as the withdrawal of certain growth factors, hormones and cytokines
(Blank M et al. 2007; Elmore S. 2007).

1.3.2.1.3

Regulators of intrinsic pathways

1.3.2.1.3.1 B cell leukemia/lymphoma (Bcl) -2 family
The Bcl-2 gene was first discovered because of its involvement in the t(14;18)
chromosomal translocations in a cell line derived from an acute lymphoblastic leukemia
(Pegoraro L et al. 1984), and somatic mutations in translocated Bcl-2 was frequently
found in lymphomas (Tanaka S et al. 1992) . Transgenic mouse studies showed that Bcl-2
protected thymocytes from cell apoptosis (Sentman CL et al. 1991), and Bcl-2 deficient
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mice displayed massive apoptosis in thymus, spleen, and kidney (Veis DJ et al. 1993;
Sorenson CM et al. 1995), indicating the critical role of Bcl-2 in suppressing apoptosis.
Later on, other proteins with structure similar to Bcl-2 were identified, and so far,
there are more than 12 core members in the Bcl-2 family that range from inhibiting
apoptosis to promoting apoptosis in their bioactivities (Youle RJ et al. 2008). The Bcl-2
family members share up to four Bcl-2 homology domains (BH1 to BH4). And they can
be subdivided into three groups: the pro-apoptotic Bcl-2-associated X protein (Bax)/Bcl-2
homologous antagonist-killer protein (Bak) family members (Bax and Bak), the antiapoptotic family members [Bcl-2, Bcl-X protein (Bcl-xl), Bcl-w, myeloid cell leukemia
sequence-1 (Mcl-1) and Bcl-2 related protein A1A (A1A)], and the pro-apoptotic BH3only proteins [Bcl-2 interacting mediator of cell death (Bim), Bcl-2 antagonist of cell
death (Bad), BH3-interacting domain death agonist (Bid), p53 upregulated modulator of
apoptosis (Puma), Noxa, death protein 5/Harakiri (Hrk), Bcl-2 interacting killer (Bik)]
(Youle RJ et al. 2008). Bax and Bak have 3 core multi-BH domains: BH1, BH2, BH3,
but anti- apoptotic members Bcl-2 have one more domain called BH4 that is required for
Bcl-2 interacting with Bax; and BH3-only proteins do not contain any other BH domains
but BH3 (Danial NN. 2007). The balance between pro-apoptotic members and antiapoptotic members in Bcl-2 family governs the commitment of the cell to death, and
constitutes a crucial switch during apoptosis.
BH3-only proteins function as initial sensors of specific apoptotic signals that are
released from various cellular processes. In normal state, BH3-only proteins are in very
low levels in the cytoplasm or in mitochondrial membranes; inactivated Bax is located in
the cytoplasm or loosely attached to the mitochondria membrane; and Bak is located in
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mitochondrial membrane, forming an inactivated complex with anti-apoptotic proteins
like Bcl-2 (Lomonosova E et al. 2008). When BH3-only proteins are upregulated or
activated by apoptotic stimuli, they liberate Bak or Bax either by binding and neutralizing
Bcl-2 (Willis SN et al. 2007) or by binding and directly activating Bax (Gavathiotis E et
al. 2008). Activated Bax, which then translocates from cytoplasm to mitochondria
membrane, as well as activated Bak, which is originally located in mitochondria and
released from Bak/Bcl-2 complex, undergo homo-oligomerization with multiple
conformational changes to form pores at mitochondrial intramembrane (Lomonosova E et
al. 2008). Once MOMP occurs, apoptogenic proteins such as cytochrome c are released
from intermembrane space, activating caspase-9 through the formation of the apoptosome
and thereby inducing the cleavage of executioner caspases, which results in the execution
phase of apoptosis (Danial NN. 2007; Youle RJ et al. 2008). Therefore, Bcl-2 family
consists of members with opposing functions in the apoptotic cascade, including
“activators” such as Bax or Bak, “inhibitors or repressors” such as Bcl-2 or Bcl-xL, and
“sensitizers or derepressors” such as BH3-only proteins (Bim or Bid) (Spierings D et al.
2005).
Bid, one of the BH3-only members, has a unique function in associating the
intrinsic pathway with the extrinsic pathway. In the extrinsic pathway, Bid is cleaved by
activated caspase-8, generating C-terminal truncated form t-Bid, which translocates to
mitochondria and activates Bax or Bak to promote MOMP and downstream caspase
activation (Youle RJ et al. 2008).
Bim is also one of the BH3-only members in the Bcl-2 family, and Bim exists in
several isoforms: BimS, BimL, BimEL, BimAD and BimG. Bim is constitutively
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expressed in various cell types but in an activated form through binding to the
microtubule-associated dynein motor complex (Puthalakath H et al. 1999). Bim-deficient
mice had abnormally high numbers of lymphoid and myeloid cells; B cells, T cells,
monocytes and granulocytes were increased 2 to 4 fold in peripheral tissues from Bimdeficient mice than those from wildtype animals; and older Bim-deficient mice develop
splenomegaly, lymphadenopathy, and autoimmune kidney disease, indicating that Bim is
critical for apoptosis and homeostasis in the lymphoid and myeloid compartments
(Bouillet P et al. 1999). Overexpression of Bim induced remarkably increased apoptosis
in NIH 3T3 fibroblasts (Marani M et al. 2002) and in Hela cells (Herrant M er al. 2004).
The mechanisms by which Bim induces apoptosis is not well understood; yet, Bim may
function through interacting with and inhibiting Bcl-2 or Bcl-xL (Willis SN et al. 2007;
Wang X et al. 2009) or through direct binding and activating Bax (Gavathiotis E et al.
2008). Antigens, cytotoxic agents, growth factor withdrawl and Reactive oxygen species
(ROS) can activate Bim through various mechanisms: 1) by releasing it from the dynein
motor complex or the anti-apoptotic Bcl2 proteins (Puthalakath H et al. 1999); 2) by
increasing its mRNA level through transcriptional factors such as Forkhead Box O
(FOXO) factors (Gilley J et al. 2003). Therefore, Bim serves as a key initiator of the
intrinsic pathway of apoptosis, and the regulation of Bim expression and activity can
tightly affect the downstream apoptotic events.
The intrinsic pathway is tightly controlled by the balance between pro-apoptotic
proteins over anti-apoptotic proteins, especially the pro-/anti-apoptotic balance in the
Bcl-2 family members.

As described before, activated Bax can translocate to

mitochondria from cytoplasm and oligomerize to generate pore-like structure in the OM,
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while Bcl-2 or Bcl-xL can bind Bax or Bak after they insert into membranes and inhibit
the oligmerization of Bax and Bak (Youle RJ et al. 2008). The pro- and anti-apoptotic
Bcl-2 members also have opposite effect on MOMP: the pro-apoptotic Bax or Bak
accelerate the openings of the VDAC channel, whereas the anti-apoptotic Bcl-xL closes
VDAC (Shimizu S et al. 1999); moreover, the pro-apoptotic Bax can cooperate with
ANT to yield an efficient composite channel, whereas the anti-apoptotic Bcl-2 inhibits
ANT activity (Brenner C et al. 2000), proving that the Bcl-2 family members regulate the
permeability of mitochondrial membrane, and thereby control both caspase-dependent
cell death and caspase-independent cell death (Tsujimoto Y et al. 2000; Donovan M et al.
2004).
Besides cell apoptosis, Bcl-2 members have been also shown regulate other forms
of programmed cell death, such as autophagy (Shimizu S et al. 2004). Both Bcl-2 and
Bcl-xL bind and inhibit Beclin1, an essential autophagy protein through interaction of
BH3 domains, while other BH3-only proteins can block the inhibition by Bcl-2 by
competitively disrupting the interaction between Bcl-2 and Beclin1, and induce cell
autophagy (Levine B et al. 2008). Therefore, Bcl-2 family members exert a duel role in
regulating both apoptosis and autophagy.

1.3.2.1.3.2 Reactive oxygen species (ROS)
In addition to contain pro- and anti-apoptotic proteins, mitochondria are the major
site producing ROS in aerobic cells, and thus another important regulator is the balance
of oxidant/anti-oxidant defense (Hengartner MO et al. 2000; Ott M et al. 2007). To
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protect against possible harmful consequences of ROS, cells also possess an endogenous
anti-oxidative defense system consisting of reductants like glutathione (GSH), and
enzyme systems that remove ROS through metabolic conversion (Ryter SW et al. 2007).
For example, superoxide (O2-) can be converted by superoxide dismutases (SOD) to
H2O2, which is in turn converted to H2O and O2 by catalase; in mitochondria, MnSOD,
encoded by SOD2 gene, is specifically used to catalyze the superoxide conversion
(Kamata H et al. 1999). When the oxidative insults are not properly resolved by the cell
anti-oxidative capacity, they can threaten cell homeostasis, and even cause intrinsic
apoptotic cascade (Han H et al. 2004). ROS has been shown to induce mitochondrial
permeability transition (Garrido C et al. 2006). Furthermore, it was found that the
oxidation of cardiolipin, which is a mitochondria-specific anionic phospholipid,
decreases the affinity of cytochrome c to cardiolipin and leads to the detachment of
cytochrome c from the inner mitochondrial membrane, which may be another mechanism
to explain the role of oxidative stress in cell apoptosis (Ott M et al. 2007). Also, peroxide
contributes the induction of apoptosis by stimulating the activity of nuclear transcription
factors to upregulate pro-apoptotic proteins or to inhibit anti-apoptotic proteins (Chandra
J et al. 2000). In the other hand, some animal models of mitochondrial disease, such as
the ANT1 knockout mice, showed remarkable increased production of hydrogen peroxide
in mitochondria isolated from skeletal muscle, heart and brain (Esposito LA et al. 1999),
suggesting that mitochondria dysfunction may lead to enhanced ROS production.
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1.3.2.1.3.3 Others
As mentioned before, the morphology of the cell and its nucleus undergo dramatic
changes during apoptosis. So does the mitochondria, and the striking morphological
change in mitochondria may contribute to the induction of MOMP and the release of
cytochrome c (Arnoult D et al. 2005). Mitochondria undergo extensive fragmentation
upon apoptosis due to increased fission and reduced fusion. The pro-apoptotic Bak has
been shown to be critical for mitochondrial fragmentation during apoptosis, which is
inhibited by Bcl-2 (Brooks C et al. 2007).
Other factors have also been found to be involved in the regulation of the intrinsic
apoptotic pathway. One type of negative regulators is inhibitors of apoptosis (IAPs), and
the functional unit in IAPs is Baculoviral Inhibitor of apoptosis Repeat (BIR). X
chromosome-linked inhibitor of apoptosis (XIAP) protein is believed to be the most
potent IAPs, containing three BIR domains. XIAP directly binds and specifically inhibits
the enzymatic activities of active caspase-3, 7 through the linker region between BIR1
and BIR2, whereas XIAP specifically inhibits active caspase-9 through BIR3 domain
(Shi Y et al. 2002). The linker region and BIR3 may occupy the active site of caspases in
a reverse orientation, thereby blocking the entry of substrates (Shi Y. 2002). XIAP also
promotes proteasomal degradation of active caspase-3 via its ubiquitin-protein ligase
activity (Blank M et al. 2007; Suzuki Y et al. 2001). The caspase-inhibitory activity of
the IAPs, in turn, is blocked by IAP inhibitors, such as serine protease Omi/HtrA2 that
can firstly sequester IAPs through its Reaper IAP-binding motif and subsequently
degrade IAPs through its protease activity (Martins LM et al. 2002; Srinivasula SM et al.
2003), and second mitochondrial activator of caspases (Smac)/direct IAP binding protein
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with low pH (Diablo) whose N-terminal residues (Ala-Val-Pro-Ile) can sequester the BIR
domains of IAPs (Vaux DL et al. 2003). Upon the induction of MOMP, Omi/HtrA2 and
Smac/Diablo are released from the inner member space of mitochondria to the cytoplasm,
and compete with caspases for IAP binding (Blank M et al. 2007; Spierings D et al.
2005).

1.3.2.2 Extrinsic pathway
1.3.2.2.1

Overview

Unlike the intrinsic pathway, the extrinsic apoptotic signaling is dependent on
transmembrane receptors, called death receptors, which binds to extracellular ligands.
The death receptors are members of the tumor necrosis factor (TNF) receptor
superfamily, featured by cysteine-rich extracellular domains and an 80 amino acid
cytoplasmic tail, also termed “death domain”, which is critical for transducting death
signal from the cell surface to inside the cells. The Fas Ligand/Fas and TNFα/TNFR are
well-known ligand/death receptor pairs (Elmore S. 2007).
As shown in Figure 1.3, the interaction between the Fas ligand or TNF to Fas or
TNFR leads to the recruitment of the adapter proteins Fas-associated death domain
(FADD) and TNFR-associated death domain (TRADD), which then binds procaspase-8
through dimerization of the death domain, generating a complex called the deathinducing signaling complex (DISC), in which procaspase-8 is processed, and
subsequently caspase-8 is activated to directly trigger caspase-3- mediated execution
phase of apoptosis (Wang Z et al. 2005).
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The above process does not invovle Bcl-2 family members; however, in some
systems such as spinal cord injury (Yu WR et al. 2009), kidney (Campbell MT et al.
2008) and various cancer cells (Bhattacharya K et al. 2009; Zhao Y et al. 2009), the
extrinsic pathway can be linked to the intrinsic pathway through Bid, which is another
group of pro-apoptotic Bcl-2 member. In the extrinsic pathway, the activated caspase-8
can cleave Bid with the generation of C-terminal truncated form t-Bid, which translocates
to mitochondria and effectively activates Bax to promote downstream caspase activation
through the induction of MOMP (Figure 1.3) (Youle RJ et al. 2008). Although MOMP is
not required for the development of extrinsic apoptotic pathway, it exerts amplifying
effect on apoptotic signals received from the death receptor at the cell surface (Blank M
et al. 2007).

1.3.2.2.2

Inducers and regulators of the extrinsic pathway

The activation of extrinsic apoptotic pathway is initiated by the stimulation of
death receptors by the binding of corresponding ligands. Besides Fas Ligand/Fas and
TNFα/TNFR, others such as lymphotoxin-α/TNFR, Apo3L (TRAMP)/DR3, Apo2L
(TRAIL)/death receptor (DR)4 and Apo2L (TRAIL)/DR5 have also been defined as
ligand/death receptor pairs to trigger the extrinsic death signaling (Fulda S et al. 2004;
Elmore S. 2007). Therefore, the expression of these death ligand/receptor pairs is
important for the regulation of the extrinsic apoptotic pathway.
LPS is a highly pro-inflammatory molecule which can induce apoptosis through
extrinsic apoptotic pathway in various systems, including endothelial cells (Bannerman
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DD et al. 2003). Toll like receptor (TLR)-4 is the receptor of LPS, and LPS activates a
caspase-8-initiated apoptosis dependent of FADD instead of TNFR1, Fas or DR3 in
endothelial cells (Choi KB. 1998). In addition, the intrinsic apoptotic pathway is found to
be required for LPS-induced apoptosis in human lung microvascular endothelial cells
because the overexpression of Bcl-xL or deficiency of Bid can protect against cell death
triggered by LPS (Wang HL et al. 2007).
Signal transduction of the extrinsic pathway can be negatively regulated by the
cellular Fas-associated death domain like interleukin-1-converting enzyme inhibitory
protein (c-FLIP), an enzymatically inactive homolog of caspase-8, which inactivates the
extrinsic apoptotic pathway by competing with caspase-8 for interacting with FADD
(Schultz DR et al. 2003; Wilson NS et al. 2009). So the expression of c-FLIP is
negatively correlated with the activity of the extrinsic apoptotic pathway. Another protein
called phosphoprotein enriched in diabetes/phosphoprotein enriched in astrocytes-15 KD
(PED/PEA-15) also block FasL, TRAIL or TNFα –induced apoptosis by interrupting
FADD and caspase-8 interactions (Hao C et al. 2001). Additionally, the Bcl-2 family
members are involved in the regulation of the extrinsic pathway, because 1) the proapoptotic tBid integrates the extrinsic apoptotic pathway with mitochondrial
permeability; 2) in certain cell types, overexpression of the anti-apoptotic Bcl-2 and BclxL by stable transfection blocks the apoptotic activity triggered by Fas ligand (Scaffidi C
et al. 1998).
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1.3.2.3 Effectors of apoptotic cascade (caspases)
Caspases are a family of highly conserved aspartate-specific cysteine proteases,
and in the name, the “c” refers to cysteine used as the catalytic residues, and the “aspase”
stands for cleaving their substrates behind aspartic acid residues. Yet, different caspases
have different selectivity for cleavage through recognition of neighboring amino acid of
aspartate (Alnemri ES et al. 1996). Each of these enzymes is synthesized as an inactive
proenzyme in cells, which is proteolytically activated to form a heterodimetic catalytic
domain (Alnemri ES et al. 1996). Caspases can either autoactivate themselves or are
activated by other capases, followed by the initiation of caspase cascade and
amplification of apoptotic signaling, which leads to rapid irreversible cell death (Elmore
S. 2007).
To date, 15 mammalian members have been identified in the caspase family, and
categorized into two subfamilies which are 1) inflammatory caspases (caspase-1, 4, 5, 11,
12, 13 and 14); and 2) apoptotic caspases that can be further grouped into
initiator/apoptotic activator (caspase-2,8,9,and 10) and effector/apoptotic executioner
(caspase-3,6,7) (Chowdhury I et al. 2008). Once receiving pro-apoptotic signals, the
activation of the upstream initiator caspases (caspase-2, 8, 9, and 10) results in the
proteolytic activation of the downstream executioner caspases (caspase-3, 6, and 7), and
these effector caspases are the one that cleave the following protein substrates (Saikumar
P et al. 1999; Saraste A et al.2000).
The substrates of caspases include: 1) cytoskeletal proteins such as actin and
actin-binding proteins gelsolin and fodrin, which degradation by caspases leads to the
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blebbing of the plasma membrane in apoptotic cells; 2) lamins and the nuclear matrix
protein (NuMA), which function in maintaining nuclear integrity, and whose caspasedependent cleavage is responsible for nuclear fragmentation; 3) the apoptotic chromatin
condensation inducer in the nucleus (ACINUS), which is a modulator of chromatin
condensation during apoptotic process; 4) the inhibitor of caspase-activated DNase
(ICAD), when cleaved by caspases causing DNA fragmentation; 5) some DNA repair
factors, such as poly(ADP-ribose) polymerase-1 (PARP-1) and the catalytic subunit of
the DNA-dependent protein kinase (DNA-PK); 6) survival factors like MEKK-1, Akt-1,
Bcl-2 (Blank M et al. 2006). Therefore, the activation of the effector caspases and their
actions on protein cleavage initiate the apoptotic execution phase including DNA
breakdown and morphological modifications.
Caspase-3 is thought to be the most important effector caspases. Caspase-3,
activated by caspase-8, caspase-9, or caspase-10, preferentially activates caspase
activated DNase (CAD) and ACINUS to induce DNA degradation and chromatin
condensation respectively, and also cause cytoskeletal disassembly and the formation of
apoptotic bodies (Elmore S. 2007).
Both the activity and the expression of caspases can be regulated. The natural
inhibitors of caspase activity include IAPs, cytokine response modifier A (CrmA), p35
and v-FLIP, etc (Chang HY et al. 2000). Unlike IAPs which have mammalian homologs,
virus proteins CrmA and p35 do not have cellular homologs so far, and they function as
pan-caspase inhibitors through covalent modification of catalytic site of caspases (Shi Y.
2002).

Posttranslational modifications also modulate the activity of caspases. For

example, the phosphorylation of caspase-9 by Akt inhibits the activity of caspase-9; and
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denitrosylation enhances the activity of mature caspase-3 (Earnshaw WE et al. 1999;
Chang HY et al. 2000).

1.3.2.4 Other apoptotic features
1.3.2.4.1

DNA fragmentation

One of the earliest prominent features showing an irreversible commitment to cell
death is DNA breakdown by Ca2+ - and Mg2+ -dependent endonucleases, ending up with
DNA fragments of 180 to 200 base pair and multiple thereof, containing blunt end and
single base 3’ overhangs (Allen RT et al. 1997; Saraste A et al.2000). A number of
caspase substrates are responsible for DNA breakdown during apoptosis, such as DNA
fragmentation factor (DEF40)/CAD, which bind their inhibitory proteins DEF45/ ICAD
respectively to form inactive heterodimers in normal condition, but these substrates can
be selectively activated once cleaved by caspase-3 or other caspases, and then further
breakdown double strand DNA to induce nuclear morphological changes (Saraste A et
al.2000).
1.3.2.4.2

Phosphatidylserine translocation

To ensure apoptotic cell debris rapidly engulfed, there must be some changes in
plasma membrane (PM) to create a recognition site by phagocytes (Allen RT et al. 1997).
So another biochemical characteristic is the expression of cell surface markers; for
example, phosphatidylserine, which is normally inward-facing in the cell lipid bilayer,
translocates to outer leaflet of the PM during apoptosis, mediating phagocytic recognition
as a ligand for phagocytes and subsequent elimination of apoptotic cells (Elmore S.
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2007). In addition, other protein markers are also expressed in the cell surface when the
cell undergoes apoptosis and phagocytosis, such as Annexin V, calreticulin, and
thrombospondin-1 (Elmore S. 2007).

1.3.2.5 Apoptotic detection/quantification
One of commonly-used approaches to study the presence of apoptosis is to
demonstrate the activation of caspases, either by western blot to show the caspase
cleavage or by enzymatic assay to determine caspase activity (Saraste A et al.2000), and
both are commercially available. The formation of DNA fragments has been applied for
the detection of apoptosis: a characteristic “DNA ladder” pattern is evident in agarose gel
stained with ethidium bromide and viewed under ultraviolet illumination; also, cell
carrying DNA strand breaks can be visualized under microscope with the terminal
transferase mediated DNA nick end labeling (TUNEL) assay (Saraste A et al.2000;
Elmore S. 2007). Some markers such as Annexin V which are expressed at cell surface
during apoptosis have also been used for detection of apoptotic cells commercially.

1.3.3

Regulation of apoptosis
The levels of apoptotic factors control the susceptibility of the cell to apoptosis.

Based on the study from heterozygous and null mice of caspase-3, the expression of
caspase-3 correlated with the sensitivity of T cells to apoptosis induced by etoposide
(Sabbagh L et al. 2004). Human U937 cells treated by γ-interferon which can induce
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caspase expression showed enhanced susceptibility to apoptosis triggered by gammairradiation or antitumor agents (Tamura T et al. 1996). The deregulation of apoptotic
factors is highly related to tumorigenesis; for example, lymphomas were often found to
bear chromosomal translocation of the anti-apoptotic gene Bcl-2 resulting in
hypomethylation and high-level expression of Bcl-2 gene (Hanada M et al. 1993); and the
expression of the pro-apoptotic Bim at both mRNA levels and protein levels were shown
significantly lower in chronic myeloid leukemia (CML) cells than that in normal cells
(Aichberger KJ et al. 2005). The expression of apoptotic factors is also important for
development (such as caspases) and function of immune system (such as FasL/Fas)
(Kuida K et al. 1996; Ettinger R et al. 1995). The apoptotic cascade is controlled by the
balance between pro-apoptotic proteins and anti-apoptotic proteins, and this regulation
can occur in a variety of levels including transcriptional levels, post-transcriptional levels
and translational levels.

1.3.3.1 Transcription levels
The gene expression can be controlled by transcription factors interacting with
their specific DNA sequences with other co-activators/co-repressors (Lemon B et al.
2000). The expression of apoptotic factors such as caspases, Bcl-2 family members, and
factors in the extrinsic pathway have been shown to be tightly regulated by certain
transcription factors and cofactors.
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1.3.3.1.1 Forkhead box O (FOXO) factors
FOXO proteins are a family of transcription factors with important roles in
metabolism, cell cycle, stress tolerance and possibly lifespan (van der Horst A et al.
2007). FOXO family consists of FOXO1, 3a, 4 and 6, and FOXO proteins undergo posttranslational

modification

like

phophorylation,

ubiquitination,

acetylation

and

methylation which activates or inhibits FOXO activity (Huang H et al. 2007; Yamagata K
et al. 2008). In the presence of growth factors, FOXO phosphorylation by Akt, serum and
glucocorticoid inducible protein kinase (SGK), I-kappa B kinase (IKK) and cyclindependent kinase (CDK2) is inhibitory. However, under stress, the phosphorylation by
JNK or MST1 is stimulatory, and can induce cell death in neurons (Barthélémy C et al.
2004; Lehtinen MK et al. 2006). When FOXO proteins are inactivated, they are excluded
out of the nucleus and then degraded by proteasome; however, activated FOXOs stay in
nucleus and initiate the transcription of their target genes, including DNA repair-related
Gadd45, oxidative detoxification-related SOD2 and catalase, cell cycle-related p27KIP1,
cyclin D1 and cyclin D2, as well as apoptosis-related caspase-3, FasL, Bim, and TRAIL
(Huang H et al. 2007).
FOXO1-deficient mice died at around embryonic day 11 due to branchial arch
defects and abnormal vascular remodeling in the yolk sacs, indicating that FOXO1 is
required for mouse vascular development (Furuyama T et al. 2004). Also, FOXO1, 3, 4
triple-knockout mice developed thymic lymphomas and hemangiomas (endothelial cell
tumor), suggesting that FOXOs are tumor suppressors and specifically important for
endothelial cell homeostasis (Paik JH et al. 2007). The tumor suppressing effect of
FOXOs may be related to their pro-apoptotic functions. Also, constitutively activated
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form FOXO1-TM has been shown to induce apoptosis in leukemia-derived cell lines via
TRAIL (Kikuchi S et al. 2007); knock-down of FOXO3a by small interfering RNA
abolished free fatty acid-induced hepatocyte apoptosis and Bim induction (Barreyro FJ et
al. 2007), further indicating the promoting role of FOXOs in cell apoptosis.
FOXOs are also found to converge with the Wnt/β-catenin signaling; in 2005,
Essers MA discovered a functional interaction between FOXO and β-catenin under
oxidative stress, so a new model of Wnt/FOXO was then proposed: upon Wnt signaling
which turns TCF on, or upon insulin signaling that turns FOXOs off, β-catenin favors
interacting with TCF instead of FOXO to promote cell proliferation; in contrast, under
oxidative stress conditions where FOXO activity is on, β-catenin preferentially binds to
FOXOs to induce apoptosis or quiescence (Essers MA et al. 2005; Bowerman B. 2005).
1.3.3.1.2 p53
The transcription factor p53 is a tumor suppressor which is activated in response
to DNA damage or oncogenic transformation, and its functions in inducing cell cycle
arrest, cell death and DNA repair are well known (Harms KL et al. 2005). P53 can
promote cell apoptosis through the following mechanism: 1) p53 transactivates target
genes such as the pro-apoptotic Puma and Noxa to activate Bax both by directly
interacting with Bax and by inhibiting anti-apoptotic Bcl-xL (Nakano K et al. 2001;
Zhang Y et al. 2009); 2) p53 transactivates Bax, Bak and Bid as well as Apaf-1 to induce
MOMP which is following by caspase activation (Miyashita T et al. 1995; Kannan K et
al. 2001; Moroni MC et al. 2001; Schuler M et al. 2005). More recently, p53 has been
demonstrated to induce apoptosis through a novel transcription-independent activity.
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Upon stress, p53 translocates to mitochondria and functions as a direct apoptogenic factor
to induce MOMP by neutralizing the inhibitory effects of Bcl-2 and Bcl-xL and by
activating Bax/Bak (Mihara M et al. 2003; Chipuk JE et al. 2004). Also, p53 integrates its
transcription activity with its transcription-independent activity to induce cell apoptosis
by Puma, which is transcriptionally upregulated by nuclear p53, and also liberates p53
from Bcl-xL, allowing p53 to induce MOMP and cell apoptosis (Chipuk JE et al. 2005;
Vaseva AV et al. 2009).

1.3.3.2 mRNA stability
The fate of mRNAs has been believed to be one of the key steps in regulation of
gene expression, and the stability of mRNAs is closely controlled post-transcriptionally
(Donnini M et al. 2004). The Bcl-2 mRNA harbors an evolutionary conserved A+U-rich
element (ARE) containing several AUUUA motifs in 3’-untranslated region (UTR). The
Bcl-2 ARE has a moderate destabilizing activity, which is greatly enhanced by apoptotic
stimuli while greatly reduced by PKC stimulation, thereby decreasing or prolonging the
half-life of Bcl-2 mRNA (Schiavone N et al. 2000; Donnini M et al. 2001). Besides ARE,
the CA repeats located upstream of ARE also contribute to the degradation of Bcl-2
mRNA in the steady states (Lee JH et al. 2004).
In addition, some other members of Bcl-2 family also can be regulated at their 3’UTR area. Similar to the Bcl-2 mRNA, the expression of the anti-apoptotic Bcl-xL is
increased during apoptosis induced by UVA due to the enhanced mRNA stability through
promoting the binding of 3’-UTR with RNA-binding proteins (Bachelor MA et al. 2004).
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Another example is anti-apoptotic Bcl-w, which expression is down-regulated by miR122, a hepato-specific microRNA, by being directly targeted at 3’-UTR (Lin CJ et al.
2008).

1.3.3.1 Translational regulation
Eukaryotic translation is composed of three phases: initiation, elongation and
termination, and initiation, the rate-limiting step, is believed to be the most important and
best studied process for translational regulation (Holcik M et al. 2005). Under
physiological conditions, the majority of mature eukaryotic mRNAs undergoes
translational initiation by a cap-dependent ribosomal scanning mechanism, which
involves numerous eukaryotic initiation factors: eIF4F (cap-binding protein complex,
composed of eIF4E, 4A and 4G), eIF2 (catalyzing transfer of methionyl-tRNA to 43S
pre-initiation complex), and adaptor eIF3, etc (Graber TE et al.2007).
In contrast, in the context of apoptosis induced by cell stress, the cap-dependent
translational

initiation

is

impaired

via

distinct

mechanisms

including

eIF2

phosphorylation, eIF4E sequestration, and eIF4G proteolysis by caspases. But the
paradox is that de novo protein synthesis is needed during cell stress because the cell
must decide to live or to die by producing either more anti-apoptotic proteins to recover
itself or more pro-apoptotic proteins to sustain the death signal, so in this case, there is a
switch between the cap-dependent translation to alternative mechanisms, such as
ribosomal shunting, re-initiation and internal ribosome entry (Graber TE et al.2007;
Kozak M. 2003).
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The process of internal ribosome entry is a cap-independent translational
mechanism. Instead of employing scanning of the preinitiation complex from the 5’-cap
toward the start codon, internal ribosome entry requires the direct recruitment of
ribosomes to a complex RNA structural element called the internal ribosome entry
segment (IRES) located at 5’-untranslated region (UTR) of the mRNA, which is
facilitated by IRES trans-acting factors (ITAFs) (Spriggs KA et al.2005; Marash L et al.
2005). For example, the mRNA of X-linked inhibitor of apoptosis (XIAP), which inhibits
caspase-3 and 7 directly, has been demonstrated to contain the functional IRES motif,
and the translation directed by XIAP-IRES is resistant to cell stress induced by γirradiation or serum starvation in Hela and H661 cell lines (Holcik M et al. 1999). So the
transcription of XIAP is maintained in these tumor cells even under stress, which may be
one of mechanisms that tumor cells employ to escape apoptosis. Another anti-apoptotic
factor carrying IRES at 5’-UTR is Bcl-2, and Bcl-2 IRES activity is induced in response
to stress, resulting in increased protein levels (Sherrill KW et al. 2004). However, besides
anti-apoptotic proteins, numerous pro-apoptotic proteins initiate their translation through
IRES mechanism upon apoptosis. C-myc is a proto-oncogene, but its ectopic
overexpression can sensitize cells to apoptosis, and c-myc-deficient cells fail to undergo
apoptosis induced by DNA damage (Adachi S et al. 2000). Therefore, c-myc is necessary
for cell apoptosis. During apoptosis in Hela cells triggered by the extrinsic pathway
initiator TRAIL or the intrinsic pathway inducer staurosporine, the general protein
translation is inhibited while c-myc protein expression remains constrained, and c-myc
IRES is active while there is no increase for c-myc mRNA levels and no change in c-myc
half life, indicating c-myc protein synthesis is initiated via IRES mechanism during
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apoptosis (Stoneley M et al. 2000). Also, IRES-mediated translation of Apaf-1, but not
XIAP is enhanced during UVC irradiation induced cell death in HEK-293T cells
(Ungureanu NH et al. 2006). Additionally, under etoposide-induced DNA damage, p53
synthesis is dramatically induced in MCF-7 cells, and this translational regulation can be
at least partially explained by the identification of an active IRES site from p53 transcript
(Yang DQ et al. 2006).
The death associated protein (DAP) 5, also named p97 and NAT1, a member of
the eIF4G family lacking the eIF4E binding site, acts as a dominant negative form to
prevent cell from apoptosis (Marash L et al. 2005). Yet, DAP5/p97 can be activated
during apoptosis by caspase cleavage, yielding a C-terminal truncated protein of 86KD,
which promotes IRES mediated translation of death proteins, including c-Myc, Apaf-1,
DAP5 and XIAP (Henis-Korenblit S et al. 2000; Henis-Korenblit S et al. 2002).
Therefore, the activation of DAP5 IRES under cell apoptosis creates a positive feedback
loop to potentiate the translation of DAP5 itself and other death proteins when the general
translation machinery is abrogated, in order to help the cell to determine to live or die
under stress circumstances.

1.3.4

Biological significance
Cell death programs are believed to be key players in embryonic development,

tissue homeostasis, and cellular responses to stress, and the role of apoptosis in
physiological conditions is as important as its counterpart, cell mitosis (Blank M et al.
2007; Elmore S. 2007).
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1.3.4.1 Development
Apoptosis is a common and conserved characteristic in the development of many
mammalian organs or tissues, and apoptosis plays a critical role in the process of normal
development in vertebrate, including neural tube closure, eye development, palate
development, and deletion of Mullerian duct in males or Wolffian duct in females
(Mirkes PE. 2002). As for neural development, the nervous system initially overproduces
cells, which is then followed by the elimination of at least half of the original population
through cell apoptosis, resulting in removal of unconnected neural cells, as well as
optimization of synaptic connection and neurons (Nijhawan D et al. 2000). Furthermore,
caspase-3 knockout mice showed profound defects in brain development featuring
multiple indentations and ectopic cell masses, and these supernumerary cells were found
primarily due to a decrease of cell apoptosis in the brain, which supports that caspase-3
mediated apoptosis is crucial during morphogenetic cell death in the brain development
(Kuida K et al. 1996).

1.3.4.2 Immune system
Apoptosis is a central regulator of immune system for the maintenance of selftolerance and tight control of lymphocyte populations, which includes negative selection
of developing B cells (removing B cells expressing autoreactive B cell receptors), as well
as positive and negative selection of developing T cells (Maniati E et al. 2008).
Moreover, regulation of peripheral T cells is also dependent on cell apoptosis: T cell are
in resting status in peripheral lymphoid organs until they receive stimulating signals
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(antigen presentation); when immune response is over, activated T cell must be
eliminated via apoptosis to keep the homeostasis of immune systems (Krammer PH et al.
2007). Additionally, cytotoxic T lymphocytes (CTL) can induce apoptosis in target cells
through granzyme/perforin or Fas/Fas ligand, which is of vital importance to protect the
host from pathogenic viruses (Osborne BA. 1996; Keckler MS et al. 2007). Deregulated
immune cell death is able to give rise to severe consequences: an aberrant expansion of
apoptotic cells leads to immunodeficiency like AIDS, whereas failed apoptosis of
lymphocytes leads to lymphoma or autoimmune disorders such as autoimmune
lymphoproliferative syndrome and autoimmune diabetes (Saikumar P et al. 1999; Maniati
E et al. 2008).

1.3.4.3 Wound healing
Wound healing need a series of quick changes of specific cell populations
functioning in preparing, depositing and maturing the wound. Different cell types are
needed in specific stages, and once finishing their own missions, these cells have to be
removed through apoptosis before the next step starts, which minimizes the inflammatory
reaction and tissue injury. In the early stage of wound healing, apoptosis starts from 12
hours after wounding to eliminate inflammatory cells (neutrophils and macrophages); in
the later phase, fibroblasts and endothelial cells are found to undergo apoptosis in a
similar pattern, along with decreased cellularity and vascularity in wound during
maturation phase. Also, deregulation of cell apoptosis in wound healing causes
pathological damage to the tissue like hypertrophic scarring (Greenhalgh DG. 1998).
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1.3.4.4 Carcinogenesis
A major cause of malignant transformation and tumor formation is the genetic
abnormalities in pathways that regulate cellular growth and death. Indeed, suppression or
failure of apoptosis is one of key features in cancer cells, and one of the central players in
the development and progression of some cancers (Elmore S. 2007). Inhibited apoptosis
not only is associated with the transformation process in tumor development, but also
lead to the resistance of cancer cells to treatments such as chemotherapy. Thus FasL
delivery by tissue-specific virus is based on tumor-specific translation of tumor-killing
genes, and showed antitumor effect in prostate cancer cells and in mice (Li X et al. 2007).
Mutations of apoptotic factors affect either their activity or their expression.
Apoptosis-related genes that draw most attentions in cancer research are p53 and Bcl-2.
Mutations of p53 have been found in nearly all the tumor types, and may be associated
with half of all cancers, which makes p53 one of most prominent tumor suppressor
(Amundson SA et al. 1998). The majority of p53 mutations is missense and located in the
DNA binding domain, leading to disrupted p53 activity in cancers (Rose SL et al. 2003).
The proto-oncogene bcl-2 was identified at the chromosomal break point of t(14;18) in
patients with B cell follicular lymphomas, resulting in abnormally high-level expression
of Bcl-2 at transcription levels (Sentman CL et al. 1991; Malagurneral L. 2004). Bcl-2
transgenic mice showed elongated survival of B cells and T cells, and more resistance to
cell apoptosis induced by glucocorticoid, radiation and anti-CD3 (Sentman CL et al.
1991). Besides, other factors in apoptotic pathways are also related to tumorigenesis.
Bax-deficient mice displayed accelerated tumor growth and abolished apoptosis (Yin C et
al. 1997), and a human study also reported that 21 out of 41 case of primary colon
83

adenocarcinomas carried frameshift mutations within Bax gene, further proving that the
relationship between genetic alternation of apoptotic molecules and carcinogenesis
(Rampino N et al. 1997).

1.3.5

Endothelial cell apoptosis

1.3.5.1 Physiological importance
Vascular endothelial cells (ECs) form the inner lining of blood vessels and the
heart, and regulate the permeability of blood vessels to leukocytes and inflammatory
factors (Choy JC et al. 2001). During both physiological development and pathological
conditions, neovascularization and the vessel regression are determined by the balance
between proliferation and apoptosis of ECs; and in mature vessels, EC turnover is also
tightly controlled to maintain vessel homeostasis (Mallat Z et al. 2000).
EC apoptosis have been shown to be required for vessel regression during normal
vessel development and remodeling. Macrophage ablation transgenic mice showed eye
defects due to persistence of normally transient remnants of hyaloid vessel system of the
eye and persistence of the excessive papillary membrane, demonstrating that macrophage
actively elicits endothelial cell apoptosis, leading to normal capillary regression, which
ensures the proper development of the eye (Lang RA et al. 1993). The dead cells are
thereby mobilized into the capillary lumen causing restriction and a block to blood flow.
At this point, vascular ECs undergo a secondary apoptosis with a synchronous pattern,
leading to another capillary regression to clear off all remaining cells in the affected
segment (Meeson A et al.1996). Another example is that during the regression of the
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corpus luteum in the guinea pig, there is rapid endothelial cell death in ovarian blood
vessel with prominent apoptotic features (nuclear condensation and fragmentation) (Azmi
et al. 1984), also indicating the relationship between endothelial cell apoptosis and vessel
regression.
1.3.5.2 Pathological importance
As the vascular endothelium is critical for various normal conditions, endothelial
cell apoptosis may be involved in diverse pathological circumstances like atherosclerosis
and angiogenesis (Mallat Z et al. 2000; Dimmeler S et al. 2000).
Atherosclerosis is a multifactorial disease which develops in the arterial wall in
response to numerous pathological insults and results in excessive inflammatory injury
and fibro-proliferative plaque (Sima AV et al.2009). A number of evidences have shown
increased EC apoptosis in atherosclerotic plaques compared with normal tissues (Choy
JC et al. 2001). EC apoptosis may be induced by oxLDL, cytotoxic T lymphocytes
(CTL), cytokines, ROS or local inflammatory mediators (Sima AV et al.2009). In the
early stage of atherosclerosis, EC apoptosis induces loss of EC number and EC integrity,
leading to enhanced vascular permeability, vascular smooth muscle cell migration and
increased blood coagulation (Choy JC et al. 2001).
Angiogenesis is the process of neovasuclarization during both development and
postnatal period, mediated by proliferation, migration and remodeling of differentiated
endothelial cells. Unlike being mainly deleterious in atherosclerosis, EC apoptosis,
counteracting proliferation, has an inhibitory function in tumor angiogenesis (Dimmeler
S et al. 2000). Vascular endothelial growth factor (VEGF), which is a required growth
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factor for angiogenesis, can efficiently block endothelial cell apoptosis through various
mechanisms including: 1) inducing Bcl-2 expression (Pidgeon GP et al. 2001); 2)
activating extracellular signal regulated kinase (ERK) 1 and ERK2 signaling and
inhibiting stress-activated protein kinase (SAPK) /JNK signaling (Gupta K et al. 1999);
3) activating PI3-kinase/Akt pathway through VEGF receptor, fetal liver kinase-1(Flk1)/kinase-insert domain-containing receptor (KDR) (Gerber HP et al. 1998). Moreover,
administration of anti-VEGF monoclonal antibodies results in regression of tumorassociated vasculature in xenograft mouse models (Yuan F et al. 1996). Thus, VEGF
becomes a privileged target for the control of angiogenesis in anti-tumoral goal, and antiVEGF treatment has been applied in tumor therapy. A single infusion of the anti-VEGF
antibody bevacizumab reduced blood

perfusion of tumor, vascular volume,

microvasucular density (MVD) and interstitial fluid pressure (IFP), as well as amount of
circulating endothelial cells and progenitors in 6 patients with rectal cancer, which
directly indicates the antivascular role of anti-VEGF therapy in human tumors (Willett
CG et al. 2004).

1.3.6

Wnts/wnt signaling and cell apoptosis

1.3.6.1 Wnt proteins and cell apoptosis
Wnt proteins, serving as stem cell factors in development and adult homeostasis,
are usually thought to have proliferating or anti-apoptotic functions. Nonetheless, the role
of Wnts in cell apoptosis is more complex: generally speaking, in transformed cells, Wnts
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show anti-apoptotic actions; in contrast, in normal cells, Wnts seem to have pro-apoptotic
functions.
Transformed HEK293 cells stably transfected with Wnt3a and 5a showed reduced
apoptosis induced by serum-starvation compared to cells transfected with vectors (Jia L
et al. 2008). And Wnt1, 3a and 5a were found to prevent cell apoptosis in the
uncommitted bipotential C2C12 cells, the pre-osteoblastic cell line MC3T3-E1, and bone
marrow-derived OB-6 osteoblasts (Almeida M et al. 2005). However, Wnt7b was shown
to mediate macrophage-induced programmed cell death in the developing mouse eye
(Lobov IB et al. 2005). And the overexpression of Wnt5a led to increased apoptosis in
thymocytes in vitro (Liang H et al. 2007). Wnt3a showed pro-apoptotic functions in the
H9C2 cardiomyoblast line subjected to hypoxia reoxygenation (HR) injury (Zhang Z et
al. 2009).
Our laboratory showed that nuclear Wnt13 forms significantly increased the
appearance of apoptotic nuclei in BAEC. At the basal level, the caspase-3 cleavage was
undetectable in BAEC transfected with different Wnt13 isoforms; however, the activated
caspase-3 was observed when BAEC was treated with TNF-α (5ng/ml) for 12 hours, and
under this condition, nuclear Wnt13 forms further increased the levels of caspase-3
activation, suggesting that nuclear Wnt13 forms enhance the susceptibility of endothelial
cells to stimuli during apoptosis (Struewing IT et al. 2006).
All these studies show that the differential effects of Wnts on cell apoptosis are
dependent on cell type and possibly cell status. And since Wnt13 have 3 different
isoforms with distinct subcellular localizations which can underlie possible differential
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effects of three Wnt13 forms, it is of our interest to further analyze the role of Wnt13
isoforms in apoptosis and to determine the mechanisms.

1.3.6.2 GSK-3β and cell apoptosis
GSK-3β, a multi-functional serine/threonine kinase, is the key regulator in Wnt
signaling and insulin signaling, and also implicated in the development of a variety of
human diseases including cardiovascular diseases, neurodegenerative disease, bipolar
disorder and cancer (Luo J. 2009). Overexpression of GSK-3β was sufficient to trigger
apoptosis in different types of cells, such as neurons, vascular smooth muscle cells,
human umbilical vein endothelial cells (HUVEC), and astrocytes (Li M et al. 2000; Hall
JL et al. 2001; Kim HS et al. 2002; Sanchez JF et al. 2003). And GSK-3β has been found
to promote the intrinsic apoptotic pathway triggered by different cellular insults, such as
DNA damage, ER stress, hypoxia, removal of NGF or BDNF, hypertonic stress,
oxidative stress, mitochondrial toxins and ceramide, by regulating transcription factors
like p53 that controls pro- and anti-apoptotic proteins, by promoting microtubule
disruption, and by inducing mitochondrial disruption though activating pro-apoptotic
members like Bax or degrading anti-apoptotic members like Mcl-1 (Beurer E et al. 2006;
Forde JE et al. 2007). Moreover, the subcellular localization of GSK-3β was shown
important for its functions. In embryonic stem cells (ESCs), GSK-3β shuttled between
the cytoplasm and the nucleus through Akt signaling: Akt activity inactivated and
exported GSK-3β to the cytosol; however, the decreased Akt signaling promoted
accumulation of the active GSK-3β which inhibit c-myc through phosphorylation,
resulting in differentiation instead of self-renewal in ESCs (Bechard M et al. 2009). Also,
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in untreated human neuroblastoma cells, GSK-3β was mainly located in cytoplasm;
however, the exposure of cells to different pro-apoptotic stimuli like serum-starvation,
heat shock or staurosporine induced a rapid increase of nuclear GSK-3β (Bijur GN et al.
2001), further suggesting that the subcellular distribution of GSK-3β is dynamically
regulated by pro-apoptotic or anti-apoptotic signals. On the other hand, Lithium, the
inhibitor of GSK-3β, reduced mouse acute renal failure induced by LPS via attenuating
inflammation and renal cell apoptosis (Wang Y et al. 2009), further indicating that GSK3β has promoting role in cell apoptosis and inflammation.
Ironically, GSK-3β was also been found to prevent apoptosis in some conditions.
For example, lithium was shown to sensitize primary rat hepatocytes to TNFα-induced
apoptosis (Schwabe RF et al. 2002); also, inhibition of GSK3 by chemical or RNA
interference led to glioma cell death, accompanied with c-myc activation, the
upregulation of pro-apoptotic factors and destroyed NF-κB activity (Kotliarova S et al.
2008). The homozygous GSK-3β knockout mouse embryos were non-viable, and
histological examination of GSK-3β-/- embryos showed multifocal hemorrhage in liver
with severe apoptosis, and embryonic fibroblasts from GSK-3β-/- embryos had increased
sensitivity to TNF-induced apoptosis, also indicating that GSK-3β is required for cell
survival (Hoeflich KP et al. 2000).All the above observations make it difficult to clearly
define the function of GSK-3β in cell apoptosis due to its range of conflicting roles, but
in general, more evidence supports the pro-apoptotic function of active GSK-3β.
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1.3.6.3 C-myc and cell apoptosis
The transcription factor c-myc is a proto-oncogene which constitutive expression
results in the development and progression of tumors. c-myc transactivates cell cycle
promoting genes like cdc25A, cdk4 as well as cyclin D2,-E, -A while suppresses cell
cycle inhibiting genes such as gas1, p15, p21cip and p27kip (Gartel AL et al. 2003).
Interestingly, increasing evidence shows that inappropriate c-myc expression not only
promotes cell proliferation and oncogenesis, but it also can induce or sensitize cells to
apoptosis (Hoffman B et al. 1998). For example, in IL-3 dependent myeloid cell line,
enforced c-myc expression accelerated cell apoptosis in the absence of IL-3 (Askewe DS
et al. 1991). Besides, other cell types like hepatocytes and epithelial cells can also be
subjected to similar apoptotic responses induced by c-myc (Hoffman B et al. 1998). The
underlying mechanisms implicated in c-myc-induced apoptosis are very complex: 1) cmyc stabilizes p53 by p19ARF; 2) c-myc upregulates the expression of pro-apoptotic Bax
and Bim, while blocks the expression of anti-apoptotic Bcl-2 and Bcl-xL, resulting in
cytochrome c release; 3) c-myc may cause DNA double strand breaks to induce apoptosis
(Adhikary S et al. 2005; Hoffman B et al. 2008).

1.3.6.4 Other Wnt signaling components and cell apoptosis
Overexpression of Wnt receptors like Fz1 and Fz2 in COS7 and HEK293 cells
resulted in increased cell apoptosis detected by TUNEL staining and DNA ladder assay
(van Gijn ME et al. 2001). Also, Xenopus embryos injected with Xfz8 showed increased
cell apoptosis with the involvement of JNK activation (Lisovsky M et al. 2002).
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Moreover, the JNK pathway, which is the downstream signaling of Wnt-PCP pathway,
has been shown a causal role in inducing apoptosis: one mechanism could be the
upregulation of pro-apoptotic TNF superfamily members (TRAIL, FasL) at the
transcription level; the other mechanism may be related to the inactivation of Bcl-2 by
phosphorylation (Basu S et al. 1998; Shen HM et al. 2006).
In the canonical Wnt signaling, accumulated β-catenin can translocate to the
nucleus and activate TCF/LEF to regulate the expression of cell proliferation-related
genes. Transgenic mice expressing a stabilized form of β-catenin in T cell compartment
showed increased number of CD4+CD8+ double-positive (DP) thymocytes than wildtype,
and DP thymocytes protection against spontaneous and glucocorticoid-induced apoptosis
by upregulating Bcl-xL levels transcriptionally (Xie H et al.2005). However, the same
group found that the β-catenin transgenic mice had accelerated deletion of Vβ8+ CD4+ T
cells than wildtype mice, which was associated with AICD by promoting Fas-induced T
cell apoptosis through enhancing Fas promoter activity (Huang Z et al. 2008). These
results indicate that β-catenin has distinct roles between in early developing T cells and in
peripheral mature T cells. Moreover, in HCT116 colon cancer cells, stabilized β-catenin
inhibited FOXO3a-induced cell apoptosis (Dhener M et al. 2008).
Axin, a component of β-catenin destruction complex, shows pro-apoptotic
functions as a tumor repressor in cells. Exogenous Axin expression induced cytochrome c
release, while knockdown of Axin attenuated UV-induced apoptosis in vitro (Li Q et al.
2007). Upon UV irradiation, Axin is found to translocate to the nucleus where it binds
Daxx, a death-domain associated protein, to interact with p53, thereby inducing apoptosis
by stimulating p53 transcription activity (Li Q et al. 2007; Lin SC et al. 2007). In
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astrocytoma cases, the expression levels of Axin was inversely correlated to the
progression of the tumor, and overexpression of Axin in astrocytoma cells promoted cell
death while inhibited cell proliferation possibly through the p53-dependent pathway
(Zhang LY et al. 2009).
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Figure 1.3 Schematic representation of the extrinsic and intrinsic apoptotic pathways. In
the intrinsic apoptotic pathway, BH3-only proteins like Bim liberate Bax from Bcl-2 and
promote Bax oligomerization and the formation of MOMP, resulting in the release of
pro-apoptotic molecules like cytochrome c, Smac/DIABLO from the mitochondria.
Cytochrome c binds and activates apoptotic protease-activating factor (Apaf)-1, forming
the apoptosome complex with procaspase-9, which leads to the generation of active
caspase-9. Meanwhile, Smac can inhibit inhibitor of apoptotic proteins (IAP) to further
activate caspase-9, which in turn, induces the cleavage of executioner caspase-3, 6 and 7.
In the extrinsic apoptotic pathway, the interaction between Fas ligand/TRAIL/TNF and
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Fas/DR4, 5/TNFR leads to the recruitment of adapter proteins FADD and TRADD,
which then bind procaspase-8, and subsequently caspase-8 is activated to trigger effector
caspases either directly or through a BH3 only protein tBid. The activation of executioner
caspases will cleave their substrates (actin, Lamins, ACINUS, ICAD) to induce
morphological changes and DNA fragmentation in apoptotic cells (Blank M et al. 2006).

Copyright © Tao Tang 2009
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CHAPTER 2. CENTRAL HYPOTHESIS AND SPECIFIC AIMS

Wnt proteins are critical for development and adult homeostasis by controlling
cell fate (Moon RT et al. 1997), and they can have either pro-apoptotic or anti-apoptotic
functions in different cell systems (Almeida M et al. 2005; Lobov IB et al. 2005). Wnt13
is one of the major Wnt genes expressed in differentiated endothelial cells (Struewing IT
et al. 2006). Three isoforms of human Wnt13 have been identified in endothelial cells
with different subcellular localizations: secreted Wnt13A (localized in endoplasmic
reticulum), mitochondrial Wnt13B and nuclear Wnt13C, which are generated through
alternative promoter, alternative splicing, and alternative translational start sites
(Struewing IT et al. 2006). Wnt13 nuclear forms showed an increased sensitivity to LPS
or TNF induced apoptosis in primary endothelial cells (Struewing IT et al. 2006).
However, it is unclear whether the expression Wnt13 isoforms undergo regulation and
whether there are differential functions of Wnt13 isoforms depending on their subcellular
localizations.
Central hypothesis: In differentiated endothelial cells, the expression of
nuclear Wnt13C is regulated at translational levels during apoptosis; and nuclear
Wnt13 isoforms favor apoptosis through regulating the activity or expression of
apoptosis-related factors; also, distinct isoforms of Wnt13 may have differential
effects on endothelial cell apoptosis and apoptosis-related factors.
Wnt13C and short form of Wnt13B encodes the same protein translated form
AUG+74, but the expression of this protein encoded by Wnt13C was found out much
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lower than those which are encoded by Wnt13B and M1L-Wnt13B (Struewing IT et al.
2006), suggesting a possible regulation during Wnt13C translation. During apoptosis, the
general translational machinery via cap-dependent mechanism is inhibited. But, protein
synthesis of some apoptotic-related factors is required to help cell fate decision of either
self-recovery or suicide, so alternative mechanisms, such as internal ribosomal entry, are
employed to initiate translation of some proteins, including anti-apoptotic XIAP, Bcl-2,
as well as pro-apoptotic c-myc, Apaf-1, p53. Since nuclear Wnt13 forms increase the
endothelial cell susceptibility to apoptotic stimuli, it is of interest to know if nuclear
Wnt13C behaves like other pro-apoptotic or anti-apoptotic factors (c-myc and Bcl-2),
which expression is maintained or induced under stress and regulated at translational
level during apoptosis.
Aim 1: To study whether the expression of nuclear Wnt13 form is regulated
at translational levels during endothelial cell apoptosis (Figure 2).

Cell apoptosis is believed to be a key player in embryonic development and cell
homeostasis, and it can be tightly regulated at different levels (Blank M et al. 2007;
Elmore S. 2007). Apoptosis is controlled by the balance of pro-apoptotic factors against
anti-apoptotic factors, which serves as an indicator of cell susceptibility to apoptosis
(Nakajima T et al. 2006). Indeed, apoptotic events take place in different subcellular
organelles: the release of cytochrome c from the mitochondria, caspase cleavage in the
cytoplasm, and DNA fragmentation or the transactivation of transcription factor p53 in
the nucleus. Therefore, three Wnt13 isoforms may show differential effects on
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endothelial cell susceptibility to apoptosis through regulating different apoptotic events in
the organelles where they are located.
Also, the mechanism that increased endothelial cell apoptosis by nuclear Wnt13
has yet to be investigated. The Bcl-2 family includes pro-apoptotic members like Bax and
Bim as well as anti-apoptotic members like Bcl-2, which balance functions as a crucial
switch to determine whether the cell undergo apoptosis (Youle RJ et al. 2008); also, Bcl2 members are involved in the Wnt-related apoptosis during development (Liang H et al.
2007). Akt signaling is a pro-survival pathway, which inactivation leads to cell apoptosis
by activating pro-apoptotic factors such as caspase-9, Bcl-2 family member Bad, and
FOXO factors (Jiang BH et al. 2008; Dillon RL et al. 2007). And Akt signaling not only
cross-talks with Wnt signaling through GSK-3β, but it plays a critical role in Wnt cascade
(Longo KA et al. 2002; Almedida M et al. 2005; Constantinou T et al. 2008; Naito AT et
al. 2005). Therefore, it is necessary to study whether the nuclear Wnt13 forms increase
apoptosis in endothelial cells through tipping the balance of Bcl-2 family to pro-apoptotic
members, and the involvement of Akt signaling.
Aim 2: To study the differential effects of Wnt13 isoforms located in different
subcellular organelles in endothelial cell apoptosis, and whether Wnt13 forms affect
apoptosis though modulating the activity or expression of apoptotic effectors and
regulators (Figure 2).

In Aim2, we found that nuclear Wnt13 forms increased endothelial cell sensitivity
to apoptosis possibly through upregulating the activity/expression of caspases, and Bim
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expression. FOXO transcription factors, which activation is inhibited by Akt survival
signaling, target and transactivate some apoptotic-related genes like caspase-3, Bim,
FasL as well as TRAIL, and can induce apoptosis when constitutively activated in certain
cell types (Huang H et al. 2007). Additionally, FOXOs are also found to converge with
Wnt-signaling (Essers MA et al. 2005). Therefore, FOXOs could be the upstream
regulator to increase BAEC apoptosis by Wnt13 proteins. Moreover, stress resistancerelated SOD2 and catalase are also the target genes of FOXOs (Huang H et al. 2007), and
activated FOXOs can bind Forkhead binding site in SOD2 gene to promote SOD2 gene
transcription (Kops GJ et al. 2002), so the expression and transcription of SOD2 and
catalase may be another way to confirm FOXO activation since different posttranslational modifications of FOXOs might be important for apoptotic genes and
oxidative stress resistance genes. Therefore, to confirm the activation of FOXOs by
Wnt13 proteins, it is interesting to know the effect of Wnt13 forms on the expression of
oxidative stress resistance genes and SOD2 transcriptional regulation.
Aim 3: To study whether Wnt13 forms have differential effects on the
expression and activation of FOXOs that mediate the transcriptional regulation of
FOXO target genes related to apoptosis and oxidative stress resistance (Figure 2).
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Figure 2 Specific aims in this dissertation. As some apoptotic factors are translationally
regulated by cell apoptosis, the Aim1 is to study whether the expression of nuclear
Wnt13 form is regulated at translational levels during endothelial cell apoptosis. Since
caspases, Bcl-2 family members and FOXOs are crucial players in apoptosis, the Aim 2
is to study the differential effects of Wnt13 forms located in different subcellular
organelles in endothelial cell apoptosis, and whether Wnt13 forms affect apoptosis
through modulating expression/activation of apoptotisis-related factors. Moreover,
FOXOs are transcription factors to transactivate pro-apoptotic factors such as Bim, and
SOD2 and catalase are also oxidative stress resistance-related FOXO target genes, so
Aim3 is to study whether Wnt13 forms have differential effects on the expression and
activation of FOXOs that mediate the transcriptional regulation of FOXO target genes
related to apoptosis and oxidative stress resistance.
Copyright © Tao Tang 2009
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CHAPTER 3. GENERAL METHODS

3.1 Materials
Lipolysaccharide (LPS) and tumor necrosis factor (TNF) α were purchase form
Calbiochem. The rabbit polyclonal antibodies against β-actin, D175 cleaved-caspase-3,
and the secondary horseradish peroxidase (HRP) –conjugated antibodies were products
from Cell Signaling Technology. The rabbit polyclonal anti-Flag tag antibodies were
purchased from Cayman-Chemicals. Alexa-488 and Alexa-568 secondary antibodies as
well as Mitotracker-633 deep red were products from Moleuclar Probes.

3.2 Cell culture
The bovine aortic endothelial cells (BAEC) were purchased from Cambrex, and
maintained in 1 g/l glucose Dulbecco Modified Enriched medium (DMEM)
supplemented with 5% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml
streptomycin at 37oC, 5% CO2.

3.3 Transient transfection
Cells were plated and grown to 70% confluency before transfection. Cell transient
transfections were performed with ExGen 500 reagent (MBI Fermentas) according to the
recommendations of the manufacturer. Briefly, for 1 105 cells, 1 µg plasmid DNA was
diluted with 50 µl sterile 150 mM NaCl, and mixed with 50 µl diluted ExGen 500 reagent
(1:9 in150 mM NaCl). The ExGen-DNA complex was then incubated at room
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temperature for 15 minutes, and mixed with DMEM (no serum). After media change,
cells were incubated with ExGen-DNA complex under 37oC, and 2 hours later, the
transfection complex was replaced by complete growth media.

3.4 Plasmid constructs
The Wnt13A-Flag, Wnt13B-Flag, Wnt13C-Flag, M1L-Wnt13B-Flag and M1LWnt13B-Flag expression constructs were previously described (Struewing IT et al. 2006).

3.5 RNA isolation and real-time PCR
3.5.1 RNA isolation
Total RNA was isolated using Trizol reagent (Invitrogen). Briefly, for a 6 well
plate, cells in each well were added with 1ml Trizol after medium removal, and scrapped
off the plate, followed by being transferred into a microcentrifuge tube. 200 µl
Chloroform was then added to the tube, and mixed. After 10 minute incubation, the
Trizol-CHCl3 mixture was centrifuged at 12,000g for 10 minutes. The top layer was
transferred to another tube, and mixed with 500 µl isopropanol prior to another 10 minute
incubation and centrifuge. The RNA pellet was then washed by 500 µl 70% ethanol,
followed by centrifugation for 5 minutes. After the supernatant was discarded, the pellet
was left in room temperature until it became clear. Then 22 µl nuclease free water was
added to dissolve the pellet. 1µl of RNA solution was used to measure the OD value and
260/280 ratio by spectrometer, and another 1µl of RNA was loaded to fresh 1% agarose
gel for electrophoresis to check the RNA quality. The isolated RNA was either used for
reverse transcription immediately or stored at -80oC for later experiments.
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3.5.2 Reverse Transcription
Total RNA (1μg) was firstly treated by DNase-I (Invitrogen) with reaction buffer
for 15min at room temperature to remove any genomic DNA contaminations until 2 µl 25
mM EDTA was added to stop the reaction. After 10 minute incubation at 65 oC, The
RNA-DNase I mixture was transferred on ice and added with 0.5 μg Oligo(dT)
(Invitrogen), followed by another 10 minute incubation at 65 oC. The RNA mixture was
then left on ice for at least 1 minute prior to being incubated with 1 µl (200U)
SuperScript III reverse transcriptase (Invitrogen) as well as its reaction buffer (1 µl 0.1 M
DTT, 0.6 µl RNaseOUT (Invitrogen), and 0.4 µl 25mM dNTP) at 50 oC for 1 hour, then
inactivated by incubation at 70 oC for 15 minutes. Then the 20µl cDNA solution was
diluted to 60 µl of total volume with Nuclear-Free Water and then stored in -80 oC.

3.5.3 Real-time PCR
The real-time PCR was performed in duplicates, with an equivalent of 16ng total
RNA reaction and 10 pmoles of primers, using the SYBR-Green Kit (Applied Biosystems) in ABI7000 apparatus (Applied Bio-systems). Each 25µl reaction also contained
1

SYBR-Green PCR reaction buffer, 3.0 µl 25mM MgCl2 solution, 2.0 µl 12.5mM

dNTP, 0.25µl 1U/µl Amperase UNG, 0.125µl 5U/µl AmpliTaq Gold. RPL30 was used as
the internal standard gene. Real-time PCR conditions for all genes were as follows: 2
minutes at 50 oC; 10 minute at 95 oC; 40 cycles of 15 seconds at 95 oC and 1 minute at 60
o

C. At the end of the runs, data were analyzed. Ct values obtained from the amplification

curve of the gene of interest were normalized to that obtained form the amplification
curve of RPL30, to correct for equal amounts of starting RNA.
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3.6 Cell extracts and western blot analysis
For whole cell extracts, cells were harvested by centrifugation at 600g for 5
minutes after being scrapped off the plates. After washing by PBS buffer, each 1 105
cells were lysed with 125 µl 50mM HEPES, pH7.4, 0.1% CHAPS, 5mM DTT, and 2mM
EDTA in the presence of protease and phosphatase cocktail inhibitors (Sigma). After
freeze-thaw cycles, each 125 µl cell lysate was added with 25 μl 6 Laemmli buffer, and
then boiled for 5 minutes. Subsequently, 25ul lysates from each sample were loaded on
SDS-polyacrylamide gels (ranging from 8% to 14%, depending on the size of protein of
interest) for electrophoresis, and proteins were then transferred onto Immobilon P
membrane (Minipore). After blocking with 3% fat free milk (BioRad), the membranes
were incubated with specific primary antibodies overnight, followed by washing with 3
time TBS-Tween buffer (10 minutes for each time). Subsequently, the membranes were
incubated with the corresponding secondary antibodies conjugated to horseradish
peroxidase (HRP) for 1-2 hours and also followed by the same wash for 3 times. Each
membrane with Immuno-reactive proteins and conjugated HRP were detected using the
mixture of 1.5 μl stable peroxide buffer and 1.5 μl Lumino enhancer buffer supplied by
SuperSignal chemiluminescence (Pierce Chemical Co), and exposed for an appropriate
time ranging from 1 second to 20 minutes. At last, the intensity of each band including
loading control β-actin was quantified by densitometry with Scion software, and the
expression level of each protein of interest was shown as the ratio of Density (protein of
interest)/Density (β-actin).
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3.7 Plasmid DNA purification
3.7.1 Minipreps
For small amount of plasmid DNA isolation, Wizard® Plus SV Minipreps DNA
Purification Systems (Promega) were used. According to the manufacture’s instruction,
for each sample, 1ml bacterial culture was harvested by centrifugation for 5 minutes at
highest speed (14 103 rpm) in a tabletop centrifuge. Supernatant was then poured, and
250µl Cell Resuspension Solution was added to the cell pellet, followed by thorough
resuspension by pipetting. 10µl Alkaline Protease Solution was then added and mixed
with cell pellet suspension by inverting the tube 4 times. Subsequently, 250µl of Cell
Lysis Solution was added and mixed by inverting the tube 4 times, which was then
incubated for 5 minutes. 350µl Neutralization Solution was added to the tube and mixed
immediately by inverting the tube 4 times, followed by centrifuging the bacterial lysate at
maximum speed for 10 minutes at room temperature. Afterwards, the cleared lysate was
transferred to the prepared Spin Column by decanting, and then centrifuged at maximum
speed for 1 minute at room temperature. The Spin Column was removed, and reinserted
into the Collection Tube after flowthrough was discarded from the Collection Tube. The
Spin Column was then added by 750 µl Column Wash Solution, and centrifuged at
maximum speed for 1 minute at room temperature, with flowthrough discarded. The
wash procedure was repeated using 250 µl Column Wash Solution, followed by
centrifugation at maximum speed for 2 minutes. Then, the Spin Column was transferred
to a new, sterile microcentrifuge tube, and plasmic DNA was eluted by adding 100 µl
Nuclease-Free Water and subsequent centrifuging for 1minute.
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3.7.2 Maxipreps
For large amount of plasmid DNA purification, UltraMobiusTM 200 plasmid Kits
(Novagen) were used in our study, based on the manufacture’s manuals. For each sample,
100ml bacterial culture was centrifuged at 6,000 rpm for 20 minutes (4oC), and the pellet
was then resuspended in 3ml Bacterial Resuspension Buffer supplemented with RNase A.
After this, the pellet was added with 3ml Bacterial Lysis Buffer, which was then mixed
by inverting the bottle, followed by 5 minute incubation at room temperature. 3ml of
Mobius Neutralization Buffer was added to the lysate, which was then incubated on ice
for 5 minutes, prior to centrifuging at 10,000 rpm for 20 minutes. The supernatant was
filtered, supplemented with 1.5ml Detox Agent, and incubated on ice for 30 minutes. The
supernatant mixture was then applied to the equilibrated Mobius 200 Column, which was
subsequently washed with 10ml Mobius Wash Buffer, and eluted with 2.5ml Mobius
Elution Buffer. The elution was added and mixed with 1.75ml isopropanol prior to the
centrifugation at 15,000 rpm for 20 minutes. Then, the pellet was washed by 3ml 70%
ethanol, followed by another centrifugation for 10 minutes. Once dried, the pellet was
dissolved in 400ul TE buffer, and the OD value was measured by spectrometer before the
storage of the purified DNA solution.

3.8 Immunofluorescence microscopy
BAECs were plated in LabTek slide chambers 24 hours prior to transfection. 40
hours after transfection, when required, BAECs were incubated with 100nM Mitotracker633 deep red (Molecular Probes) in growth media for 1 hour to stain mitochondria,
followed by cell washes 3 times with PBS supplemented with 1mM CaCl2 and 1mM
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MgCl2. Then cells were fixed in 4% formaldehyde for 17 minutes prior to 3 time cell
washes, and were permeabilized and blocked in PBS, 0.1% Triton X-100, 0.7% fish skin
gelatin (Sigma) at 37oC for 30 minutes. Fixed cells were then incubated sequentially with
primary antibodies and Alexa-secondary antibodies for 2 hours each in the gelatin buffer,
and each incubation was followed by 3 time cell wash using the gelatin buffer.
Subsequently, cells in the chambers were finally washed with PBS (CaCl2 and MgCl2),
and mounted with Vectashield H1200 (Vectro Laboratories Inc.) supplemented with 4’,
6-diamidino-2-phenylindole (DAPI) to stain nuclei, and finally observed under Nikon
ECLIPSE TE 2000-U.

3.9 Statistical analysis
All results are expressed as mean ± SEM. Analysis of variance (ANOVA) is valid
if 1) all groups of observations represent random samples; 2) the population distributions
must be approximately normal (Probability and statistics Ebook, Statistics Online
Computational Resource, SOCR). Thus, for the values represented by the relative levels
over PCR3 control, if PCR3 control was set as 1, which did not fall in normal
distribution, One Way ANOVA analysis was not appropriate at this point; therefore, as
suggested by stasticians, One Sample T-test (hypothesized value = 1) was used.
Statistical significance was accepted at a value of P<0.05. However, if the values of
PCR3 control follow normal distribution, One Way ANOVA analysis was used followed
by Tukey’s test for differences between groups.
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3.10 Wnt13-Flag-expressing system
3.10.1 Transient transfection
After transient transfection, the expression of Wnt13-Flag isoforms was detected
by immunoblotting. As shown in Figure 3.1, PCR3 was the vector control which did not
express Wnt13-Flag proteins. Wnt13A-Flag displayed one single band of 41KD in size,
and Wnt13B-Flag expressed a protein doublet because Wnt13B mRNA gave rise to a
long form and a short form at protein levels due to alternative start codons, (AUG (+1)
and AUG (+74) (Struewing IT et al. 2006). For Wnt13C-Flag, only one single protein
equivalent to short form of Wnt13B was detected, and the expression level is very low.
M1L-Wnt13B-Flag only encoded the short form of Wnt13B because the first codon AUG
(+1) was mutated, and the expression was dramatically higher than that of Wnt13C,
which will be stated in the Aim1. And M74L-Wnt13B exclusively expressed the long
form of Wnt13B since AUG+74 was mutated. The expression pattern in Wnt13-Flag
protein

level

during

transient

transfection

were

M1L-

Wnt13B>Wnt13B>Wnt13A>M74L-Wnt13B>Wnt13C. Moreover, the protein level of
Wnt13C was increased upon LPS treatment, which is also described in Aim1.

3.10.2 Stable transfection
We have tried to track the expression of Wnt13-Flag in stably-transfected BAECs
by western blotting, but except Wnt13A, all the other forms of Wnt13 were almost
undetectable (data not shown), suggesting that stable transfection has lower expression
levels than transient transfection. Therefore, we employed immunofluorescence
microscopy to determine the expression of Wnt13-Flag in stably-transfected BAECs. As
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shown in Figure 3.2, the subcellular localization of Wnt13 isoforms in stable transfection
was not distinguishable than that in transient transfection: Wnt13A-Flag was localized in
ER; Wnt13B and M74L-Wnt13B were mitochondrial forms; Wnt13C and M1L-Wnt13B
were localized in the nucleus. However, the expression pattern in stable transfection was
found out different: Wnt13A>Wnt13C=M1L-Wnt13B>M74L-Wnt13B>Wnt13B (data
not shown). And this difference in protein levels may underlie the difference in the
effects of Wnt13 forms between stable transfection and transient transifection which is
described in Aim2.
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Figure 3.1 The expression patterns of Wnt13-Flag isoforms in transiently transfected
BAECs with or without LPS treatment. BAECs were transiently transfected with the
PCR3 vector or Wnt13-Flag constructs for 24 hours followed by being treated with or
without 100ng/ml LPS. 16 hours later, cells were harvested and lysed whole cell exacts
were prepared and Flag-tag and β actin were analyzed by immunoblotting with specific
antibodies.
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Figure 3.2 The expression patterns and subcellular localizations of Wnt13-Flag isoforms
in stably transfected BAECs. BAECs with stably-expressed Wnt13-Flag constructs were
incubated with growth media supplemented with Mitotracker-633 deep red for
mitochondrial staining (blue), and then fixed with 4% formaldehyde, permeabilized in
0.1% Triton, and stained with rabbit polyclonal anti-Flag antibody (green) and mouse
monoclonal β-catenin (red), followed by the incubation of Alexa goat anti-rabbit 488 and
Alexa goat anti-mouse 568 antibodies.
Copyright © Tao Tang 2009
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CHAPTER 4. SPECIFIC AIM 1
To study the expression of nuclear Wnt13 forms is regulated at translational
levels during endothelial cell apoptosis

4.1 Summary
Wnt proteins control cell proliferation, cell differentiation and cell fate during
embryonic development and homeostasis in adulthood. Our laboratory has demonstrated
the complexity of human Wnt13 gene in human cells, and the association of the nuclear
Wnt13 forms with cell apoptosis, but the regulation of Wnt13 forms has yet to be
defined. Wnt13B, Wnt13C and M1L-Wnt13B have been shown to encode the same
protein translated form AUG+74, but the expression of this protein encoded by Wnt13C
mRNA is found out much lower than those who encoded by the mRNAs of Wnt13B and
M1L-Wnt13B (Struewing IT et al. 2006), suggesting a possible translational regulation
for Wnt13C. In our study, Wnt13C expression was increased in response to stress and
apoptosis-inducers (including MG132), and appeared to be correlated with caspase-3
cleavage. This regulation did not seem to occur at the transcriptional level since there was
no significant increase at mRNA level upon the treatment of MG132. And in BAEC, the
insertion of Myc tag at the first AUG in Wnt13C mRNA not only inhibited the
expression of exogenous Wnt13C at basal level, but also totally abolished the increase of
Wnt13C expression by MG132 treatment, which indicates RNA sequences or structures
are critical for Wnt13C expression. Therefore, our data suggest that nuclear Wnt13C can
be regulated during apoptosis more likely at the translational levels than the
transcriptional levels, and since the nuclear Wnt13 forms were reported to increase EC
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sensivity to apoptosis (Struewing IT et al. 2006), this regulation may underlie a possible
association of the nuclear Wnt13 forms with apoptosis in BAECs.

4.2 Introduction
Wnt proteins form a large family of cysteine-rich glycoproteins which expression
is tightly regulated in a spatial and temporal fashion during development and adult
homeostasis. So far there are 19 different Wnt members in mammals, and they function
critically in embryonic development, organogenesis and later-on self-renewal in adult
tissues by controlling cell fate, including cell proliferation, differentiation, and apoptosis
(Clevers H. 2006; Almeida M et al. 2005).
The complexity of human Wnt13 gene has been displayed in various human cell
types with three isoforms identified: secreted Wnt13A, mitochondrial Wnt13B and
nucleus Wnt13C, which differ in their N-terminal sequences and generated through
alternative promoter, alternative splicing and alternative start codons (Struewing IT et al.
2006; Bunaciu RP et al. 2008). Moreover, the Wnt13 nuclear forms showed an increased
sensitivity to LPS- or TNF- induced apoptosis in primary endothelial cells (Struewing IT
et al. 2006), indicating the function of the Wnt13 nuclear forms is associated with
apoptosis. The 5’-leader sequences of Wnt13B and Wnt13C mRNAs are rather long,
featuring highly stable secondary structures based on M-fold analysis, which are the
characteristics suggesting possible translational regulation (Tang T et al. 2008).
Increasing evidence has suggested that translational regulation is a crucial
mechanism to allow the cell to alter its phenotype in response to different environmental
changes, and the expression of a number of either apoptosis-related factors or growth
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factors (FGF2 and VEGF) via translational mechanisms plays a significant role in the
regulation of their functions (apoptosis or proliferation) (Graber TE et al. 2007; Willis
AE. 1999). During cell stresses, the global translational machinery is compromised, and
the translation of most mRNAs is thereby inhibited. Paradoxically, the synthesis of
several proteins is still needed to mount an appropriate response to apoptosis by
increasing either death signals or survival signals to help the cell make decision to die or
not to die (Graber TE et al. 2007). So under stress, while the global rate of translation by
classical cap-dependent mechanism is reduced, the mRNAs of some proteins are not
treated the same way: alternative translational mechanisms are used to maintain the
synthesis of these proteins. For example, during apoptosis, pro-apototic proteins c-myc
(Adachi S et al. 2000), as well as anti-apoptotic proteins Bcl-2 (Sherrill KW et al. 2004)
maintain their protein synthesis by employing a cap-independent mechanism called
internal ribosomal entry, which involves specific RNA secondary structures able to
recruit IRES trans-acting factors (ITAFs) that initiate translation from the alternative
AUG site (Spriggs KA et al.2005; Marash L et al. 2005). Besides IRES, there are some
other mechanisms also responsible for the process of translational control, such as
ribosomal shunting, leaky scanning and re-initiation through small upstream open reading
frames (ORFs) (Graber TE et al. 2007; Kozak M. 2003).
Therefore, in this study, we aim to investigate whether nuclear Wnt13 forms
behave like other apoptotic factors like c-myc or Bcl-2, which undergo regulation at
translational levels during apoptosis.
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4.3 Materials and methods:
4.3.1 Materials
ALLN, MG132, LY294002 and tunicamycin were from Sigma. The specific
proteasome inhibitors epoxomycin and eponomycin were kind gifts from Dr. Kyung-Bo
Kim (University of Kentucky). The monoclonal anti-Myc antibody was purchased from
Cell Signaling Technology.

4.3.2 Cell culture and transfection
Please refer to 3.2 and 3.3.

4.3.3 Myc-Wnt13C-Flag plasmid constructs:
To obtain the pCR3.1-Myc-Wnt13C construct, Myc-tag was inserted into the start
codon

AUG

of

Wnt13C

by

PCR

using

the

primers

5’-

CCACCATGGGCGAACAAAAACTCATCTCAGAAGAGGATCTGGTGTTGGATGG
CCTTG-3’,

and

5’-

TCACTTATCGTCGTCATCCTTGTAATCTGCGGTCTGGTCCAGCCAC-3’ (Tang T
et al. 2008). To obtain the pCR3.1-Myc-Wnt13C-Flag construct, as shown in Figure 4.1,
pCR3.1- Myc-Wnt13C construct and pCR3.1-Wnt13B-Flag were digested by BamH1
(Invitrogen) at 37oC for 2 hours, and the products were loaded to 1% agarose gel. The
digest product from pCR3.1-Wnt13B-Flag was specifically treated with 1µl Calf
Intestinal Alkaline phosphatase (CIAP, Invitrogen) for 5 minutes to dephosphorylate
linerized vector DNA prior to gel running. After electrophoreses, a 300bp fragment from
pCR3.1-Myc-Wnt13C and a 6kb fragment from pCR3.1-Wnt13B-Flag were expected
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and extracted from the agarose gel using QIAGEN Gel Extract Kit. The two DNA
fragments were then ligated using T4 ligase (Invitrogen) at 8-12 oC overnight, followed
by transformation, which were subsequently spread evenly to a pre-warmed LB plate and
incubated at 37oC. After 18 hours, colonies were seen on the plate, and each of them was
then picked gently and mixed with 3ml LB broth in each tube. After incubation for 6
hours, minipreps were performed for each colony to purify DNA, and 10µl of each
purified DNA was digested by Pvu II (Invitrogen) to test the orientation during ligation.
The DNA miniprep with right orientation was then sent to SegWright for sequencing, and
maxiprep was performed to purify amplified pCR3.1-Myc-Wnt13C-Flag plasmid DNA,
which was stored at -20 oC.

4.3.4 RNA isolation and real-time PCR
Please refer 3.5.

4.3.5 Cell extracts and western blot analysis
Pleases refer 3.6.

4.3.6 Statistical analysis
All results are expressed as mean ± SEM. The values were represented by the
relative levels over PCR3 control (set as 1), and One Sample T-test (hypothesized value =
1) was used. Statistical significance was accepted at a value of P<0.05.
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4.4 Results
4.4.1 Short form of Wnt13B, Wnt13C and M1L-Wnt13B express differently when
transfected into BAEC
As described previously, Wnt13B and C mRNAs (Figure 1.2B) contain two
translational start sites: AUG (+1) and AUG (+74), so Wnt13B mRNA encodes a long
form and a short form (Figure 3.1). M1L-Wnt13B, where Met1 is replaced by leucine1,
only gives rise to the short Wnt13B form (Figure 3.1), which is localized in the nucleus.
However, for Wnt13C mRNA, the absence of all 71 nucleotides in exon 2 leads to a
change in the open reading frame of exon 4 and formation of a stop codon, so the
translation from AUG (+1) and AUG (+74) gives rise to a short peptide and the short
Wnt13B form, respectively. But only the short Wnt13B was detected by immunoblotting
in Wnt13C-transfected BAEC (Figure 3.1). Also, both Wnt13C and M1L-Wnt13B are
localized in the nucleus when transfected into BAEC, further indicating Wnt13C and
M1L-Wnt13B are equivalent to the short form of Wnt13B (Struewing IT et al. 2006).
Nonetheless, in normal cell culture conditions, the exogenous expression of Wnt13C was
always found out much lower than short protein form of Wnt13B or M1L-WntB (>10
folds) in primary BAEC cells (Figure 3.1).

4.4.2 The expression of Wnt13C increased in response to apoptotic inducers
Next, we tried to determine that whether the expression of Wnt13C can be also
regulated during apoptosis in apoptosis-sensitive BAEC cells. Tunicamycin, an
endoplasmic reticulum (ER) stress inducer (He L et al. 2009), and LY294002, a PI3
Kinase inhibitor, together with pro-inflammatory factors (LPS and TNFα) as well as
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proteasome inhibitors (MG132, ALLN, epoxomycin and eponomycin) can induce
apoptosis in various cell types. However, in our experimental conditions, BAECs were
sensitive to apoptosis induced by 100ng/ml LPS, 10ng/ml TNFα, 1µM MG132, 1 µM
epoxomycin and 1 µM eponomycin, but insensitive to 2.5 µg/ml Tunicamycin or 10 µM
LY294002(LY). As shown in Figure 4.2A, Tunicamycin and LY294002 did not induce
obvious apoptosis in BAEC as there was no or very little caspase-3 cleavage, and in this
case, Wnt13C expression was not significantly changed. In contrast, BAEC cells
underwent apoptosis upon the treatment of inflammatory agents like TNFα, LPS, as well
as proteasome inhibitors ALLN, MG132, epoxomcin and eponomycin, and at the same
time, the expression of Wnt13C was shown to be increased with these stimuli. Therefore,
even endothelial cell apoptosis was induced at different levels and via different
mechanisms, all the stimuli inducing apoptosis can increase the expression of Wnt13C in
BAEC.

4.4.3 The regulation of Wnt13C by apoptosis may be at translational levels
The increased expression of Wnt13C upon the treatment of apoptotic stimuli
could result from either transcriptional regulation or translational regulation of Wnt13C.
Thereby, we performed real-time analysis and found that the mRNA levels of exogenous
Wnt13C-Flag were increased by 47% after MG132 treatment (see Figure 4.2B), which
can not explain the 4 fold-increase of protein expression by MG132, suggesting that the
regulation of Wnt13C is not mainly due to transcriptional levels.
Furthermore, in BAEC cells, modification of AUG (+1) by the insertion of a myctag sequence in Wnt13C not only led to a total absence of Wnt13C expression from the
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downstream AUG (+74) at basal levels, but also abolished the increase of Wnt13
expression induced by MG132 treatment. This phenomenon implies that the mRNA
structures of Wnt13C, especially the sequences surrounding AUG (+1) is critical for the
regulation of Wnt13C by MG132, confirming that the increased expression of Wnt13C
by MG132 is more likely at translational levels than transcriptional levels. In contrast, in
HEK293 cells, the insertion of myc-tag at AUG (+1) did not change the expression
pattern of Wnt13C, indicating this regulation is cell type-specific (see Figure 4.3A). We
also tried to track the small peptide translated from AUG (+1) of Myc-Wnt13C-Flag by
using specific Myc antibody to see whether Wnt13C AUG (+1) was also regulated
translationally. Unfortunately, even when 20% Acralymide gel was used, the Myc-tagged
small peptide was undetectable (Figure 4.3B).

4.5 Discussion
Translational control is one of the critical regulatory mechanisms in eukaryotic
gene expression, which allows the cell to respond rapidly to environmental changes
(Graber TE et al. 2007; Willis AE. 1999). The majority of the mRNAs able to undergo
translational regulation, especially those who encode growth factors and oncoproteins,
carries long 5’ untranslated regions (UTRs) with complex secondary structure that
impedes the scanning during translational initiation, and such structure may harbor
internal ribosomal entry site or upstream open reading frames (Willis AE. 1999;
Pickering BM et al. 2005). Wnt13 proteins also function in controlling stem cell growth
during development and are associated with human cancers. Also, like those mRNAs of
growth factors, the 5’-UTRs of Wnt13B and Wnt13C are very long (120 nucleotides
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before AUG+1, and 340 or 229 nucleotides before AUG+74 in Wnt13B or Wnt13C
mRNAs, respectively), and highly structured with high free energies (-88~-104 kcal/mole
for Wnt13B mRNA, and -70~-75 kcal/mole in Wnt13C mRNA) (Tang T et al.2008),
which gives the evidence

for sendonary structure to support possible translational

regulation in the mRNAs of Wnt13B or Wnt13C (Willis AE. 1999).
Wnt13C and M1L-Wnt13B have been shown to encode the same protein (the
short form of Wnt13B) which is translated from AUG+74 in the mRNA (Struewing IT et
al. 2006). In this study, we found that the exogenous expression pattern of this protein in
regular

cell

culture

condition

differs

a

lot:

M1L-Wnt13B>short

form

of

Wnt13B>Wnt13C (Figure 3.1). However, the exogenous mRNA levels between Wnt13B
and Wnt13C lack the significant difference, suggesting that the translation of Wnt13C is
not as efficient as that of Wnt13B or M1L-Wnt13B.
Our results also show that the expression of Wnt13C is increased during
endothelial cell apoptosis triggered by a variety of stimuli. The protein expression of
Wnt13C is correlated with the level of cleaved caspase-3, and all the proteasome
inhibitors are able to induce higher levels of Wnt13C than TNFα and LPS, suggesting
that increased protein stability by proteasome inhibitors may potentiate the increasing
effect on Wnt13C-Flag expression by apoptosis-inducers. Subsequently, we also show
that the slight increase of exogenous Wnt13C at mRNA levels after MG132 treatment,
unable to fully explain the 4 fold increase of Wnt13C-Flag at protein levels, further
indicating that the positive regulation of exogenous Wnt13C expression by stimuli may
be more possibly at translational levels than transcriptional levels.
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Moreover, as shown in Figure 4.3, in BAEC cells, the insertion of myc tag at
AUG (+1) in the Wnt13C mRNA totally abolishes the exogenous protein expression of
Wnt13C, even under the treatment of MG132, indicating that Wnt13C expression is
greatly dependent on the RNA sequences and/or structures, especially surrounding AUG
(+1). Indeed, our laboratory also showed that the deletion of the first 12 amino acids with
a start codon inserted in Wnt13B mRNAs resulted in almost undetectable expression of
both the long form translated from AUG (+12) and the short form translated from AUG
(+74), while the deletion of the first 17 amino acids with a start codon inserted led to
more expression of the long form than the short form (Tang T et al. 2008), which
confirms that the RNA sequences and/or structures surrounding AUG+1 are crucial for
the translation initiation at AUG (+74) for the mRNAs of both Wnt13B and Wnt13C.
And our data showed that the translational regulation of Wnt13C occurred in BAEC cells,
but not in HEK293 cells. The possible explanation is that HEK293 cells are immortalized
transformed cells, which may determine distinct response of Wnt13C to undergo
translational regulation by apoptosis than primary cells.
Since both c-myc and Bcl-2 have shown to be regulated via IRES-mediated
translation, the presence of IRES in Wnt13C mRNA was firstly suspected to explain the
regulation mechanism of Wnt13C. However, using dicistronic Renilla –firefly (FL)
luciferase assay, the 5’-UTR of Wnt13C does not exhibit an IRES activity with or
without the treatment of MG132 (Tang T et al. 2008).
As the presence of IRES in Wnt13C mRNA is excluded, upstream opening
reading frame (uORF) becomes a possible mechanism for translational regulation of
Wnt13C. In some mRNAs, there exist a number of AUG codons at the upstream of the
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main open reading frame (ORF), which sequester ribosome from the AUG which
precedes the main ORF, resulting in the general decrease of the initiation efficiency of
translation (Meijer HA et al. 2002). For example, Bcl-2 contains a small ORF located
from -119 to -84, which is well conserved between mouse, rat, chicken and humans.
Deletion or mutation of this uORF from chloramphenicol acetyltransferase (CAT)
reporter gene resulted in a significant increase in CAT activity in vitro; conversely,
positioning this uORF into the reporter gene led to a remarkable inhibition of CAT
protein production without decreasing CAT mRNA, which indicates that the uORF
located within the 5'UTR of the bcl-2 gene is important and sufficient for translational
regulation of bcl-2 gene (Harigai M et al. 1996).
Indeed, it has been demonstrated by our laboratory that the insertion of 5’ leader
sequences of Wnt13C into RL reporter lead to a 95% and 85% inhibition of translation
activity in BAEC cells and HEK293 cells, respectively (Tang T et al. 2008). Furthermore,
two uORFs were found in Wnt13C-leader sequences, and the expression of Wnt13C-Flag
increased with the deletion of upstream AUG or CUG and the mutation of AUG (+1),
indicating that two upstream ORFs are responsible for the reduced translational
efficiency in Wnt13C. Also, the 5’ leader sequences of Wnt13B contain only one uORF,
which explains the higher expression of Wnt13B encoded from AUG+74 than Wnt13C.
In conclusion, our data demonstrated that nuclear Wnt13C undergoes regulation
at translational levels during apoptosis induced by a variety of stress stimuli. Considering
that nuclear Wnt13 forms favor apoptosis in endothelial cells, the upregulation of
Wnt13C forms during apoptosis may potentiate the progression of apoptosis in
endothelial cells, which forms a positive feedback to facilitate the completion of
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apoptosis. And further studies in our laboratory showed that unlike some other apoptotic
factors like c-myc and Bcl-2, the translational regulation of Wnt13C mRNA is not via
IRES mechanism, but more likely attributed by the presence of upstream open reading
frames.
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Figure 4.1 Schematic representation of the process to obtain the pCR3.1-Myc-Wnt13CFlag construct. For mRNA sequence, Wnt13B has an extra exon2 (E2) compared to
Wnt13C. pCR3.1- Myc-Wnt13C construct and pCR3.1-Wnt13B-Flag were digested by
BamH1 (Invitrogen) at 37oC for 2 hours, and the products were loaded to 1% agarose gel.
After electrophoreses, a 300bp fragment from pCR3.1-Myc-Wnt13C and a 6kb fragment
from pCR3.1-Wnt13B-Flag were extracted from the agarose gel using QIAGEN Gel
Extract Kit. The two DNA fragments were then ligated using T4 ligase, followed by
transformation to E coli, and the expressed pCR3.1-Myc-Wnt13C-Flag was purified by
minipreps. After orientation check and sequencing check, the plasmid DNA was
amplified by maxipreps.

123

A)

B)

Figure 4.2 Wnt13C expression is increased in response to apoptotic stimuli. A) BAEC
were transiently transfected with the Wnt13C-Flag construct for 24 hours, followed by
being treated with 100ng/ml LPS, 10ng/ml TNFα, 2.5 µg/ml Tunicamycin (Tu), 10 µM
LY294002(LY), 1µM MG132, 1 µM epoxomycin (EPX) and 1 µM eponomycin (EPN).
16 hours later, whole cell exacts were prepared and Wnt13C-Flag proteins, cleaved
caspase-3 and β actin were analyzed by immunoblotting with specific antibodies. B) The
mRNA levels of exogenous Wnt13C-Flag in BAEC with or without the treatment of 1µM
MG132 were determined using real-time PCR with RPL30 as internal control. The
relative mRNA levels after normalization are represented in the graph (mean±SEM, n=2
independent transfection experiments).
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A)

B)

Figure 4.3 The insertion of Myc-tag into 5’-UTR of Wnt13C-Flag abolished the
translation of Wnt13C in BAECs rather than in HEK293 cells. A) Wnt13C-Flag or MycWnt13C-Flag were transfected into BAEC cells or HEK293 cells for 24hrs, followed by
1µM MG132 treatment for 16 hours, and whole cell extracts were prepared for
subsequent immunoblotting analysis with anti-Flag antibody. B) Wnt13C-Flag or MycWnt13C-Flag were transfected into BAEC cells for 24hrs, followed by 1µM MG132
treatment for 16 hours. Media were harvested and whole cell extracts were prepared for
subsequent immunoblotting analysis with anti-Flag and anti-Myc antibodies.
Copyright © Tao Tang 2009
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CHAPTER 5. SPECIFIC AIM 2
To study the differential effects of Wnt13 isoforms located in different
subcellular organelles in endothelial cell apoptosis, and whether Wnt13 forms affect
apoptosis though modulating the activity or expression of apoptotic effectors and
regulators.

5.1 Summary
Wnt proteins control cell proliferation, cell differentiation and cell fate during
development and postnatal homeostasis. Our laboratory has illustrated the complexity of
human Wnt13 gene, with three isoforms (secreted Wnt13A, mitochondrial Wnt13B and
nuclear Wnt13C) encoded in human cells, and the association of nuclear Wnt13 forms
with cell apoptosis. Also, nuclear Wnt13C was shown to be increased at the translational
level during apoptosis induced by various stimuli including LPS. However, it is still
unclear 1) whether Wnt13 forms exert different effects on cell apoptosis in BAECs due to
their different subcellular localizations of Wnt13 isoforms; 2) what are the mechanisms
underlying the increased apoptosis by nuclear Wnt13 forms. In this study, we found that
1) in all the apoptotic assays, the activity of Wnt13 forms in increasing EC sensitivity to
apoptosis in BAEC were different: nuclear (robust) > mitochondrial (moderate) >
secreted forms (weak); 2) Wnt13 forms affected executioner caspase-3/7, but not the
caspase-8 in the extrinsic pathway, nor the inflammatory caspase-4/5: nuclear Wnt13
forms increased the expression of caspase-3/7 both at basal levels and after LPS
treatment, followed by an increase in caspase-3/7 cleavage induced by LPS; 3) Wnt13
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forms did not change the phosphorylation/activity of Akt and GSK, and showed a mild
effect on ROS production; 4) exogenous Wnt13 forms upregulated the pro-apoptotic Bcl2 family member Bim expression without changing Bax/Bcl-2 ratio; 5) Wnt13 forms did
not significantly increase apoptotic factors (TRAIL, DR5, and caspase-8) in the extrinsic
apoptotic pathway. To sum up, our data suggest that Wnt13 forms increase apoptosis in
BAEC with different strengths: nuclear > mitochondrial > secreted forms, and Wnt13
forms increase caspase activation though upregulating the expression of caspases and
Bim protein, without affecting the extrinsic apoptotic pathway, the Akt-GSK signaling
and ROS production.

5.2 Introduction
Wnt proteins constitue a large family of cysteine-rich glycoproteins whose
expression is tightly regulated in a spatial and temporal pattern during development. They
bind specifically to frizzled receptors (Fz) to activate three different signaling pathways:
1) the Wnt/β-catenin/TCF pathway resulting in cell proliferation and cell survival, 2) the
Wnt/planar cell polarity (PCP) pathway involved in cytoskeleton regulation and tissue
morphogenesis and 3) the Wnt/Ca2+ dependent pathway leading to changes in cell
migration (Fodde R et al.2007). Due to the crucial roles in organism development and
postnatal homeostasis, Wnts and Wnt signaling are highly related to diseases, such as
cancer, Alzheimer’s disease, and metabolic syndrome (Clevers H. 2006). Wnt proteins
are crucial for development and tissue homeostasis by controlling cell fate including cell
proliferation, differentiation, and especially apoptosis (Moon RT et al. 1997). Generally,
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Wnt proteins show anti-apoptotic action in transformed cells, but they display proapoptotic functions in primary cells, which details have been stated in 1.3.5.1.
So far, 19 different Wnt family members displaying a conserved pattern of 21-23
cysteine residues have been identified in mammals (Clevers H. 2006). Wnt13, also called
Wnt2b, was shown to be critical for embryogenesis or organogensis, and to be related to
some human diseases. We have shown the complexity of human Wnt13 gene expression
from human cells with the identification of three Wnt13 isoforms: the secreted Wnt13A,
mitochondrial Wnt13B, and nuclear Wnt13C forms, which were generated through
alternative promoter, alternative splicing site and alternative start codon (Struewing IT et
al.2006). Also, our laboratory showed that Wnt13 nuclear forms had an increased
sensitivity to TNF-induced apoptosis in primary endothelial cells (Struewing IT et
al.2006), and nuclear Wnt13C underwent translational regulation during apoptosis (Tang
T et al. 2008). Indeed, apoptotic events take place in different subcellular organelles: the
release of cytochrome c from the mitochondria, caspase cleavage in the cytoplasm, and
DNA fragmentation or the transactivation of transcription factor p53 in the nucleus.
Therefore, we are wondering whether the three Wnt13 isoforms have differential effects
on endothelial cell apoptosis through regulating different apoptotic events in the
organelles where they are located.
During apoptosis, caspase activation is one of the biochemical hallmarks.
Caspase-3, 6, 7 are the executioner caspases which cleave proteins, including cytoskeletal
proteins and nucleases, leading to the characteristics DNA breakdown and morphological
modifications (Saraste A et al. 2000). Caspase-3 is thought to be the most important
effector capases. Caspase-3, activated by caspase-8, caspase-9, or capase-10, has the
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substrate specificity for the amino acid sequence Asp-Glu-Val-Asp (DEVD) and cleaves
a number of different proteins, such as poly (ADP-ribose) polymerase-1 (PARP-1),
DNA-dependent protein kinase, which are important for apoptosis initiation (Villa P et al.
1997; Nicholson DW et al. 1995).

Also, caspase-3 preferentially activates caspase

activated DNase (CAD) and ACINUS to induce DNA degradation and chromatin
condensation respectively, and also cause cytoskeletal modifications and the formation of
apoptotic bodies (Elmore S. 2007).
The regulation in caspase expression at transcription levels or translational levels
is important for caspase processing and activity (Eearnshaw WC et al. 1999). Human
U937 cells treated by γ-interferon which can induce caspase expression showed enhanced
susceptibility to apoptosis triggered by gamma-irradiation or antitumor agents (Tamura T
et al. 1996), which is important for U937 cell differentiation to monocytes/macrophages.
And based on the study from heterozygous and knockout mice of caspase-3, the
expression of caspase-3 correlated to the sensitivity of T cells to apoptosis induced by
etoposide (Sabbagh L et al. 2004), further indicating the significance of caspase-3
expression in apoptosis.
The activation of caspases is in particular regulated by Bcl2 family, which can be
subdivided into three groups: the pro-apoptotic Bax and Bak, the anti-apoptotic family
members Bcl-xl, Bcl-w, Mcl-1 and A1A, and the pro-apoptotic BH3-only proteins Bim,
Bad, Bid (Youle RJ et al. 2008). Bax and Bak are major pro-apoptotic members in Bcl-2
family, which oligomerization will form the channels or pores at mitochondrial innner
membrane, leading to the release of cytochrome c and initiation of downstream apoptotic
events. However, Bcl-2 and Bcl-xL are major anti-apoptotic members, which form
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heterodimer with Bax or Bak and inhibit their apoptosis-promoting function
(Lomonosova E et al. 2008). The status of this pro-apoptotic/anti-apoptotic balance in
Bcl-2 family not only governs whether the cell is committed to cell death, but it also
determines the ability of the cell to respond to an apoptotic signal (Perlman H et al.
1999). The Bax/Bcl-2 rheostat has been shown to be critical for the sensitivity of human
melanoma cells to cell death induced by Fas and ceramide (Raisova M et al. 2001);
estrogen enhanced Bax/Bcl-2 ratio and induced apoptosis both in ovariectomized rats and
cultured anterior pituitary cells (Zaldivar V et al. 2009). Moreover, the Bax/Bcl-2 ratio
was found to accurately predict the clinical response and outcome of patients with acute
myeloid leukemia because patients with higher Bax/Bcl-2 ratio had significantly longer
overall survival and disease free survival (Del Poeta G et al. 2002). So Bax/bcl-2 ratio
has been used as an index to roughly predict the susceptibility of the cell to apoptosis.
In addition, BH3-only proteins such as Bim can promote pro-apoptotic signals
through either directly activating Bax, or inhibiting anti-apoptotic Bcl-2, resulting in Bax
oligomerization (Danial NN. 2007). Bim-deficiency mice had abnormally high numbers
of lymphoid and myeloid cells; and older Bim-deficient mice develop splenomegaly,
lymphadenopathy, and autoimmune kidney disease, indicating that Bim is critical for
apoptosis and homeostasis in the lymphoid and myeloid compartments (Bouillet P et al.
1999). Overexpression of Bim induced a remarkable increase of apoptosis in NIH 3T3
fibroblasts (Marani M et al. 2002) and in Hela cells (Herrant M er al. 2004). Therefore,
Bim serves as a key initiator of the intrinsic pathway of apoptosis, and the regulation of
Bim expression and activity can tightly affect the downstream apoptotic events.

130

Bcl-2 family is the hub to connect the intrinsic apoptotic pathway with the
extrinsic apoptotic pathway (Youle RJ et al. 2008). In endothelial cells, LPS-induced
apoptosis involves the extrinsic pathway (Bannerman DD et al. 2003). Generally, the
extrinsic apoptotic pathway is dependent on transmembrane death receptors binding
extracellular ligands, (for example, DR5/TRAIL is one of the death receptor/ligand
pairs), leading to the recruitment of adapter proteins TRADD, which form death-inducing
signaling complex (DISC) with caspase-8 and activates caspase-8 to induce downstream
caspase-3 activation (Wang Z et al. 2005). C-FLIP can regulate and inhibit extrinsic
pathway by competing with caspase-8 for DISC activation (Wilson NS et al. 2009). So
upregulating pro-apoptotic TRAIL, DR5 and caspase-8 or downregulating anti-apoptotic
FLIP may be the mechanisms to promote apoptosis through the extrinsic pathway.
PI3K-Akt pathway can be activated by a variety of extracellular signals, and
involved in cell proliferation, survival and protein synthesis, and tumor growth. The
activation of Akt can inhibit apoptosis through activating pro-survival factors like NF-κB
and inactivating pro-apoptotic factors such as Bad (a Bcl-2 family member), FOXOs,
caspase-9, as well as GSK3β (Jiang BH et al. 2008; Dillon RL et al. 2007). Moreover,
Akt signaling has been found to be required in the functions of Wnt-1, 3a, 5a, and 8a in
different systems (Longo KA et al. 2002; Almedida M et al. 2005; Constantinou T et al.
2008; Naito AT et al. 2005), suggesting the critical role of Akt signaling in Wnt cascade
which is involved in cell survival.
GSK3β, which can inhibit Wnt/β-catenin signaling, has also been shown to be
associated with cell apoptosis and inflammation. Overexpression of GSK-3β is sufficient
to trigger apoptosis in different types of cells, such as neurons, vascular smooth muscle
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cells, endothelial cells, and astrocytes (Li M et al. 2000; Hall JL et al. 2001; Kim HS et
al. 2002; Sanchez JF et al. 2003). And GSK-3β has been found to promote the intrinsic
apoptotic pathway triggered by different cellular insults, such as DNA damage, ER stress,
hypoxia, removal of NGF or BDNF, hypertonic stress, oxidative stress, mitochondrial
toxins and ceramide, by regulating transcription factors that control pro- and antiapoptotic proteins, by promoting microtubule disruption, and by inducing mitochondrial
disruption though activating pro-apoptotic members like Bax or degrading anti-apoptotic
members like Mcl-1 (Beurer E et al. 2006; Forde JE et al. 2007). On the other hand,
Lithium, the inhibitor of GSK-3β, reduces mouse acute renal failure induced by LPS via
attenuating inflammation and renal cell apoptosis (Wang Y et al. 2009), further indicating
that GSK-3β plays a positive role in promoting cell apoptosis and inflammation.
For GSK3β, direct phosphorylation of N-terminal Ser9 is associated with the
inhibition of GSK3β activity (Forde JE et al. 2007), and the activation of Akt leads to the
phosphorylation of Ser9, thereby inhibiting GSK3β (Pearl LH et al. 2002). So Akt
activation through phosphorylation at Ser473 and GSK inactivation through
phosphorylation at Ser9 may be negatively correlated with cell apoptosis.
Also, ROS can be another mechanism that induces apoptosis. ROS has been
shown to induce mitochondrial permeability transition (Garrido C et al. 2006).
Furthermore, it was found that the oxidation of cardiolipin, which is a mitochondriaspecific anionic phospholipid, decreases the affinity of cytochrome c to cardiolipin and
leads to the detachment of cytochrome c from the inner mitochondrial membrane, which
may be another mechanism to explain the role of oxidative stress in cell apoptosis (Ott M
et al. 2007). Also, peroxide contributes to the induction of apoptosis by stimulating the
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activity of nuclear transcription factors to upregulate pro-apoptotic proteins or to inhibit
anti-apoptotic proteins (Chandra J et al. 2000). Some studies showed that ROS-induced
apoptosis is related to Akt signaling. Manumycin-A stimulated superoxide production
and apoptosis in lymphoid tumor and myeloma cell lines, and led to dephosphorylation of
Akt in ROS-dependent manner (Sears KT et al. 2008). And Cao J et al further revealed a
direct interaction between Akt and ROS: ROS mediated a conformational change of Akt
by forming an intramolecular disculfide bond and disrupted Akt activity by promoting
dephosphorylation at Ser473 (Cao J et al. 2009).
Consequently, to study the possible mechanisms of the increased apoptosis by
nuclear Wnt13 forms, here we have investigated the effect of Wnt13 forms on caspase
activation and expression, Bcl-2 family members including Bax, Bcl-2 and Bim,
apoptotic factors in the extrinsic pathway, the Akt-GSK signaling and ROS production.

5.3 Materials and methods
5.3.1 Materials
Geneticin (G-418) were purchased from Invitrogen. The rabbit polyclonal
antibodies against cleaved caspase-7 (Asp198), and caspase-7, Bax, Bim, Akt, P-Akt
(Ser473), GSK3β, P-GSK3β (Ser9) were products from Cell Signaling Technology. The
rabbit polyclonal Bcl-2 antibody was from Santa Cruz. EnzChek® Caspase-3 Assay Kit
was from Molecular Probes.
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5.3.2 Cell culture and transfection
Cell culture and transient transfection were described in 3.2 and 3.3. For stable
transfection, BAECs were plated into a 6-well plate and each well was transfected
transiently with either PCR3 vector control or one of Wnt13 constructs using Exgene500.
40 hours later, cells in each well were trypsinized and plated into an individual dish, and
maintained with culture media supplemented with 750µg/ml Geneticin for 2-3 weeks till
colonies appeared. After selection, cells positive for plasmid were remained and
amplified for the use of experiments.

5.3.3 Plasmid constructs
Please refer 3.4.

5.3.4 RNA isolation and real-time PCR (refer 3.5)

5.3.5 Cell extracts and western blot analysis (refer 3.6)

5.3.6 Caspase-3 like activity assay
Caspase-3 like activity was determined using EnzChek® Caspase-3 Assay Kit.
According to the manufacture’s handbook, cells were harvested after treatment by
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scrapping off the plates and subsequently underwent centrifuge at 600g for 5 minutes.
After washing with PBS, cell pellet of each sample was lysed by 100µl 1X cell lysis
buffer supplemented with 10mM NaF, 1X Phosphatase Cocktail and Apotonin (Sigma),
and underwent freeze-thaw cycle. The lysed cells were then centrifuged at 5000rpm for 5
minutes (4oC). 25µl of supernatant was used for caspase-3 like activity assay, and another
20µl of supernatant was used to determine protein content.
For caspase-3 like activity assay, 25µl of supernatant sample was transferred to a
96 well microplate and mixed with 75µl substrate working solution, which was a mixture
of 25µM Z-DEVD-R110 and 1X reaction buffer at room temperature. At the same time,
to generate standard curve, 5mM R110 standard solution was diluted to yield R110
solutions ranging in concentration from 0- 25µM, which were then transferred to the
same microplate. After 30 minutes, the fluorescence intensity was measured by Fusion
Microplate Reader (excitation/emission 475/520nm). Once the standard curve was drawn,
the fluorescence intensity of each sample was calculated, and divided by protein content
of the same sample for correction.

5.3.7 Protein determination
Protein content was measured using Bio-Rad DC Protein Assay kit, based on
Lowry assay. Firstly, 10µg/µl BSA was diluted into the cell lysis buffer used in caspase-3
activity assay, to make 5 different dilutions for protein standard. For each 20µl sample
and protein standard, 100µl Reagent A’, which was made from Reagen A (alkaline
copper tartrate solution) mixed with Reagent S) was added to the tube and mixed with the
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sample. Then, 1ml Reagent B (dilute Folin Reagent) was pipetted into the tube containing
Reagent A and the sample/standard, and then mixed with by vortex. After 15 minute
incubation at room temperature, the reaction solution of each sample was transferred into
a 96 well microplate, and the absorbance was read at wavelength 750nm by
spectrophotometer. When the standard curve was drawn, the protein content of each
sample was calculated using the equation generated from the standard curve.

5.3.8 Determination of reactive oxygen species
5.3.8.1 CM-H2DCFDA assay for intracellular ROS (peroxide, peroxyl radical,
peroxynitrite, and nitric oxide)

5-(and-6)-chloromethyl-2', 7'-dichlorodihydrofluorescein diacetate, acetyl ester
(CM-H2DCFDA) is a cell-permeable indicator and sensitive to intracellular ROS. The
fluorescent signal used to detect the ROS results from the intracellular removal of the
acetate groups of CM-H2DCFDA and oxidation. BAECs were plated in a 24-well plate
and then transfected with Wnt13-Flag constructs. After 40 hours, media were removed
from the plate, and cells were washed with PBS once. Subsequently, cells were added
with PBS (Ca2+, Mg2+) supplemented with CM-H2DCFDA dye (final concentration 2µM)
and incubated at 37oC for 30 minutes. Then cells were washed with PBS (Ca2+, Mg2+) for
3 times followed by incubation at 37oC for 15 minutes. The fluorescence intensity was
read using Fusion Microplate Reader at wavelength 490 (Excitation) /520 (Emission) nm.
CyQuant assay was then performed to determine the cell number. The relative CM-

136

H2DCFDA intensity was calculated by CM-H2DCFDA fluorescence intensity/CyQuant
fluorescence intensity.

5.3.8.2 Dihydroethidium (DHE) assay for superoxide
BAECs were plated in a 24-well plate and then transfected with Wnt13-Flag
constructs. After 40 hours, media were removed from the plate, and cells were washed
with PBS once. Subsequently, cells were added with no-serum DMEM supplemented
with DHE dye (final concentration 10 µM) which upon reaction with superoxide anions
forms a red fluorescent product (ethidium), and incubated at 37oC for 30 minutes. Cells
were then washed with PBS (Ca2+, Mg2+) for 3 times. The fluorescence intensity was read
using Fusion Microplate Reader at wavelength 520 (Excitation) /590 (Emission) nm.
CyQuant assay was then performed to determine the cell number. The relative DHE
intensity was calculated by DHE fluorescence intensity/CyQuant fluorescence intensity.
5.3.8.3 CyQuant assay
The CyQUANT assay is based on the use of the green-fluorescent CyQUANT GR
dye, which exhibits strong fluorescence enhancement when bound to cellular nucleic
acids. Also cellular DNA content is highly regulated, and it is closely proportional to cell
number, so the CyQUANT assay is one of the methods to measure cell number. After the
CM-H2DCFDA or DHE assay, PBS was removed from the plate and cells were frozen in
-80oC. After the freeze-thaw cycle, the plate were read by Fusion Microplate Reader at
wavelength 485 (Excitation) /520 (Emission) nm for determination of background
fluorescence. Then cells were added with a mixture of 1× CyQuant substrate and 1× lysis
buffer followed by 10-minute incubation at room temperature. Then the fluorescence
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intensity was read using Fusion Microplate Reader at 485 (Excitation) /520 (Emission)
nm. The CyQuant fluorescence intensity was calculated by (Intensity after adding
substrate – Intensity before adding substrate).

5.3.9 Statistical analysis
All results are expressed as mean ± SEM. All values in this chapter are
represented by the relative levels over PCR3 control. Since all the values in the control
groups were set as 1, which does not fit normal distribution, One Way ANOVA analysis
is not appropriate at this point. Thus, One Sample T-test (hypothesized value = 1) was
used. Statistical significance was accepted at a value of P<0.05.

5.4 Results
5.4.1 The effect of Wnt13 isoforms on caspases in BAECs
5.4.1.1 Caspase-3 activation
Caspase-3 activation is one of the hallmarks during apoptosis, so we firstly
determined caspase-3 like activity in BAECs. As shown in Figure 5.1A, after transient
transfection with different Wnt13-Flag constructs, the caspase-3 like activity at basal
levels was increased only by the nuclear M1L-Wnt13B (around 60%) compared to the
vector control PCR3. After 100ng/µl LPS treatment for 16 hours, caspase-3 activity went
up to 8 fold higher than that in basal level (data not shown), and M1L-Wnt13B showed
increased activity by 50% compared to the vector control. Although this increase was not
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statistically significant, the increase trend is still similar than that in basal levels. We also
established BAECs which stably expressed Wnt13-Flag isoforms, and similar to transient
transfection, M1L-Wnt13B still showed 1.5 fold increase of caspase-3 like activity
compared to the vector control both at basal levels and after LPS treatment. But unlike
transient transfection, stably-transfected Wnt13C (Figure 5.1B) had up to 2 fold increase
of caspase-3 activity than control group in LPS-treated BAECs. For M74L-Wnt13B,
there was a moderate increase (40%-50%) in transient transfection, but the increase in
stable transfection was even bigger (by 80%), especially in basal levels showing the
statistical significance.
To further confirm caspase-3 activation, we also measured the amount of protein
product after caspase-3 cleavage by western blotting. Two markers were used: one is
cleaved caspase-3/actin, which demonstrated the absolute amount of cleaved caspase-3
produced during apoptosis; the other is cleaved caspase-3/total caspase-3, which
represented the ratio of cleavage compared to total caspase-3 (pro-caspase-3 plus
cleaved-caspase-3). There was no cleaved-caspase 3 detected at basal levels, but LPS
treatment induced obvious caspase-3 cleavage in BAECs. In transient transfection
(Figure 5.2A), M1L-Wnt13B showed around 2 times increase in cleaved caspase-3/actin
during LPS-induced apoptosis, and the mitochondrial forms (Wnt13B and M74LWnt13B) increased the amount of cleaved caspase-3 to a less extend (around 50%). Also,
cleaved caspase-3/total caspase-3 ratio was increased by mitochondrial forms and nuclear
forms, but all the Wnt13 isoforms showed less increase of cleaved caspase-3/total
caspase-3 than that of cleaved caspase-3/actin, especially M1L-Wnt13B (40% increase in
cleaved caspase-3/total caspase-3), suggesting that the increase of caspase-3 cleavage
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may partially result from the increase of pro-caspase-3 expression. However, in stable
transfection (Figure 5.3A), Wnt13C-Flag was the only form to obviously elevate cleaved
caspase-3/actin (2.3 fold), and M1L-Wnt13B and M74L-Wnt13B had a moderate
increase by 50%. But the ratio of cleaved caspase-3/total caspase-3 remained unchanged
for all the Wnt13 isoforms, further suggesting the increase of pro-caspase 3 levels by
Wnt13 forms.
5.4.1.2 Caspase-3 expression
We then analyzed caspase-3 expression at protein levels and mRNA levels. As
expected, transiently-transfected M1L-Wnt13B had bigger increase (> 2 fold) of capase-3
protein expression both at basal levels and after LPS treatment than all the other Wnt13
forms, as is shown in Figure 5.4A, supporting the previous hypothesis that increased
caspase-3 cleavage was partially due to the increase of pro-caspase-3 expression. At
mRNA levels, M1L-Wnt13B still produced higher increase of caspase-3 than other
Wnt13 isoforms (Figure 5.4B). However in stable transfection (Figure 5.5), all the Wnt13
isoforms increase both the protein and mRNA expression of caspase-3 at basal level more
than Wnt13B, which can be explained by the stably-transfected Wnt13B expression level
which was the least among all the isoforms. After LPS treatment, the protein level of
caspase-3 went up to 4 fold of the expression at basal levels, and all the Wnt13 isoforms,
showed a trend of increase (more than 50%), especially M1L-Wnt13B and M74LWnt13B (> 2 fold), but only Wnt13A had statistical significance.
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5.4.1.3 Caspase-7 cleavage and expression
The EnzChek® Caspase-3 Assay Kit we used for caspase-3 like activity allowed
the detection of not only caspase-3 activity, but also other DEVD-specific protease
activities, such as caspase-7. Therefore, we also determine the cleavage of caspase-7 to
see whether caspase-7 contributed to the increase of caspase-3 like activity. As shown in
Figure 5.6A, Wnt13A, Wnt13B and M1L-Wnt13B increased the absolute amount of
cleaved caspase-3 (cleaved caspase-3/actin) in transiently-transfected BAECs during
LPS-induced apoptosis. However, the ratio of cleaved caspase-7/caspase-7 was not
changed by any Wnt13 isoforms. Thus we then investigated the caspase-7 expression,
and we found that Wnt13 forms, except Wnt13C and M74L-Wnt13B, showed a trend in
increasing the protein expression of caspase-7 at basal levels. LPS treatment induced a 4
fold increase in protein levels of caspase-7 compared to basal levels (data not shown),
and Wnt13A and M1L-Wnt13B further elevated caspase-7 protein expression (Figure
5.6B). Wnt13B showed a similar increase, but it was not statistically significant.
Therefore, Wnt13A and M1L-Wnt13B increase the amount of cleaved caspase-7 mainly
by increasing caspase-7 expression.

5.4.2 The effect of Wnt13 forms on Bcl-2 family members in BAEC
5.4.2.1 Bax/Bcl-2
Bcl-2 family governs the switch on or off of apoptosis by the pro-apoptotic
members such as Bax and anti-apoptotic members such as Bcl-2. Therefore, to study the
underlying mechanisms by which nuclear Wnt13 forms increase the caspase activation,
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we analyze the levels of Bax and Bcl-2. Firstly, in transient transfection (Figure 5.7A),
both protein levels and mRNA levels of Bax were shown upregulated (around 50%) by
M1L-Wnt13B at basal levels in BAECs; during LPS-induced apoptosis, the protein levels
of Bax were also increased by M1L-Wnt13B (Figure 5.7B). However, stably-transfected
Wnt13 isoforms did not show any effect on Bax expression at either protein levels or
gene levels (Figure 5.8). Moreover, in transiently-transfected BAECs at basal levels,
M1L-Wnt13B and M74L-Wnt13B upregulated both the protein expression and mRNA
expression of Bcl-2 by 80% and 60%, respectively, which is shown in Figure 5.7 and 5.9.
After LPS treatment, the protein expression of Bcl-2 had a similar trend of increase by
M1L-Wnt13B and M74L-Wnt13B (Figure 5.7B). Like Bax, the Bcl-2 expression in
stable transfection was not obviously changed by Wnt13-Flag isoforms (Figure 5.8 and
5.10).
Importantly, Bcl-2 forms heterodimer with Bax to antagonize Bax/Bax
homodimerization and disrupts Bax-induced apoptosis, so the ratio of Bax/Bcl-2
represents a cell-autonomous rheostat determining the life or death response of the cell to
apoptotic stimuli (Korsmeyer SJ et al. 1995). We then calculated the Bax/Bcl-2 ratio
which imbalance will cause the activation of downstream apoptotic events. Figure 5.11
demonstrated that for both transient transfection and stable transfection, the ratio of
Bax/Bcl-2 remained unchanged by Wnt13 isoforms either at basal levels or after LPS
treatment.
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5.4.2.2 Bim expression
Besides Bax and Bcl-2, BH3 only proteins, such as Bim, represent one subfamily
under Bcl-2 family, which function in activating Bax to promote pro-apoptotic action.
Thus we determined the expression of Bim in BAECs. In transient trasfection (Figure 5.7
and 5.9), M1L-Wnt13B upregulated Bim expression at protein levels both at basal levels
(>2 fold) and after LPS treatment (around 1.8 fold), and also upregulated its mRNA
levels up to 4 fold at basal levels. Like M1L-Wnt13B, Wnt13B had a similar increasing
effect but with lower extent. Wnt13A showed a trend of increasing Bim expression, but
only the protein expression at basal levels had statistical significance. For stable
transfection (Figure 5.8 and 5.10), like other markers described previously, Wnt13B
induced lower Bim expression than all the other Wnt13-Flag isoforms (Figure 5.12).
Nuclear forms of Wnt13 and M74L-Wnt13B increased Bim expression at mRNA levels
by 2-3 fold. Moreover, only M74L-Wnt13B showed the statistical significance in
increasing Bim expression at protein levels in LPS-treated BAECs. Therefore, although
there was no difference in Bax/Bcl-2 ratio in Wnt13-transfected BAECs, the increase of
pro-apoptotic Bim expression may be one of the mechanisms driving elevated caspase
activation by nuclear Wnt13 forms.

5.4.3 The extrinsic pathway and inflammatory caspases
We were also wondering whether the increased caspase activation in BAECs was
due to the change in apoptotic factors involved in extrinsic pathways, such as TRAIL,
DR5, caspase-8 and anti-apoptotic FLIP. Realtime PCR analysis in transient transfection
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showed that only M1L-Wnt13B had a trend in increasing mRNA levels of TRAIL and
DR5, caspase-8 (Figure 5.12). Wnt13B demonstrated a weaker effect on increasing
mRNA levels of caspase-8. However, the increasing trend in pro-apoptotic caspase-8 by
M1L-Wnt13B and Wnt13B was accompanied by the same or even stronger increase in
anti-apoptotic FLIP, suggesting that the extrinsic apoptotic pathway might not be the
main force to drive EC apoptosis by Wnt13 forms.
Besides executioner caspases (caspase-3 and 7) and initiator caspases (caspase-8),
we also tried to discover whether Wnt13 forms increase the expression of inflammatory
caspases (caspase-4 and 5). As shown in Figure 5.13, Wnt13 forms did not show an
increase in mRNA expression of caspase-4 and caspase-5 in transiently-transfected
BAECs. Therefore, our findings showed that Wnt13 forms mainly increased the
expression/activation of the executioner caspase-3/7, but not the extrinsic pathway factor
caspase-8, nor inflammatory caspase-4/5.

5.4.4 Akt-GSK signaling and ROS production
Since PI3K-Akt is a pro-survival signaling, and the decrease in Akt activation is
related to apoptosis, we thereby tried to investigate whether Wnt13 forms had effect on
Akt signaling. The phosphorylation at Ser473 of Akt is required for the full activation of
Akt, and we found out the P-Akt (Ser473)/Akt was not obviously changed by transient
transfection of Wnt13 forms (Figure 5.14A). Moreover, Akt targets GSK3β, a kinase
inhibiting Wnt/β-catenin signaling and promote apoptosis in its downstream activation
events, so we determined the phosphorylation of GSK3β at Ser9 which is inhibitory to
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GSK activity. As shown in Figure 5.14B, Wnt13 forms did not decrease this
phosphorylation; instead, M1L-Wnt13B showed an increasing trend in GSK
phosphorylation. Therefore, the increased apoptosis by Wnt13 forms is independent of
Akt activation and GSK activation.
ROS can be one of the events that induce apoptosis with the involvement of Akt,
so we then determined if Wnt13 forms affected ROS production in BAECs. As shown in
Figure 5.15, all the Wnt13 forms were able to decrease the fluorescence intensity in CMH2DCFDA staining slightly (by 20%). However, Wnt13 forms did not decrease the
fluorescence intensity in DHE staining; instead, mitochondrial forms increased the
intensity of DHE by 20-40%, and Wnt13B was statistically significant. What these two
dyes measure differs in species of ROS: the CM-H2DCFDA probe is indicative of
intracellular ROS, including peroxide, peroxyl radical, peroxynitrite, and nitric oxide
whereas DHE dye is mainly indicative of superoxide. Thus, our results suggest that
Wnt13 forms slightly decrease the amount of peroxide, peroxyl radical, peroxynitrite, and
nitric oxide, while mitochondrial forms may have a mild increase in the production of
ROS (mainly superoxide). Overall, Wnt13 forms showed limited effect on the production
of total ROS, and the increased caspase-3 activation by Wnt13 fomrs may not be due to
ROS production.

5.5 Discussion
Altogether the results presented in this study showed: 1) exogous nuclear Wnt13
forms increase caspase-3 like activity, cleavage of caspase-3,7 and caspase-3,7
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expression in BAEC; 2) exogenous mitochondrial Wnt13 forms increased cleavage and
protein expression of caspase-3,7, but not caspase-3 like activity; 3) except caspase-3
expression, secreted Wnt13A did not increase caspase-3 like activity and caspase-3
cleavage in BAECs; 4) Wnt13 forms were unable to change Bax/Bcl-2 ratio, but
upregulated Bim expression; 5) Wnt13 forms did not significantly increase apoptotic
factors (TRAIL, DR5, and caspase8) in the extrinsic apoptotic pathway; 6) Wnt13 forms
did not increase inflammatory caspase-4 and caspase-5; 6) Wnt13 forms did not change
the phosphorylation of Akt and GSK. Hence, Wnt13 forms increase apoptosis in BAEC
with different strengths, and Wnt13 forms, especially nuclear forms, increase the
activation of caspases possibly though upregulating the expression of caspases and Bim
protein.

5.5.1 BAECs are sensitive to LPS-induced apoptosis
Bacterial lipopolysaccharide (LPS) is an outer envelope of gram-negative
bacteria, and it has been shown to cause systemic inflammatory responses as well as the
injury of BAECs in vitro (Chakravortty D et al. 2000). And endothelial cell death induced
by LPS in a dose range is apoptotic in nature (Bannerman DD et al. 2003). In our study,
BAECs started to undergo morphological changes, such as cell shrinking, rounding, and
the formation of intercellular gaps after 100ng/ml LPS treatment for 6 hours. 16 hours
later, LPS induced obvious caspase-3 and 7 cleavage (Figure 5.2 and 5.6), 8-9 fold of
increase in caspase-3 like activity, and 4-5 fold of increase in the expression caspase-3
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and caspase-7, suggesting that BAECs are the cell type sensitive to undergo apoptosis
induced by LPS.
5.5.2 Wnt13 forms do not induce apoptosis at basal levels, but increase the susceptibility
of BAECs to LPS-induced apoptosis
At basal levels, although the caspase-3 like activity and the expression of caspase3, 7 were increased by Wnt13 forms, there was no caspase-3 cleavage detected in BAECs
transfected with Wnt13-Flag constructs. However, LPS-challenged cells showed obvious
cleavage of caspase-3, and Wnt13 isoforms, especially nuclear forms further increased
caspase-3 cleavage, as well as caspase-3 like activity in BAECs treated with LPS,
implying that Wnt13 proteins per se are not apoptotic inducers or stimuli, but the factors
that promote the apoptotic process, in particular by increasing the expression of proapoptotic factors such as executioner caspase-3/7.
5.5.3 The nuclear forms of Wnt13 have stronger pro-apoptotic effect in BAECs than
other forms of Wnt13
In our study, the nuclear forms of Wnt13 demonstrated robust effects on
increasing apoptosis in BAECs due to the following facts: 1) the nuclear Wnt13 forms
increased caspase-3 like activity (in both transient and stable transfection) with or without
LPS treatment, caspase-3 cleavage (in transient transfection) and caspase-3 expression (in
both transient and stable transfection) in BAECs (Figure 5.1-5.5); 2) the nuclear Wnt13
forms increased caspase-7 cleavage due to the increase of caspase-7 expression in BAEC
treated with LPS (in transient transfection; Figure 5.6); 3) the nuclear Wnt13 forms
upregulated expression of both Bax and Bcl-2 at both protein levels and mRNA levels in
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transient transfection (Figure 5.7-5.10), without changing Bax/Bcl-2 ratio (Figure 5.11);
4) the expression of BH3-only protein Bim was upregulated by nuclear Wnt13 forms
(transient transfection) both at basal levels and after LPS treatment (Figure 5.7), which
may be one of the explanations for the increased caspase activation by nuclear Wnt13
proteins.
Mitochondrial forms of Wnt13 seem to have moderate effects on increasing
apoptosis in BAECs because: 1) mitochondrial forms increased protein expression of
caspase-3 (Figure 5.2-5.3), but not caspase-3 like activity in BAEC in transient
transfection (Figure 5.1), so mitochondrial forms may be unable to reach the threshold of
caspase expression to induce caspase activation; 2) M74L-Wnt13B increased caspase-3
expression at basal levels and caspase-3 like activity after LPS treatment in stable
transfection (Figure 5.5); 3) transiently-transfected Wnt13B increased caspase-7 cleavage
in BAEC treated with LPS (Figure 5.6). For the Bcl-2 family members, mitochondrial
Wnt13 forms have weaker effects on increasing expression of Bax (around 50%, Figure
5.7-5.10) as well as Bcl-2 (Figure 5.7-5.10), and have no effect on Bax/Bcl-2 ratio
(Figure 5.11). Besides, Wnt13B upregulated Bim expression up to 2 fold in transient
transfection, and this increase was slightly lower than nuclear Wnt13 forms which
upregulated Bim up to 2.7 fold (Figure 5.7 and 5.9).
Secreted Wnt13A form is the one with the least activity in increasing apoptosis in
BAECs. Wnt13A upregulated caspase-3 expression (Figure 5.4 and 5.5), but Wnt13A
was not able to increase caspase-3 like activity and caspase-3 cleavage in BAECs (Figure
5.1-5.3). And Wnt13A showed a mild effect on caspase-7 cleavage and caspase-7
expression (Figure 5.6). As for Bcl-2 family members, Wnt13A did not show the ability
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of increasing in the expression of Bax or Bcl-2, nor Bax/Bcl-2 ratio (Figure 5.7-5.11), but
Wnt13A displayed a moderate effect on upregulating Bim expression (Figure 5.7-10).
Therefore, the strength of Wnt13 isoforms in increasing BAEC apoptosis is:
nuclear >mitochondrial >secreted forms. This phenomenon is consistent with the findings
our laboratory has reported in 2006, i.e., nuclear forms of Wnt13, other than
mitochondrial forms or Wnt13A, increased the appearance of apoptotic nuclei as well as
the sensitivity of BAECs to TNFα-induced apoptosis (Struewing IT et al. 2006).
Furthermore, some other Wnts showed pro-apoptotic action in cells. For example, Wnt7b
mediated macrophage-induced programmed cell death in the developing mouse eye
(Lobov IB et al. 2005), and Wnt5a overexpression cause increased apoptosis in
thymocytes in vitro (Liang H et al. 2007). Additionally, components of Wnt signaling
including Fz receptors, GSK-3β, c-myc have been shown to function in increasing cell
apoptosis (van Gijn ME et al. 2001; Li M et al. 2000; Askewe DS et al. 1991). So our
study further indicates that together with other Wnts, Wnt13 proteins, especially nuclear
Wnt13 forms, are important for the regulation of cell apoptosis.
5.5.4 The difference of expression patterns in transient transfection and stable
transfection
In transient transfection, although Wnt13C and M1L-Wnt13B are equivalent in
translated protein, the expression of Wnt13C is always much weaker than that of M1LWnt13B in normal culture condition (Figure 4.2A), so it is expected that M1L-Wnt13B
showed bigger effect in increasing apoptotic markers in BAEC than Wnt13C.
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However, stable transfection is another case. For Wnt13 expression, except
Wnt13A, all the other exogenous Wnt13 forms could not be detected by immunoblotting
using Flag antibodies. Based on the immnofluoresence staining, we found that the
expression

pattern

is:

Wnt13A>Wnt13C=M1L-Wnt13B>M74L-Wnt13B>Wnt13B

(described in 3.10.2), which makes easier to understand some phenomenon in stable
transfection: 1) the advantage of M1L-Wnt13B over other forms in increasing caspase-3
activation and expression was not that obvious (Figure 5.1-5.2 and Figure 5.4) due to the
lower levels of M1L-Wnt13B in stable transfection (maybe more M1L-Wnt13 positive
cells died during G418 selection because of the increased EC sensitivity by M1LWnt13B); 2) Wnt13C sometimes had stronger effects than in transient transfection
(caspase 3 in Figure 5.1-5.3 and Bim in Figure 5.8, 5.10); 3) Wnt13A had higher incease
in caspase-3 expression (Figure 5.5); 4) the effect of Wnt13B was the weakest in
upregulating the expression of caspase-3 and Bim (Figure 5.5 and 5.8, 10). And we also
noticed that Wnt13 forms in stable transfection had stronger effects than those in
transient transfection. For example, the mRNA expression of caspase-3 was increased by
Wnt13 forms up to 5 fold in stable transfection instead of 2 fold in transient transfection
(Figure 5.4-5.5). A possible explanation is that in stable transfection, Wnt13 forms has
been expressed continuously although in lower amount, which might produce durable and
accumulated actions, ending up with a bigger effects on EC sensitivity to apoptosis.
5.5.5 The putative significance of Wnt13 forms in apoptosis
In the previous chapter (Aim1), our data demonstrated that nuclear Wnt13C was
increased at translational levels during apoptosis induced by a variety of stress stimuli.
And in this chapter, we have shown that nuclear forms of Wnt13 was able to increase
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caspase activation through upregulating caspase and Bim expression, further suggesting
the presence of the positive loop between expression and function of Wnt13 nuclear
forms, which may facilitate the completion of apoptosis in BAECs upon stress challenge.
5.5.6 Wnt13, Akt/GSK signaling and ROS
PI3K-Akt pathway is involved in cell proliferation, survival and protein synthesis,
and tumor growth through activating pro-survival factors like NF-κB and inactivating
pro-apoptotic factors such as Bad, FOXOs, caspase-9, as well as GSK3β (Jiang BH et al.
2008; Dillon RL et al. 2007). Akt signaling is required in the functions of Wnt-1, 3a, 5a,
and 8a in different systems (Longo KA et al. 2002; Almedida M et al. 2005;
Constantinou T et al. 2008; Naito AT et al. 2005). GSK3β, which can inhibit Wnt/βcatenin signaling, has also been shown to promote cell apoptosis. The activation of Akt
leads to the phosphorylation of GSK3β at Ser9, thereby inhibiting GSK3β (Pearl LH et
al. 2002). So Akt activation through phosphorylation at Ser473 and GSK inactivation
through phosphorylation at Ser9 may be negatively correlated with cell apoptosis.
However, our study showed that Wnt13 forms did not significantly decrease either Akt
phosphorylation at Ser473 or GSK3β phosphorylation at Ser9, indicating that Wnt13
forms did not inhibit Akt activation nor promote GSK activation in BAECs. Instead,
M1L-Wnt13 showed a moderate increase in GSK (Ser9) phosphorylation, which suggests
that the effect of M1L-Wnt13B on GSK3β is relatively independent of Akt activity, and
other signaling pathway, such as ERK1/2 which also phosphorylates GSK3β at Ser9
(Kim SD et al. 2007) may be involved in the increased EC sensitivity to apoptosis by
Wnt13 forms.
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Also, increased ROS production can be another mechanism that induces
apoptosis, and some studies showed that ROS-induced apoptosis is related to Akt
signaling. In our study, CM-H2DCFDA staining showed that Wnt13 forms slightly
decreased the amount of ROS including peroxide, peroxyl radical, peroxynitrite, and
nitric oxide, while DHE staining showed that mitochondrial forms had a mild increase in
the production of ROS (mainly superoxide). The net effect of Wnt13 forms is limited on
the production of total ROS. Thereby, the increasing effect on EC susceptibility to
apoptosis by Wnt13 forms may be not attributed by increased ROS production, or by
Akt-GSK signaling. In addition, for H2DCFDA staining, we used intensity of CyQuant
staining for normalization. However, CyQuant staining is measuring cell number without
indicating cell status, so it would be more appropriate to use oxidized DCFDA for the
control of probe uptake and the activity of esterase in cells.
Altogether, our data showed that Wnt13 forms, especially the nuclear forms,
increased EC sensitivity to LPS-induced apoptosis via upregulating the expression of key
apoptotic factors such as the executioner caspases and the pro-apoptotic Bim, without
affecting the extrinsic apoptotic pathway, inflammatory caspases, ROS production or
Akt/GSK signaling. Thus, our next goal is to determine which transcription factor is
activated or regulated by Wnt13 forms to increase the expression of executioner caspases
and Bim.
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A)

B)

Figure 5.1 The nuclear Wnt13 forms increased caspase-3 like activity in BAECs. BAECs
were transiently transfected with the PCR3 vector or Wnt13-Flag constructs for 24 hours
(A) or stably transfected (B), followed by treatment of 100ng/ml LPS; 16 hours later,
cells were harvested and lysed for caspase-3 like activity determination. The relative
activity levels after normalization with basal or LPS treated PCR3 values (set as 1) are
represented in the graph (mean±SEM, n=6 independent transfection experiments; *<0.05,
**<0.01, ***<0.001).
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A)

B)

Figure 5.2 The nuclear and mitochondrial Wnt13 forms increased caspase-3 cleavage in
BAECs in transient transfection. BAECs were transiently transfected with the PCR3
vector or Wnt13-Flag constructs for 24 hours, followed by LPS treatment (100ng/ml). 16
hours later, whole cell exacts were prepared and Flag-tag, cleaved caspase-3 and β actin
were analyzed by immunoblotting with specific antibodies. A) The relative cleavage
levels after normalization with basal or LPS treated PCR3 values (set as 1) are
represented in the graph (mean±SEM, n=6-15 independent transfection experiments;
*<0.05, **<0.01). B) Representative images of western blotting analysis are shown.
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A)

B)

Figure 5.3 The nuclear Wnt13 forms increased caspase-3 cleavage in BAECs in stable
transfection.

BAECs were stably transfected with the PCR3 vector or Wnt13-Flag

constructs, followed by LPS treatment (100ng/ml). 16 hours later, whole cell exacts were
prepared and Flag-tag, cleaved caspase-3 and β actin were analyzed by immunoblotting
with specific antibodies. A) The relative cleavage levels after normalization with basal or
LPS treated PCR3 values (set as 1) are represented in the graph (mean±SEM, n=6-15
independent transfection experiments; *<0.05). B) Representative images of western
blotting analysis are shown.
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A)

B)

Figure 5.4 The nuclear Wnt13 forms increase caspase-3 expression more than the other
forms in transient transfection. BAECs were transiently transfected with the PCR3 vector
or Wnt13-Flag constructs for 24 hours, followed by LPS treatment (100ng/ml), A) 16
hours later, whole cell exacts were prepared and caspase-3 and β actin were analyzed by
immunoblotting with specific antibodies; or B) 6 hours later, cells were harvested and
treated with Trizol prior to RNA extraction and real-time PCR analysis. The relative
protein or mRNA levels after normalization with basal or LPS treated PCR3 values (set
as 1) are represented in the graph (mean±SEM, n=6-15 independent transfection
experiments; *<0.05, **<0.01).
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A)

B)

Figure 5.5 All the Wnt13 isoforms induced increase in caspase-3 expression at basal
levels in stable transfection. BAECs were stably transfected with the PCR3 vector or
Wnt13-Flag constructs, followed LPS treatment (100ng/ml). A) 16 hours later, whole cell
exacts were prepared and caspase-3 and β actin were analyzed by immunoblotting with
specific antibodies; or B) 6 hours later, cells were harvested and treated with Trizol prior
to RNA extraction and real-time PCR analysis. The relative protein or mRNA levels after
normalization with basal or LPS treated PCR3 values (set as 1) are represented in the
graph (mean±SEM, n=6 independent transfection experiments; *<0.05, **<0.01,
***<0.001).
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A)

B)

C)

Figure 5.6 Transiently-transfected Wnt13 forms increase caspase-7 cleavage due to the
increase of caspase-7 expression in BAECs treated with LPS. BAECs were transiently
transfected with the PCR3 vector or Wnt13-Flag constructs for 24 hours, followed by
LPS treatment (100ng/ml). 16 hours later, whole cell exacts were prepared and cleaved
caspase-7, caspase-7 and β actin were analyzed by immunoblotting with specific
antibodies. The relative cleavage or protein levels after normalization with basal or LPS
treated PCR3 values (set as 1) are represented in the graph (mean±SEM, n=10
independent transfection experiments; *<0.05, **<0.01). Caspase-7 cleavage (A), the
protein expression of caspase-7(B), and representative images of western blotting
analysis (C) are shown.
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A)

B)

C)

Figure 5.7 Effect of Wnt13 forms on the protein expression of Bcl-2 family members in
transient transfection. BAECs were transiently transfected with the PCR3 vector or
Wnt13-Flag constructs for 24 hours, followed by LPS treatment (100ng/ml). 16 hours
later, whole cell exacts were prepared, and Bim, Bax, Bcl-2 and β actin were analyzed by
immunoblotting with specific antibodies. The relative protein levels after normalization
with (A) basal or (B) LPS treated PCR3 values (set as 1) are represented in the graph
(mean±SEM, n=10 independent transfection experiments; *<0.05, **<0.01, ***<0.001).
C) Representative images of western blotting analysis are shown.
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A)

B)

C)

Figure 5.8 Effect of Wnt13 forms on protein expression of Bcl-2 family members in
stable transfection. BAECs were stably transfected with the PCR3 vector or Wnt13-Flag
construct, followed by LPS treatment (100ng/ml). 16 hours later, whole cell exacts were
prepared and Bax and β actin were analyzed by immunoblotting with specific antibodies.
The relative protein levels after normalization with (A) basal or (B) LPS-treated PCR3
values (set as 1) are represented in the graph (mean±SEM, n=6 independent transfection
experiments; *<0.05). C) Representative images of western blotting analysis are shown.
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A)

B)

Figure 5.9 Effect of Wnt13 isoforms on mRNA expression of Bcl-2 family members in
transient transfection. BAECs were transiently transfected with the PCR3 vector or
Wnt13-Flag constructs for 24 hours, followed by LPS treatment (100ng/ml). 6 hours
later, cells were harvested and treated with Trizol prior to RNA extraction and real-time
PCR analysis. The relative mRNA levels after normalization with A) basal or B) LPS
treated PCR3 values (set as 1) are represented in the graph (mean±SEM, n=10
independent transfection experiments; *<0.05; **<0.01).
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Figure 5.10 Effect of Wnt13 forms on mRNA expression of Bcl-2 family members at
basal levels in stable transfection. BAECs were stably transfected with the PCR3 vector
or Wnt13-Flag constructs. Cells were harvested and treated with Trizol prior to RNA
extraction and real-time PCR analysis. The relative mRNA levels after normalization
with basal PCR3 values (set as 1) are represented in the graph (mean±SEM, n=6
independent transfection experiments; *<0.05; **<0.01).

162

A)

B)

Figure 5.11 The Bax/Bcl-2 ratio remained unchanged by Wnt13 isoforms. BAECs were
A) transiently transfected for 24 hours or B) stably transfected with the PCR3 vector or
Wnt13-Flag constructs, followed by LPS treatment (100ng/ml). 16 hours later, whole cell
exacts were prepared and Bax, Bcl-2, and β actin were analyzed by immunoblotting with
specific antibodies. The relative ratio levels after normalization with basal or LPS treated
PCR3 values (set as 1) are represented in the graph (mean±SEM, n=6-10 independent
transfection experiments).
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A)

B)

Figure 5.12 Effect of Wnt13 forms on the mRNA levels of extrinsic apoptotic factors in
transiently-transfected BAECs. BAECs were transiently transfected with the PCR3 vector
or Wnt13-Flag constructs for 40 hours. Subsequently, cells were harvested and treated
with Trizol prior to RNA extraction and real-time PCR analysis. The relative mRNA
levels after normalization with basal PCR3 values (set as 1) are represented in the graph
(mean±SEM, n=5 independent transfection experiments.).
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Figure 5.13 Effect of Wnt13 forms on the mRNA levels of inflammatory caspases in
transiently-transfected BAECs. BAECs were transiently transfected with the PCR3 vector
or Wnt13-Flag constructs for 40 hours. Subsequently, cells were harvested and treated
with Trizol prior to RNA extraction and real-time PCR analysis. The relative mRNA
levels after normalization with basal PCR3 values (set as 1) are represented in the graph
(mean±SEM, n=5 independent transfection experiments.).
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A)

B)

C)

Figure 5.14 Effect of Wnt13 forms on phosphorylation of Akt and GSK3β. BAECs were
transiently transfected with the PCR3 vector or Wnt13-Flag constructs for 40 hours.
Whole cell exacts were prepared, and A) Akt, and P-Akt (Ser473) or B) GSK3β and PGSK3β (Ser9) were analyzed by immunoblotting with specific antibodies. The relative
phosphorylation levels after normalization with basal or LPS treated PCR3 values (set as
1) are represented in the graph (mean±SEM, n=6-8 independent transfection
experiments.).
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Figure 5.15 Effect of Wnt13 isoforms on the production of reactive oxygen species
(ROS) in transiently-transfected BAECs. BAECs were transiently transfected with the
PCR3 vector or Wnt13-Flag construct for 40 hours, followed by DHE staining and CMH2DCFDA (DCF) staining. The relative fluorescence intensity levels after normalization
with basal PCR3 values (set as 1) are represented in the graph (mean±SEM, n=8-20
independent transfection experiments; *<0.05).
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CHAPTER 6. SPECIFIC AIM 3
To study whether Wnt13 forms have differential effects on the expression
and activation of FOXOs that mediate the transcriptional regulation of FOXO
target genes related to apoptosis and oxidative stress resistance.
6.1 Summary
Wnt proteins control cell fate during development and postnatal homeostasis by
regulating cell proliferation, cell differentiation and cell apoptosis. In the previous
chapter, we have shown that Wnt13 forms increase apoptosis in BAEC with different
strengths: nuclear > mitochondrial> secreted forms, and Wnt13 forms increase the
activation and expression of caspases possibly though upregulating Bim protein.
Therefore, it is interesting to know what upstream factors mediate the effect of Wnt13
forms on Bim and caspases as well as subsequent apoptosis. In this study, we found that
in transient transfection, 1) nuclear Wnt13 forms increased the expression FOXO3a but
not FOXO1; 2) Wnt13A and mitochondrial Wnt13 forms reduced the phosphorylation of
FOXO3a at Ser253 which is a Akt site, but not FOXO1; 3) Wnt13A increased the nuclear
localization of exogenous FOXO1 and endogenous FOXO3a, and M1L-Wnt13B also
increased the nuclear localization of exogenous FOXO1 and FOXO3a; 4) M1L-Wnt13B
upregulated the expression of a subset of FOXO target genes such as SOD2; 5) Wnt13
forms did not have significant effect in luciferase activity of Forkhead responsive element
(FHRE from FasL promoter) reporter system and SOD2 promoter; 6) however, M1LWnt13B increased the luciferase activity of SOD2 intron 2 element (I2E) upon LPS
treatment; 7) also, a putative FOXO site was found in intron 2, which was responsive to
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activated FOXO3a form. Therefore, our conclusions are that Wnt13 forms increase
FOXO localization in nucleus through either upregulating FOXO3a expression (M1LWnt13B) or decreasing FOXO3a phosphorylation (Wnt13A) and thereby upregulate the
expression of a subset of FOXO target genes related to oxidative stress resistance;
although it is not clear whether Wnt13 forms increase FOXO activity at Bim promoter,
M1L-Wnt13B increased SOD2 transcription upon LPS treatment possibly through a
putative FOXO site at intron 2 in SOD2 gene.

6.2 Introduction

Wnt signaling is recognized as one of the handful powerful pathways that control
basic development and organism homeostasis (Clevers H. 2006 and Staal FJ et al. 2008).
Wnts and Wnt signaling function in controlling cell fate, including cell proliferation or
self-renewal, differentiation, senescence and apoptosis (Hayward P et al. 2008; Almeida
M et al. 2005).

Wnt13, also named Wnt2b, is one of the rare members in Wnt family, which is
expressed in a dynamic pattern during embryogenesis and organogenesis, and the
expression is related to human diseases, including cancer, diabetes. The complexity of
human Wnt13 gene has been shown in human cells with three isoforms identified: the
secreted Wnt13A, mitochondrial Wnt13B and nucleus Wnt13C, which differ in their Nterminal sequences and generated through alternative promoter, alternative splicing and
alternative start codons (Struewing IT et al. 2006; Bunaciu RP et al. 2008). Moreover,
Wnt13 nuclear forms showed an increased sensitivity to LPS or TNF induced apoptosis
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in primary endothelial cells (Struewing IT et al. 2006), and nuclear Wnt13C underwent
translational regulation during apoptosis (Tang T et al. 2008). In the previous chapter
(Aim 2), we have shown that Wnt13 forms increased EC sensitivity to LPS-induced
apoptosis with different strengths: nuclear (robust) > mitochondrial (moderate) > secreted
forms (weak), and Wnt13 forms increase the activation of caspases through upregulating
the expression of caspases and pro-apoptotic Bcl-2 family member Bim which tips the
balance of pro-apoptotic/anti-apoptotic factors in Bcl-2 family to pro-apoptosis. In this
case, to discover the upstream factor, we started with FOXOs which are the common
transcription factors that regulate both caspase-3 and Bim.

FOXO proteins are a family of transcription factors with important roles in
metabolism, cell cycle, stress tolerance and possibly lifespan (van der Horst A et al.
2007). FOXO family consists of FOXO1, 3a, 4 and 6, and in differentiated endothelial
cells, FOXO1 and 3a are the main forms of FOXO (Potente M et al. 2005). FOXO1deficient mice died at around embryonic day 11 due to branchial arch defects and
abnormal vascular remodeling in the yolk sacs, indicating that FOXO1 is required for
mouse vascular development (Furuyama T et al. 2004). FOXO proteins undergo posttranslational

modifications

like phophorylation,

ubiquitination,

acetylation

and

methylation, which either activate or inhibit the transcription activity of FOXOs (Huang
H et al. 2007; Yamagata K et al. 2008). In the presence of growth factors, FOXOs located
in the nucleus are phosphorylated by upstream kinases such as Akt and SGK on three
conserved residues (Thr24, Ser256, and Ser319 for FOXO1; Thr32, Ser253, and Ser315
for FOXO3a). Phosphorylated FOXOs bind 14-3-3 protein, resulting in the export out of
nucleus and subsequent degradation by proteasome in cytoplasm (Greer EL et al. 2005).
170

However, activated FOXOs (like FOXO1-AAA or FOXO3a-TM, in which 3
phosphorylation sites are mutated) stay in nucleus, and bind to the DNA binding element
(DBE) of the target genes, initiating gene transcription. FOXO target genes include DNA
repair-related Gadd45, oxidative detoxification-related SOD2 and catalase, cell cyclerelated p27KIP1, cyclin D1 and cylin D2 (Huang H et al. 2007). In addition, FOXOs also
target apoptosis-related genes such as caspase-3, Bim, as well as extrinsic pathway factors
FasL and TRAIL (Bois PR et al. 2005; Huang H et al. 2007). FOXO1, 3, 4 tripleknockout mice developed thymic lymphomas and hemangiomas (endothelial cell tumor),
suggesting that FOXOs are tumor suppressors and specifically important for endothelial
cell homeostasis (Paik JH et al. 2007). The tumor suppressing effect of FOXOs may be
related to their pro-apoptotic functions. Also, constitutively activated form FOXO1-TM
has been shown to induce apoptosis in leukemia-derived cell lines via TRAIL (Kikuchi S
et al. 2007); knock-down of FOXO3a by small interfering RNA abolished free fatty acidinduced hepatocyte apoptosis and Bim induction (Barreyro FJ et al. 2007), further
indicating the promoting role of FOXOs in cell apoptosis.
In addition, FOXOs also converge with Wnt-signaling; in 2005, Essers MA
discovered a functional interaction between FOXO and β-catenin under oxidative stress,
so a new FOXO-Wnt model was then proposed: upon Wnt signaling which turns TCF
on, or upon insulin signaling that turns FOXOs off, β-catenin prefers interacting with
TCF rather than FOXO to promote cell proliferation; in contrast, under oxidative stress
conditions where FOXO activity is on, β-catenin preferentially binds to FOXOs to induce
apoptosis or quiescence (Essers MA et al. 2005; Bowerman B. 2005).

171

The status of oxidative stress can regulate cell apoptosis because oxidative stress
is one of the inducers of intrinsic apoptotic pathway by promoting the permeability of
mitochondria (Garrido C et al. 2006). SOD2 and catalase are one of the subsets of FOXO
target genes which belong to endogenous enzyme systems to defend oxidative stress.
Superoxide (O2-) can be converted by SOD to H2O2, which is in turn converted to H2O
and O2 by catalase; in mitochondria, MnSOD (the protein product of SOD2), is
specifically used to catalyze the superoxide conversion (Kamata H et al. 1999). In SOD2
gene, the P7 fragment (-210 - +24) containing multiple Sp1- and AP-2 binding site, has a
basal promoter function (Yeh CC et al. 1998). And two DBE sites for FOXO3a at
promoter region were reported: one at -997 bp and the other one at -1, 249 bp, and only
the latter one is critical for FOXO3a activity (Kops GJ et al. 2002). Also, several NF-κB
sites in 5’- or 3’- flanking area were found to be irresponsive to the induction by TNF;
however, the NF-κB site located in intron 2 element (I2E) is critical for TNF/IL-1mediated induction (Xu Y et al. 1999), revealing the complexity of SOD2 regulation at
transcriptional levels.
To test the hypothesis that FOXOs are involved in increased caspases and Bim by
Wnt13 forms, we studied whether Wnt13 forms affect the expression, phosphorylation,
nuclear localization and other target gene expression of FOXOs, as well as FOXO
transcription activity by using Forkhead responsive element (FHRE) of FasL gene, and
the transcriptional regulation of different SOD2 regions (promoter or intron regions).
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6.3 Material and Methods
6.3.1 Materials
The rabbit polyclonal anti-phospho-FOXO1 (Thr24)/FOXO3a (Thr32), phosphoFOXO3a (Ser253), anti-FOXO1, anti-P27kip and anti-Creb as well as anti-COXIV
antibodies were from Cell Signaling Technology. The rabbit polyclonal anti-MnSOD
antibody was from Stressgene. The rabbit polyclonal anti-FOXO3a and the goat
polyclonal anti-calnexin antibodies were purchased from Santa Cruz. The nuclear
Extraction

Kit

was

from

Panomics.

5-(and-6)-chloromethyl-2',7'-

dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA), Dihydroethidium
(DHE), and th CyQuant® Cell Proliferation Assay kit were from Molecular Probes. The
Dual Luciferase Reporter Assay System was from Promega and Galacto Light Plus was
purchased from Tropix-Applied Biosystem.

6.3.2 Cell culture and transfection
Cell culture and transient transfection were described in 3.2 and 3.3. For stable
transfection, please refer 5.3.2.

6.3.3 Plasmid constructs
Please refer 3.4 for Wnt13-Flag constructs. The plamids of pEGFP-N1-GFPFOXO1, pEGFP-N1-GFP-FOXO1-AAA, pECE-HA-FOXO3a WT, pECE-HA-FOXO3aTM, pECE-HA-FOXO3a-WT DBM (H212R) and FHRE-luc were purchased from
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Addgene, which were then recovered, grown and amplified by maxipreps in our
laboratory. PGL3-SOD2-P7-luciferase, PGL3-SOD2-1.6K-luciferase, PGL3-SOD2-3Kluciferase, and PGL3-SOD2-P7-I2E-luciferase constructs were kind gifts from Dr. Daret
St Clair (University of Kentucky).

6.3.4 RNA isolation and real-time PCR (refer 3.5)

6.3.5 Cell extracts and western blot analysis (refer 3.6)

6.3.6 Immunofluorescence microscopy (refer 3.8)

6.3.7 Cell fractionation and nuclear extraction

The protocol for cell fractionation and nuclear extraction was based on
manufactures’ handbook and improved by our laboratory. Generally, for each sample, 106
BAECs were used and transfected with Wnt13-Flag constructs. After 40 hours, media
were removed from the dish and cells were washed with PBS twice before 500µl
hypotonic Buffer A (10 mM HEPES, pH 7.9; 10 mM KCl; 0.1 mM EDTA. 1mM DTT,
0.5 mM PMSF, 5 ul of protease inhibitor cocktail to 5 ml of buffer were added just before
use) was added. Then the dish was placed on a rocker at 4oC for 10 minutes. After
scrapped off from the dish, cells were transferred to a 1.5ml microcentrifuge tube, and
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syringed 20 times to break the cells. 50µl of cell suspension was taken out and saved as
whole cell extract. The rest of 450µl suspension was centrifuged at 14,000g for 3 minutes
(4oC), and the supernatant was saved as the cytosol and the membrane. The pellet was
then washed with Buffer A, and after the same centrifugation, the pellet was mixed with
150µl high salt Buffer B (20 mM HEPES, pH 7.9; 0.4 M NaCl; 1 mM EDTA; 1M KCl;
10% Glycerol; 1mM DTT, 0.5 mM PMSF, 5 ul of protease inhibitor cocktail to 5 ml of
buffer were added just before use), followed by nuclear extraction on a shaker for 1 hour
(4oC). After centrifuge at 14,000g for 10 minutes (4oC), the supernatant was isolated and
stored as nuclear extracts while the pellet was stored as unextracted nuclear fraction.

6.3.8 Dual luciferase reporter assay
According to the manufacture’s instructions, each well (105 cells) of BAECs were
co-transfected with 5 ng of pCMV-β-galactosidase construct for normalization purposes,
and with 5 ng phRGTK (expressing Renilla luciferase to normalize for transfection
efficiency), 250 ng PGL3 vector or luciferase constructs, and with 0.4 µg Wnt13-Flag
constructs as well as 0.4 µg PCR3 vector. After 40 hours, cells were lysed with 125 µl
Passive Lysis Buffer supplemented with proteasome inhibitors, and scrapped off the
plate. Cells were then transferred to a microcentrifuge tube and centrifuged at 25,000 g
for 5 minutes (4oC). 20 µl of the supernatant was loaded into a 96-well microplate for
luciferase assay with luciferase substrate for firefly activity and then Stop-Glo substrate
for Renilla activity. Another 20 µl of the supernatant was loaded to another microplate
for β-galactosidase activity assay, using Galacto Light Plus substrate for 30-minute
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incubation prior to being added with accelerating reaction buffer. Both Renilla-firefly
dual luciferase assay and β-galactosidase activity assay were performed using an LmaxII
luminometer (Molecular Device). Although two internal controls (Renilla and βgalactosidase) were used, the corrected reporter luciferase activity was calculated by
firefly luciferase activity/ β-galactosidase activity due to more consistency in βgalactosidase assay. All the transfection experiments were performed in duplicates.

6.3.9 Statistical analysis
All results are expressed as mean ± SEM. For the values represented by the
relative levels over PCR3 control which was set as 1, One Sample T-test (hypothesized
value = 1) was used when compared to PCR3 control. Statistical significance was
accepted at a value of P<0.05. Otherwise, when the values of the control group fit normal
distribution, One Way ANOVA analysis was used followed by Tukey’s test for
comparison between different groups.

6.4 Results
6.4.1 Effect of Wnt13 forms on FOXO expression in BAECs
Since increased FOXO expression may cause increased FOXO activity, we firstly
investigated whether Wnt13 isoforms have an effect on the expression of FOXOs. In the
experiments of transient transfection, we found that the expression of FOXO1 remained
unchanged by Wnt13 forms (Figure 6.1A) at both protein levels and mRNA levels;
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however, M1L-Wnt13B increased the protein expression of FOXO3a significantly, and
all the intracellular isoforms upregulated the mRNA expression of FOXO3a by 2-2.5 fold
(Figure 6.1B). In the experiments of stable transfection, Wnt13 forms did not show the
significance in increasing FOXO1 expression either at protein levels or at mRNA levels
(Figure 6.2A). But Wnt13 forms demonstrated a trend in increasing mRNA levels of
FOXO3a, and M74L-Wnt13B was statistically significant (Figure 6.2B). And both
graphs in Figure 6.2 showed that Wnt13B had less effect on the expression of FOXOs
than all the other forms did, which can be explained by the expression pattern of Wnt13B
which is the least among all the Wnt13 forms in stably-transfected BAECs as determined
by imunofluoresence micoscopy.

6.4.2 Effect of Wnt13 forms on FOXO phosphorylation in BAEC
Post-translational modifications, such as phosphorylation, are regulatory events
for FOXO activity. When FOXOs are phosphorylated by upstream kinases such as Akt
and SGK on three conserved residues (Thr24, Ser256, and Ser319 for FOXO1; Thr32,
Ser253, and Ser315 for FOXO3a), they bind 14-3-3 protein, resulting in the export out of
nucleus and subsequent degradation by proteasome in cytoplasm (Greer EL et al. 2005).
We used anti-phospho-FOXO1 (Thr24)/FOXO3a (Thr32) antibody which detects mainly
FOXO1 phosphorylation because the expression of FOXO1 is 10 times more abundant
than that of FOXO3a in BAECs (data not shown), and FOXO1 phosphorylation was
shown unchanged by Wnt13 isoforms in transient transfection (Figure 6.3A). We also
used specific anti-FOXO3a phosphorylation (Ser253) antibody and as shown in Figure
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6.3A, Wnt13A and mitochondrial forms decreased FOXO3a phosphorylation at Ser253
by 40-60%, and nuclear forms of Wnt13 showed a moderate reduction in FOXO3a
phosphorylation by 30-40% which was not statistically significant. As FOXO
phosphorylation at Ser253 is inhibitory for FOXO transcriptional activity, the decreased
FOXO3a phosphorylation by Wnt13 forms suggests that Wnt13 forms possibly increase
FOXO activity.

6.4.3 Effect of Wnt13 forms on subcellular localization of FOXOs in BAEC
6.4.3.1 Exogenous localization of FOXOs
Decreased phosphorylation of FOXO3a may lead to less nuclear exclusion, so we
then investigated the effect of Wnt13 forms on the subcellular localization of FOXOs in
transient transfection. On one hand, we co-transfected GFP-FOXO1 or HA-FOXO3a
with Wnt13-Flag into BAECs and detected the exogenous Wnt13-Flag forms and FOXOs
by immunofluoresence microscopy. For PCR3 control (Figure 6.4), 50% exogenous
FOXO1 was localized in the nucleus while 30% was localized in the cytosol. Wnt13A,
Wnt13C, and M1L-Wnt13B were able to increase its nuclear localization up to more than
60% and decrease its cytoplasmic localization under 10%. However, as shown in Figure
6.5, PCR3 showed more exogenous FOXO3a in cytosol (45%) than in nucleus (40%).
M1L-Wnt13B increased FOXO3a nuclear localization up to 80% and decreased its
cytoplasmic localization down to 10%, and other Wnt13 forms such as Wnt13A and
Wnt13B showed a trend in increasing the nuclear localization of FOXO3a, which was not
statistically significant.
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6.4.3.2 Endogenous localization of FOXOs
On the other hand, we isolated different subcellular fractions of BAECs and
extracted the nucleus to see whether Wnt13 forms had similar effects on endogenous
FOXOs. First, we used different markers to show the quality of subcellular fractionation
and very little contamination among cell fractions (Figure 6.6C): COXIV, a
mitochondrial protein, was only found in the fraction of cytoplasm plus membrane; both
β-catenin and calnexin were mainly in the fraction of cytoplasm plus membrane, with a
small amount in nucleus; and Creb is a nuclear transcription factor, which was localized
both in extracted nucleus and in unextracted nucleus (around 1:1).
To our surprise, our data (Figure 6.6C) demonstrated that FOXO1 was totally
absent in cytoplasm or membrane, but exclusively in the nuclear fraction (both in nuclear
extracts and in unextracted pellet; around 1:6 in proportion). And Wnt13A or M1LWnt13B did not show obvious effect on FOXO1 localization in either nuclear extracts or
in unextrated pellet (Figure 6.6A). However, unlike endogenous FOXO1, endogenous
FOXO3a was shown localized both in the nucleus and in the fraction of cytoplasm plus
membrane (Figure 6.6C). Wnt13A increased FOXO3a localization in nuclear extracts by
more than 2 fold (p=0.05), and M1L-Wnt13B had a weaker increase (by around 50%).
Wnt13A and M1L-Wnt13B showed mild decreasing effect on FOXO3a localization in
the fraction of cytoplasm plus membrane. These results suggest that Wnt13A increased
the nuclear localization of endogenous FOXO3a.
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6.4.4 Effect of Wnt13 forms on the expression of FOXO target genes in BAEC
6.4.4.1 p27kip
Since the expression of Bim and caspase-3 were shown upregulated by nuclear
Wnt13 forms, we thereby tested whether Wnt13 isoforms increase the expression of other
FOXO target genes, such as cell cycle-related p27kip. As illustrated in Figure 6.7,
transiently-transfected Wnt13A (p<0.05) and M1L-Wnt13B were able to upregulate the
protein expression of p27kip at basal levels by around 50%, and M1L-Wnt13B increased
its mRNA expression by 5 fold. In stable transfection (Figure 6.8), Wnt13A (p<0.01) and
M1L-Wnt13B increased the protein expression of p27kip by 2 folds at basal levels, and
Wnt13A showed more effect in increasing mRNA expression of p27kip at basal levels
than other isoforms, implying that Wnt13A may be related to cell quiescence.
6.4.4.2 Oxidative stress resistance-related genes
Another subset of FOXO target genes is oxidative stress resistance-related SOD2
and catalase, and they are associated with the function of FOXOs in stress resistance. As
shown in Figure 6.9A, Wnt13A, Wnt13B and M1L-Wnt13B increased the protein
expression of MnSOD both at basal levels and after LPS treatment in transient
transfection, and M1L-Wnt13B showed bigger effect (2.5 fold at basal levels and 70%
after LPS treatment) than other forms. Wnt13 forms also showed a trend in upregulating
mRNA levels of MnSOD at the basal levels, and M1L-Wnt13B had the statistical
significance. In the experiments of stable transfection (Figure 6.10), Wnt13A had slightly
higher increase in MnSOD protein at basal levels than other forms, and a similar
phenomenon was also seen in mRNA levels of MnSOD: 5 fold increase by Wnt13A
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while 2-3 fold by other isoforms. These results suggest that Wnt13 forms increased the
expression of MnSOD with differential strengths.
As for catalase, the intracellular Wnt13 forms increased the protein levels of
catalase by 60-80% at basal levels in transient transfection, and M1L-Wnt13B had
stronger effect (Figure 6.11A). But the Wnt13 isoforms did not show significant effect in
increasing mRNA expression of catalase (Figure 6.11B). In stable transfection (Figure
6.12), the protein levels of catalase were not obviously upregulated by Wnt13 forms
either at basal levels or upon LPS treatment except M74L-Wnt13B, other Wnt13 forms
increased mRNA levels of catalase by 2-3 fold, and M1L-Wnt13B was statistically
significant (p<0.05). So Wnt13 forms, especially nuclear forms, increased catalase
expression mainly at protein levels.

6.4.5 Effect of Wnt13 forms on FHRE-luciferase activity in BAEC
As Wnt13 forms decreased FOXO phosphorylation and increased their nuclear
localization, we then studied the effect of Wnt13 forms on FOXO transcription activity
by using FHRE-luc Reporter construct. Forkhead Responsive Element (FHRE) is the
DNA element to bind FOXO factors in FasL promoter, the nucleotide sequence for
FHRE is “TAAATAA” (Brunet A et al. 2002), which has one nucleotide difference than
the core sequence of canonical FOXO site T/A AAAC A/C” (Biggs WH et al. 2001). The
FHRE-luc reporter construct we used was provided by Addgene, which carries a small
region of Fas Ligand promoter containing three canonical copies of FHREs (Brunet A et
al. 1999).
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As shown in Figure 6.13A, either FOXO1-WT or FOXO3a-WT was unable to
induce FHRE luciferase activity, so we then used constitutive-activated (CA) or
dominant-negative (DN) forms of FOXOs as positive or negative controls to test our
system. CA form FOXO3a-TM contains three mutations at phosphorylation sites of Akt,
which increased FHRE luciferase activity by 50%, and FOXO3a-H213R is a DN form
due to the mutation at DNA binding domain, which reduced FHRE-luciferase activity by
50%; interestingly, FOXO1-AAA did not show any increasing effect on this luciferase
activity, suggesting that the FHRE luciferase system was responsive to FOXO3a
activation but not FOXO1.
When co-transfected with GFP-FOXO1 or HA-FOXO3a, Wnt13A was able to
increase FHRE luciferase activity by 60% or 30%, respectively, but M1L-Wnt13B did
not affect the transcriptional activity of exogenous FOXOs (Figure 6.13A). And this
phenomenon is inconsistent with the result of FOXO3a localization: M1L-Wnt13B
increased the nuclear localization of exogenous FOXO3a more than Wnt13A. Perhaps for
FHRE, even though M1L-Wnt13B pushed exogenous FOXO3a into the nucleus, this
nuclear FOXO3a-WT was not able to transactivate FHRE, which is supported by the fact
that only active form of FOXO3a, not FOXO3a-WT increased the FHRE luciferase
activity. For endogenous FOXO activity, none of Wnt13 forms were able to increase the
FHRE luciferase activity either at basal levels (Figure 6.13B) or after LPS treatment (data
not shown). Therefore, although Wnt13A increased exogenous FOXO transcription
activity at FHRE, Wnt13 forms were unable to increase endogenous FOXO transcription
activity at FHRE.
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6.4.6 Effect of Wnt13 forms on SOD2 transcriptional regulation in BAECs
6.4.6.1 SOD2 promoter region
Since MnSOD expression was upregulated by Wnt13 forms at both mRNA levels and
protein levels, we tried to determine whether Wnt13 forms function through increasing
FOXO activity to promote SOD2 gene transcription. First, we used the 3 constructs with
different lengths of fragments from human SOD2 promoter region: P7, 1.6K, and 3K
(Figure 6.14). And the DNA binding element (DBE) of FOXOs is at -1,249 bp, so if
FOXO transcription activity is increased, the luciferase activity of 1.6K or 3K should be
greatly enhanced compared to P7. According to Figure 6.15A, without the co-transfection
of exogenous FOXOs, Wnt13A had a 1.4 fold increase in P7 than PCR3 control, but not
further increase when 1.6K and 3K luciferase constructs were used, suggesting that
Wnt13A increase SOD2 gene transcription not through FOXO factors. Moreover, other
Wnt13 forms including M1L-Wnt13B did not show obvious effect on the luciferase
activity of 1.6K or 3K, indicating that intracellular Wnt13 forms did not enhance SOD2
transcription at promoter region.
Also, as shown in Figure 6.15B, exogenous FOXO1-WT or FOXO3a-WT were
unable to increase the luciferase activity of 1.6K. So FOXO activated forms, FOXO3aAAA and FOXO3a-TM, were used to test the system. And exogenous FOXO3a-AAA
and FOXO3a-TM increased the PGL3-1.6K-Luciferase activity by 2 fold or 4 fold,
respectively, indicating that the SOD2 1.6K promoter fragment is responsive to FOXO
activation. Also, compared to PCR3, Wnt13A enhanced 1.6K luciferase activity up to 2
fold when co-transfected with FOXO1-WT or FOXO3a-WT, indicating that Wnt13A
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may increase exogenous FOXO transcription activity at SOD2-1.6K promoter region,
which is consistent with the result that Wnt13A increased exogenous FOXO transcription
activity at FHRE. However, M1L-Wnt13B did not show any increasing effect on either
exogenous or endogenous FOXO transcription activity at SOD2 1.6K region.
Then we investigated whether Wnt13 forms, especially M1L-Wnt13B, affect
SOD2 promoter luciferase activity upon LPS treatment. Compared to the luciferase
activity at basal levels, the activity of PGL3 vector, PGL3-P7 and PGL3-1.6K constructs
was not induced by LPS challenge. As shown in Figure 6.16A and 6.16B, the luciferase
activity of PGL3 vector, PGL3-P7 and PGL3-1.6K showed a small increase by transient
transfection of Wnt13A after LPS treatment, which is similar to the result at basal levels.
M1L-Wnt13B had a trend in increasing in luciferase activity of PGL3-P7 and PGL3-1.6K
but not PGL3 vector after LPS treatment (Figure 6.16 B and C). Therefore, our results
suggest that Wnt13A increase SOD2 transcription at promoter region at basal levels and
after LPS treatment independent of FOXOs; M1L-Wnt13B had a very limited effect on
increasing SOD2 transcription at promoter region.

6.4.6.2 Intron 2 region
Since the promoter region of SOD2 gene can not fully explain the increased
SOD2 mRNA levels by Wnt13 forms, especially M1L-Wnt13B, we then tested whether
the intron2 element (I2E), which are responsive to stress stimuli including TNF and IL-10
because of the NF-κB site, could be regulated by Wnt13 forms. At the basal levels
(Figure 6.17A), all the Wnt13 forms except Wnt13B showed slight increase in PGL3-P7184

I2E-luciferase activity, but this was not significant. However, after LPS treatment, the
activity of PGL3-P7-I2E was greatly induced (up to 12 fold) compared to that at basal
levels, which is expected due to the existence of NF-κB site in the intron 2 region that is
responsive for stress stimuli. Moreover, Wnt13A increased PGL3-P7-I2E activity by 50%
at basal levels (Figure 6.17A), which is similar to the increase shown in PGL3-P7 and
PGL3-1.6K, indicating that this increase may be more from the common fragment P7;
and after LPS treatment, Wnt13A did not have further increase in PGL3-P7-I2E activity
than basal levels, further suggesting that Wnt13A increases SOD2 transcription activity
mainly through P7 fragment instead of I2E. M1L-Wnt13B enhanced PGL3-P7-I2Eluciferase activity only by 30% at basal levels; however, this increase went up to 2 fold
(p<0.05) after LPS treatment, which explains a similar increase of SOD2 mRNA levels
upon LPS treatment (Figure 6.9). This result suggests that M1L-Wnt13B increases SOD2
transcription activity mainly through I2E, especially when challenged by LPS.
In order to find out which site in I2E is responsible for the increase by M1LWnt13B dependent of LPS, we subsequently looked into the sequence of I2E for FOXO
site. And, an “AAACA” was found from +2053 though + 2057, which is exactly the
same as the core sequence of FOXO binding site. To test whether this putative FOXO site
was responsive to both FOXO and M1L-Wnt13B, our labatory mutated this putative
FOXO site “AAACA” to “AAAGA”, and made two maxipreps, I2E-M1, and I2E-M2. As
shown in Figure 6.18A, PGL3-P7-I2E luciferase activity at basal levels was induced by
the transfection of FOXO3a-TM, a constitutively activated form of FOXO3a by 3 fold.
Compared to wildtype PGL3-P7- I2E, the basal luciferase activity of PGL3-P7-I2E-M1
and -M2 was increased by 60% (p<0.05) and 30% (p<0.07), respectively. And FOXO3a185

TM increased the luciferase activity of PGL3-P7-I2E-M1 and -M2 by 1.5 and 1.3 fold,
respectively, which is less than the increase in I2E wildtype. After the treatment with
LPS, the PGL3-P7-I2E luciferase activity was induced by 10 fold than that of basal
levels, and transfection of FOXO3a-TM increased the activity by 1.2 fold. Also
compared to wildtype PGL3-P7- I2E, the basal luciferase activity of both PGL3-P7-I2EM1 and -M2 was increased by 1 fold. But FOXO3a-TM showed much less increase of
luciferase activity of these two mutants by 50% and 20%, respectively than I2E wildtype,
showing mutation at this FOXO site can, at least partially, diminish the increase of
PGL3-I2E-P7 luciferase activity dependent of LPS. All these data support that the
putative FOXO site may be functional.
Then we questioned whether this putative FOXO site is responsible for the
increased I2E activity by Wnt13 forms. Figure 6.18C demonstrated that the increase of
PGL3-P7-I2E luciferase activity by Wnt13 forms, especially by M1L-Wnt13B, was
totally abolished through mutation of the FOXO site located at I2E. Therefore, this
putative FOXO site is important for M1L-Wnt13B function, and M1L-Wnt13B enhanced
PGL3-P7-I2E luciferase activity after LPS treatment possibly through this novel FOXO
site at I2E, suggesting that M1L-Wnt13B may increase SOD2 transcription after LPS
treatment mediated by FOXOs.

6.5 Discussion
FOXOs are a family of critical transcriptional integrators for the homeostasis of
endothelial cells (Potente M et al. 2005). FOXO1 deficiency is embryonic lethal for mice
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due to branchial arch defects and abnormal vascular remodeling in the yolk sacs
(Furuyama T et al. 2004), and FOXO1, 3, 4 triple-knockout mice developed thymic
lymphomas and hemangiomas (endothelial cell tumor), suggesting that FOXOs are
specifically important for endothelial cell homeostasis (Paik JH et al. 2007). In HUVECs,
FOXO1 and FOXO3a are the most abundant FOXO isoforms, and overexpression of
constitutively active Foxo1 or Foxo3a significantly inhibits endothelial cell migration and
tube formation in vitro (Potente M et al. 2005). Therefore, in our BAEC system, we
focused on studying FOXO1 and FOXO3a, and we found distinct features between these
two isoforms in BAECs: 1) FOXO1 is more abundant than FOXO3a; 2) for the
subcellular localizations, the endogenous FOXO1 was exclusively found in the nucleus
but not the cytoplasm (Figure 6.6C) whereas the endogenous FOXO3a was more evenly
distributed to each fraction. The exogenous FOXO1 was also more localized in the
nucleus (50%) than in the cytoplasm (30%) (Figure 6.4), whereas more FOXO3a is
distributed in the cytosol (50%) than in the nucleus (40%) (Figure 6.5). 3) For
transcription activity, the FOXO3a-TM (constitutively active form of FOXO3a) is more
active than the FOXO1-AAA (constitutively active form of FOXO1), since FOXO3a-TM
increased FHRE luciferase activity (by 60%) more than FOXO1-AAA (Figure 6.13), and
FOXO3a-TM enhanced SOD2-1.6K luciferase activity (up to 4 fold) more than FOXO1AAA did (by 2 fold) (Figure 6.15). These data suggest that although both endogenous
and exogenous FOXO1-WT is more abundant in BAECs and more FOXO1 stays in
nucleus, the promoter assay results did not show FOXO1 is more active than FOXO3a.
In this study, we have also shown the differential effect of Wnt13 forms on
FOXOs in BAECs. In transient transfection, nuclear M1L-Wnt13B increased FOXO3a
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expression both at mRNA levels and protein levels, but had no significant effect on
FOXO3a phosporylation at Ser253, which is in agreement with the unaffected
phosphorylation of Akt by M1L-Wnt13B; M1L-Wnt13B increased the nuclear
localization of both exogenous FOXO1 and exogenous FOXO3a; M1L-Wnt13B
upregulated the expression of other FOXO target genes, such as p27cip (mRNA), MnSOD
(mRNA and protein), catalase (protein), which is in agreement with our hypothesis, so
M1L-Wnt13B may increase the expression and activation of FOXO3a. However,
Wnt13A decreased FOXO3a phosphorylation by 60% but did not increase FOXO3a
expression significantly; Wnt13A increased exogenous FOXO1 nuclear localization;
Wnt13A increased the nuclear localization of endogenous FOXO3a more than M1LWnt13B did, which is in agreement of the increased luciferase activity of FHRE (with
exogenous FOXOs) and SOD2 promoter; and Wnt13A increase the expression of FOXO
target genes, like p27 (protein), MnSOD (mRNA and protein), indicating that Wnt13A
might also increase FOXO activation. Altogether these results suggest that Wnt13A
increased the nuclear localization of FOXO3a through decreasing FOXO3a
phosphorylation while M1L-Wnt13B increased the nuclear localization of FOXO3a via
upregulating the expression of FOXO3a.
Although both Wnt13A and M1L-Wnt13B promote FOXOs to stay in nucleus,
they differ in their effect on FOXO transcription activity. Wnt13A did enhance SOD2
promoter activity, which explains the increased levels of MnSOD, but this effect was not
through FOXO site, because there was no obvious difference between SOD2-P7 activity
(40% increase) and SOD2-1.6K activity (50% increase) by Wnt13A. So Sp1 or AP-2
sites may be involved in the increased P7 luciferase activity by Wnt13A. And a bigger
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increase was seen in SOD-3K luciferase activity (2 fold) compared to SOD2-1.6K,
implying that some other element(s) located between 1.6K and 3K is important for SOD2
promoter activity. However, M1L-Wnt13B did not show any effect on SOD2 luciferase
activity of its promoter region; yet, M1L-Wnt13B enhanced SOD2 luciferase activity
through its intron 2 element possibly mediated by a novel FOXO-binding site. Similar
differences were also described in the previous chapter that Wnt13A and M1L-Wnt13B
increase EC apoptosis and Bim expression with different activity: M1L-Wnt13B
displayed robust effect while Wnt13A had mild effect. Therefore, even though both
Wnt13A and M1L-Wnt13B increased the FOXO nuclear localization, M1L-Wnt13B
seems to exert bigger effect on FOXO activity (at least for SOD2) and expression as well
as EC apoptosis while Wnt13A appears to have no significant increase in FOXO activity
and in apoptosis induction.
Both the FHRE of FasL gene and SOD2 promoter contain FOXO responsive
elements, but none of Wnt13 forms (except Wnt13A) were able to increase luciferase
activity of FHRE and SOD2 promoter (Figure 6.13). So we then looked at SOD2 region
known to be regulated by LPS, i.e. intron 2 element which has reported to be induced up
to 6 fold by TNF/IL-10 due to the existing NF-κB site (Xu Y et al. 1999). Surprisingly, in
our experiment, the PGL3-P7-I2E was also responsive to FOXO3a-TM because the
SOD2-P7-I2E luciferase activity at basal levels was induced by FOXO3a-TM up to 4
fold; and after LPS treatment, FOXO3a-TM further induced SOD2-P7-I2E luciferase
activity up to 2 fold. Therefore, we started to test if there was a consensus binding site,
and we did find one located at +2053 - + 2057 at intron 2 element. Compared to the
sequences of the FOXO sites in the other constructs (“TAAATAA” for FHRE and
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“TAAACAA” for SOD2 promoter) (Brunet A et al. 2002; Kops GJ et al. 2002), the
sequence of this FOXO at I2E is “AAAACAA”, which fits with the canonical conserved
FOXO binding site “T/A AAAC A/C” (Biggs WH et al. 2001). To test if this FOXO site
is functional, two mutants were made, and our results showed that by mutating the
putative FOXO site, the 4-fold increase of SOD2-P7-I2E luciferase activity by FOXO3aTM went down to 2.2 fold at basal levels, and after LPS treatment, the 2-fold increase by
FOXO3a-TM were diminished to 20-50% (Figure 6.18), but the big standard errors in
FOXO3a-TM groups due to the small size of data (n=2), abolished the significance of the
increase by FOXO3a-TM. These findings support the possibility of a novel FOXOresponsive site located in SOD2-I2E region.
At basal levels, Wnt13 forms had a mild increase (20-30%) in SOD2-P7-I2E
luciferase activity; after LPS treatment, this increase went up (2 fold for M1L-Wnt13B)
(Figure 6.17). Figure 6.8 demonstrated that the increase in SOD2-P7-I2E luciferase
activity (LPS treated) by M1L-Wnt13B, was absent when the putative FOXO site was
mutated, suggesting that the putative FOXO site is essential for the increasing effect of
M1L-Wnt13B on SOD2-P7-I2E activity. Compared to the DBE site of FOXOs (-1,249
bp) at SOD2 promoter region which was not responsive to M1L-Wnt13B, the novel
FOXO site at I2E region is responsible for the increased PGL3-P7-I2E luciferase activity
by M1L-Wnt13B. Therefore, M1L-Wnt13B upregulated

SOD2

expression at

transcription levels possibly through the FOXO site at I2E.
Also, the increase of PGL3-P7-I2E luciferase activity by M1L-Wnt13B was
higher than the increase at basal levels. However, the effect of M1L-Wnt13B on
upregulating of the expression of SOD2 as well as other pro-apoptotic factors (caspase-3,
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Bim, etc) is similar between basal levels and LPS treatment. Also, Wnt13A increased
SOD2 transcription and expression at basal levels independent of FOXOs. Thus, there
may be other mechanisms besides FOXOs are responsible for the effect of Wnt13A and
M1L-Wnt13B at basal levels.
Besides SOD2, is the effect of Wnt13 forms on Bim also through FOXOs? In
endothelial progenitor cells (EPCs), FOXO4 overexpression was shown to increase Bim
promoter activity and Bim expression, resulting in increased EPC apoptosis (Urbich C et
al. 2005); also in EPCs, silencing FOXO3a led to reduced Bim expression and less cell
apoptosis (Zhu S et al. 2008), indicating the regulating role of FOXOs in Bim expression
and subsequent cell apoptosis in EPCs. However, it is uncertain whether the effect of
FOXOs on Bim regulation in EPCs can extend to differentiated BAECs, so whether
Wnt13 forms, especially nuclear Wnt13 forms upregulated Bim expression also through
increasing FOXO transcriptional activity still remains to be determined. It seems that
Wnt13 forms have distinct effect on each specific target gene of FOXOs: no increase at
all in FHRE of FasL gene; no increase by M1L-Wnt13B in SOD2 promoter region, while
FOXO-dependent increase by M1L-Wnt13B in SOD2 I2E. So it is very difficult to
predict whether Wnt13 forms function also through FOXOs to regulate Bim transcription
in BAECs, unless Bim promoter is used.
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A)

B)

Figure 6.1 Effect of Wnt13 forms on the expression of FOXOs in transient transfection:
A) FOXO1 and B) FOXO3a. BAECs were transiently transfected with the PCR3 vector
or Wnt13-Flag constructs for 40 hours, and cells were then harvested for immunoblotting
with anti-FOXO1 and anti-FOXO3a antibodies or for RNA extraction and real-time PCR.
The relative levels after normalization with basal PCR3 values (set as 1) are represented
in the graph (mean±SEM, n=6-15 independent transfection experiments; *<0.05,
**<0.01, ***<0.001).
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A)

B)

Figure 6.2 Effect of Wnt13 forms on FOXO expression in stable-transfected BAECs: A)
FOXO1; B) FOXO3a. BAECs were stably transfected with the PCR3 vector or Wnt13Flag constructs, and cells were then harvested for the immunoblotting with anti-FOXO1
antibody or for RNA extraction and real-time PCR. The relative levels after
normalization with basal PCR3 values (set as 1) are represented in the graph
(mean±SEM, n=5-6 independent transfection experiments; *<0.05).

193

A)

B)

Figure 6.3 Effect of Wnt13 forms on FOXO phosphorylation in transiently-transfected
BAECs. A) BAECs were transiently transfected with the PCR3 vector or Wnt13-Flag
constructs for 40 hours, and cells were then harvested for immunoblotting with P-FOXO1
(Thr24)/FOXO3a (Thr32), P-FOXO3a (Ser253) and FOXO1 as well as FOXO3a
antibodies. The relative phosphorylation levels after normalization with basal PCR3
values (set as 1) are represented in the graph (mean±SEM, n=6-15 independent
transfection experiments; *<0.05, **<0.01, ***<0.001). B) Representative images of
western blotting analysis are shown.
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A)

B)

Figure 6.4 Effect of Wnt13 forms on subcellular localizations of exogenous FOXO1 in
transiently-transfected BAECs. BAECs were co-transfected with Wnt13-Flag constructs
and GFP-FOXO1 for 40 hours, and then fixed with 4% formaldehyde, permeabilized in
0.1% Triton, and stained with rabbit polyclonal anti-Flag (red) and mouse monoclonal
anti-GFP (green) antibodies, followed by the incubation of Alexa goat anti-rabbit 488 and
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Alexa goat anti-mouse 568 antibodies. A) Representative images are shown (Red:
Wnt13-Flag; green: GFP-FOXO1; blue: DAPI); B) quantification of the relative
percentage in the nucleus/nucleus and cytoplasm/ cytoplasm is represented in the graph
(mean±SEM, n=5 independent transfection experiments; One Way ANOVA was used for
comparison between groups, *<0.05).
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A)

B)

Figure 6.5 Effect of Wnt13 forms on subcellular localizations of exogenous FOXO3a in
transiently-transfected BAECs. BAECs were co-transfected with Wnt13-Flag constructs
and HA-FOXO3a for 40 hours, and then fixed with 4% formaldehyde, permeabilized in
0.1% Triton, and stained with rabbit polyclonal anti-Flag (red) and mouse monoclonal
anti-HA (green) antibodies, followed by the incubation of Alexa goat anti-rabbit 488 and
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Alexa goat anti-mouse 568 antibodies. A) Representative images are shown (Red:
Wnt13-Flag; green: HA-FOXO3a; blue: DAPI); B) quantification of the relative
percentage in the nucleus/nucleus and cytoplasm/ cytoplasm is represented in the graph
(mean±SEM, n=6 independent transfection experiments; One Way Anova was used for
comparison between groups, *<0.05).
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A)

B)

C)

Figure 6.6 Effect of Wnt13 forms on endogenous subcellular localizations of FOXOs in
transiently-transfected BAECs. A) BAECs were transfected with Wnt13-Flag constructs
for 40 hours, and cell fractions were isolated followed by immunoblotting. A)
Quantification of the relative percentage of FOXO1 in each subcellular fraction is
represented in the graph; B) quantification of the relative levels of FOXO3a over PCR3
value (set as 1) in each subcellular fraction is represented in the graph (mean±SEM, n=45 independent transfection experiments); C) representative images of western blotting
analysis is shown.
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A)

B)

Figure 6.7 Effect of Wnt13 forms on p27kip expression in transiently-transfected BAECs.
BAECs were transiently transfected with the PCR3 vector or Wnt13-Flag constructs for
24 hours, followed by 100ng/ml LPS treatment, A) 16 hours later, whole cell exacts were
prepared and p27cip and β actin were analyzed by immunoblotting with specific
antibodies; or B) 6 hours later, cells were harvested and treated with Trizol prior to RNA
extraction and real-time PCR analysis. The relative protein or mRNA levels after
normalization with basal or LPS treated PCR3 values (set as 1) are represented in the
graph (mean±SEM, n=1-6 independent transfection experiments; *<0.05).
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A)

B)

Figure 6.8 Effect of Wnt13 forms on p27kip expression in stably-transfected BAECs.
BAECs were stably transfected with the PCR3 vector or Wnt13-Flag constructs, followed
by 100ng/ml LPS treatment, A) 16 hours later, whole cell exacts were prepared and
p27cip and β actin were analyzed by immunoblotting with specific antibodies; or B) 6
hours later, cells were harvested and treated with Trizol prior to RNA extraction and realtime PCR analysis. The relative protein or mRNA levels after normalization with basal or
LPS treated PCR3 values (set as 1) are represented in the graph (mean±SEM, n=6
independent transfection experiments; *<0.05).
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A)

B)

Figure 6.9 Effect of Wnt13 isoforms on MnSOD expression in transiently-transfected
BAECs. BAECs were transiently transfected with the PCR3 vector or Wnt13-Flag
constructs for 24 hours, followed by 100ng/ml LPS treatment, A) 16 hours later, whole
cell exacts were prepared and MnSOD and β actin were analyzed by immunoblotting
with specific antibodies; or B) 6 hours later, cells were harvested and treated with Trizol
prior to RNA extraction and real-time PCR analysis. The relative protein or mRNA levels
after normalization with basal or LPS treated PCR3 values (set as 1) are represented in
the graph (mean±SEM, n=2-18 independent transfection experiments; *<0.05; **<0.01).
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A)

B)

Figure 6.10 Effect of Wnt13 isoforms on MnSOD expression in stably-transfected
BAECs. BAECs were stably transfected with the PCR3 vector or Wnt13-Flag construct,
followed by 100ng/ml LPS treatment, A) 16 hours later, whole cell exacts were prepared
and MnSOD and β actin were analyzed by immunoblotting with specific antibodies; or
B) 6 hours later, cells were harvested and treated with Trizol prior to RNA extraction and
real-time PCR analysis. The relative protein or mRNA levels after normalization with
basal or LPS treated PCR3 values (set as 1) are represented in the graph (mean±SEM,
n=6 independent transfection experiments; *<0.05).
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A)

Figure 6.11 Effect of Wnt13 isoforms on catalase expression in transiently-transfected
BAECs. BAECs were transiently transfected with the PCR3 vector or Wnt13-Flag
constructs for 24 hours, followed by 100ng/ml LPS treatment, A) 16 hours later, whole
cell exacts were prepared and catalase and β actin were analyzed by immunoblotting with
specific antibodies; or B) 6 hours later, cells were harvested and treated with Trizol prior
to RNA extraction and real-time PCR analysis. The relative protein or mRNA levels after
normalization with basal or LPS treated PCR3 values (set as 1) are represented in the
graph (mean±SEM, n=2-10 independent transfection experiments; *<0.05; **<0.01).
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A)

B)

Figure 6.12 Effect of Wnt13 isoforms on catalase expression in stably-transfected
BAECs. BAECs were stably transfected with the PCR3 vector or Wnt13-Flag constructs,
followed by 100ng/ml LPS treatment, A) 16 hours later, whole cell exacts were prepared
and catalase and β actin were analyzed by immunoblotting with specific antibodies; or B)
6 hours later, cells were harvested and treated with Trizol prior to RNA extraction and
real-time PCR analysis. The relative protein or mRNA levels after normalization with
basal or LPS treated PCR3 values (set as 1) are represented in the graph (mean±SEM,
n=6 independent transfection experiments; *<0.05).
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A)

B)

Figure 6.13 Effect of Wnt13 forms on FHRE-luciferase activity in transiently-transfected
BAECs: A) exogenous FOXO activity; B) endogenous FOXO activity. BAEC were
transiently transfected with the PCR3 vector or Wnt13-Flag constructs and FHRE
luciferase construct together A) with or B) without different forms of exogenous FOXO1
or FOXO3a for 40 hours, followed by luciferase activity assay. The relative luciferase
activity after normalization with basal PCR3 values (set as 1) are represented in the graph
(mean±SEM, n=2-8 independent transfection experiments).
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Figure 6.14 Schematic representations of the promoter region and intron region in human
SOD2 gene and the constructs used in this chapter. In human SOD2 gene, the DNA
binding site (DBE) of FOXO is located at -1,249. Three constructs with fragments (P7,
1.6K, 3K) from the promoter region were used, and 1.6K as well as 3K contain the
FOXO DBE. The intron 2 element (+1742-+2083) contains a NF-κB site, and the
corresponding construct is PGL3-P7-I2E (modified from Xu Y et al. 2002 Figure 1).
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A)

B)

Figure 6.15 Effect of Wnt13 forms on SOD2 promoter luciferase activity at basal levels
in BAECs: A) endogenous FOXO activity; B) exogenous FOXO activity. BAECs were
transiently transfected with the PCR3 vector or Wnt13-Flag constructs and SOD2-1.6Kluicferase constructs, together A) with or B) without different forms of exogenous
FOXO1 or FOXO3a for 36 hours, followed by luciferase activity assay. The relative
luciferase activity after normalization with basal PCR3 values (set as 1) are represented
in the graph (mean±SEM, n=3-12 independent transfection experiments; *<0.05).
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A)

B)

C)

Figure 6.16 Effect of Wnt13 forms on SOD2 promoter luciferase activity upon LPS
treatment in BAECs. BAECs were transiently transfected with the PCR3 vector or
Wnt13-Flag constructs and different luciferase constructs (A, PGL3 alone; B, PGL3-P7;
C, PGL3-1.6K) for 24 hours, followed by LPS treatment (100ng/ml). 12 hours later, the
dual luciferase activity assay was performed. The relative luciferase activity after
normalization with basal or LPS treated PCR3 values (set as 1) are represented in the
graph (mean±SEM, n=2-5 independent transfection experiments).
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A)

B)

Figure 6.17 Effect of Wnt13 forms on SOD2 P7- intron2 element (I2E) luciferase activity
in BAECs. BAECs were transiently transfected with the PCR3 vector or Wnt13-Flag
constructs and PGL3-SOD2-P7-I2E luciferase construct for 40 hours, A) without or B)
with the 100ng/ml LPS treatment for 12 hours later, the dual luciferase activity assay was
performed. The relative luciferase activity after normalization with basal PCR3 values
(set as 1) are represented in the graph (mean±SEM, n=3-10 independent transfection
experiments). For the relative luciferase activity after LPS treatment B), One Way
ANOVA was used for comparison between groups; *<0.05.
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A) Basal levels

B) LPS treated

C) LPS treated

Figure 6.18 Wnt13 forms increased PGL3-P7-I2E luciferase activity after LPS treatment
possibly through a putative FOXO site. BAECs were transiently transfected with the
PCR3 vector or FOXO3a-TM and different luciferase constructs (PGL3-P7-I2E or PGL3P7-I2EM1 or PGL3-P7-I2EM2) for 40 hours A) without or B) with LPS treatment for 12
hours, followed by luciferase activity assay. C) BAECs were transiently transfected with
the PCR3 vector or Wnt13-Flag constructs and different luciferase constructs (PGL3-P7-
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I2E or PGL3-P7-I2EM1 or PGL3-P7-I2EM2) for 24 hours, followed by LPS treatment
(100ng/ml). 12 hours later, the dual luciferase activity assay was performed. The relative
luciferase activity after normalization with basal PCR3 values (set as 1) are represented
in the graph [mean±SEM, n=1-9 independent transfection experiments; *<0.05, **<0.01,
compared to PCR3/I2E (basal); ##<0.01, compared to PCR3/I2E-M1 (basal); $<0.05,
compared to PCR3/I2E-M2 (basal)]. For Figure 6.17B, One Way ANOVA was used for
comparison between groups.
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CHAPTER 7. GENERAL DISCUSSION

7.1 Summary
The purpose of this research was to test the hypothesis that in differentiated
endothelial cells, 1) the expression of nuclear Wnt13 forms is regulated at translational
levels during apoptosis; 2) the nuclear Wnt13 forms favor apoptosis through affecting the
activity and/or expression of pro-apoptotic or anti-apoptotic factors; 3) different isoforms
of Wnt13 may have differential effects on endothelial cell apoptosis and apoptosis-related
factors.
First, since the short form of Wnt13B, Wnt13C and M1L-Wnt13B displayed
distinct expression patterns even though they encode the same protein translated form
AUG+74, and nuclear Wnt13 forms increased endothelial cell sensitivity to apoptosis
(Struewing IT et al. 2006), we were wondering whether the nuclear Wnt13 forms behave
like other apoptosis-related factors such as Bcl-2 and c-myc, which undergo translational
regulation during apoptosis. Our findings revealed that Wnt13C expression was increased
in response to stress and apoptosis-inducers (including MG132), and appeared to be
correlated with caspase-3 cleavage. This regulation did not seem to occur at the
transcriptional level since there was no significant increase at mRNA level upon the
treatment of MG132. And in BAEC, the insertion of Myc tag at the first AUG in Wnt13C
mRNA not only inhibited the expression of exogenous Wnt13C at basal level, but also
totally abolished the increase of Wnt13C expression by MG132 treatment (Figure 4.3),
which indicated the RNA sequences or structures are critical for Wnt13C expression,
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suggesting that nuclear Wnt13C can be regulated during apoptosis more likely at the
translational levels than the transcriptional levels. Further studies in our laboratory have
shown that the translational regulation of Wnt13C is not through internal ribosomal entry,
a common cap-independent mechanism by which apoptotic factors initiate their
translation during apoptosis, but more likely through upstream open reading frames
(Tang T et al. 2008).
Second, the nuclear forms of Wnt13C have been shown to increase endothelial
cell susceptibility to apoptosis (Struewing IT et al. 2006), and we confirmed this result by
showing the increase in caspase-3 like activity as well as the cleavage of caspase-3 and 7
by the nuclear Wnt13 forms (M1L-Wnt13B) after LPS treatment. The increased cleavage
of caspase-3 and 7 by may result, at least in part, from the increased expression of
caspase-3 and -7 by M1L-Wnt13B after LPS treatment. M1L-Wnt13B was unable to
significantly increase either other inflammatory caspases (caspase-4 and caspase-5) or
apoptotic factors (TRAIL, DR5, and caspase8) in the extrinsic apoptotic pathway.
However, for Bcl-2 family members, Wnt13 forms were unable to change Bax/Bcl-2
ratio, but upregulated the pro-apoptotic Bim expression.
To discover the underlying mechanisms and possible signaling pathway that the
nuclear Wnt13 forms function through, we excluded the activation of Akt or GSK3β as
the upstream event that responsible for the increased apoptosis by nuclear Wnt13 forms.
We then suspected FOXO transcription factors due to the facts that 1) the nuclear Wnt13
forms may have accessibility to certain transcription factors; 2) both caspase-3 and Bim,
which mRNA expression was upregulated by the nuclear Wnt13 forms, are target genes
of FOXOs. Subsequently, we demonstrated that nuclear Wnt13 forms upregulated the
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expression of FOXO3a but not FOXO1, but the nuclear forms did not reduce the
phosphorylation of FOXO1 at Thr24 or FOXO3a at Ser253. And the nuclear forms
increased nuclear localization of exogenous both FOXO1 and FOXO3a, implying that
enhanced FOXO activation by the nuclear forms. Our data also showed that the nuclear
M1L-Wnt13B upregulated the expression of other FOXO target genes such as cell cycle
arrest-related p27 and oxidative stress resistance-related SOD2, suggesting the increased
FOXO transcription activity by the nuclear Wnt13 forms. Thereby, to confirm that the
nuclear Wnt13 forms function via increasing FOXO transcription activity, we used FHRE
(Forkhead responsive element from FasL promoter) reporter system and the luciferase
constructs with SOD2 promoter or intron 2 for dual luciferase assay. And we showed that
nuclear Wnt13 forms were unable to enhance luciferase activity using FHRE luciferase
reporter from FasL gene and SOD2 promoter. However, the luciferase activity of SOD2
intron 2 element (I2E) was increased by M1L-Wnt13B upon LPS treatment, which may
explain the increased SOD2 expression by the nuclear Wnt13 forms. Interestingly, a
novel putative FOXO site was found in intron 2, which was responsive to activated
FOXO3a form (FOXO3a-TM), and found critical for increased I2E luciferase activity by
M1L-Wnt13B (Figure 6.18), so M1L-Wnt13B increased SOD2 transcription upon LPS
treatment possibly through a putative FOXO site (“AAACA”) from +2053 though + 2057
at intron 2 in SOD2 gene. Although we have not confirmed increased FOXO activity at
Bim promoter so far, it is still possible that M1L-Wnt13B increase FOXO-mediated Bim
transcription though upregulating FOXO3a expression and increasing FOXO nuclear
translocation, thereby upregulating Bim expression and tip the balance to pro-apoptosis,
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resulting in increased caspase activity and more percentage of apoptotic nuclei in
endothelial cells.
Third, considering that Wnt13 isoforms have different subcellular localization, we
assumed that Wnt13 forms may have differential effects on endothelial cell apoptosis and
the expression/activity of apoptotic regulators. For EC apoptosis, exogenous
mitochondrial Wnt13 forms increased cleavage and protein expression of caspase-3, 7
rather than caspase-3 like activity, and secreted Wnt13A increase caspase-3 expression
but not caspase-3 like activity or caspase-3 cleavage in BAECs. Therefore our data
indicate that compared to nuclear Wnt13 forms, the mitochondrial forms and secreted
Wnt13A had weaker action in increasing apoptosis in BAECs, and that the strengths that
Wnt13 forms increase apoptosis in BAEC were nuclear (robust) > mitochondrial
(moderate) > secreted forms (weak). All the Wnt13 forms did not significantly increase
the levels of inflammatory caspases and regulators in extrinsic pathway. For Bcl-2 family
members, like the nuclear Wnt13 forms, the mitochondrial and secreted Wnt13 forms did
not affect Bax/Bcl-2 ratio but upregulated Bim expression; however, the effect on Bim
expression by the mitochondrial or secreted forms was weaker than that by the nuclear
forms. Like the nuclear forms, the mitochondrial forms and Wnt13A also did not show
increasing effect on the activation of Akt and GSK3β. For FOXOs, unlike the nuclear
M1L-Wnt13B, Wnt13A may increase the nuclear localization of endogenous FOXO3a
by reducing FOXO3a phosphorylation at Ser253 which is an Akt site rather than
upregulating FOXO3a expression. Interestingly, Wnt13A increased SOD2 expression
moderately through SOD2 promoter region, which was independent on FOXO factors.
However, although the mitochondrial Wnt13 forms had a moderate effect on upregulating
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FOXO3a levels and decreasing FOXO3a phosphorylation, they did not affect either the
nuclear localization of FOXOs or FOXO transcriptional activity using the FHREluciferase reporter system, SOD2 promoter or SOD2 intron 2 element.
Overall, our results suggest that during EC apoptosis, on the one hand, the nuclear
Wnt13C is induced at translational level; and on the other hand, the nuclear Wnt13 forms
may increase EC susceptibility to apoptosis via upregulating pro-apoptotic factors Bim
and caspase-3/7 as well as FOXO3a, which forms a amplification loop further facilitating
the completion of apoptotic program in endothelial cells. Besides, mitochondrial Wnt13
forms and Wnt13A have similar but weaker effect on EC apoptosis than nuclear Wnt13
forms do, which appears to be a FOXO-independent event.

7.2 Insights from the regulation of Wnt13C during apoptosis
In Aim1, our results indicated that the nuclear Wnt13C can be regulated during
apoptosis more likely at translational levels than transcriptional levels. Under cell
apoptosis, while the global rate of translation by classical cap-dependent mechanism is
shunt down, alternative translational mechanisms are used to maintain protein synthesis.
For example, the pro-apototic protein c-myc (Adachi S et al. 2000), as well as the antiapoptotic protein Bcl-2 (Sherrill KW et al. 2004) allow cell fate decision towards either
apoptosis or survival by employing internal ribosomal entry, which is one of the
alternative cap-independent mechanisms. Hence, the presence of internal ribosomal entry
site (IRES) in Wnt13C mRNA was firstly suspected to explain the regulation mechanism
of Wnt13C. However, using dicistronic Renilla –firefly (FL) luciferase assay, the 5’-UTR
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of Wnt13C did not display an IRES activity with or without the treatment of MG132
(Tang T et al. 2008).
Subsequently, other alternative mechanisms such as upstream opening reading
frames (uORFs) were considered to be the possible explanation for the translational
control of Wnt13C during apoptosis. Further studies in our laboratory suggest that uORFs
may be responsible for reducing the translational efficiency in regulation of Wnt13C
expression, because 1) the insertion of the 5’ leader sequences of Wnt13C into RL
reporter led to a 95% and 85% inhibition of translation activity in vitro; 2) two uORFs
were found in Wnt13C-leader sequences, and the expression of Wnt13C-Flag increased
with the deletion of upstream AUG or CUG and the mutation of AUG (+1); 3) the 5’
leader sequences of Wnt13B harbor one less uORF than that of Wnt13C, and short
Wnt13B showed higher expression than Wnt13C.
The structural features in UTRs are crucial for post-transcriptional regulation in
gene expression. It is noteworthy that 5’- UTRs in 50% of human mRNAs and in 35% of
mammalian mRNAs contain upstream AUG, and when the uAUG is followed by an inframe stop codon, it creates an uORF, which is found in around 10% of human or
mammalian 5’-UTRs (Mignone F et al. 2002). The presence of uORFs in 5’-UTRs tightly
controls the translation of various factors, such as growth factors, cytokines, protooncogenes, and the deregulation of uORFs are involved in diseases including melanoma
and Alzheimer’s disease (Chatterjee S et al. 2009). Moreover, uORFs are also found in
the mRNAs of apoptosis-related factors like Bcl-2 (Harigai M et al. 1996), Bax
(Salomons GS et al. 1998), and Bim (Gilley J et al. 2005).
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A ribosome scanning an mRNA with multiple uORFs may have one of the
following fates: 1) it may translate a short peptide (uORF), and remain associated with
the mRNA, continuing scanning, resulting in re-initiation at a proximal or distal
downstream AUG; 2) it may translate a short peptide (uORF), remaining associated with
the mRNA, and then continue scanning until recognize the AUG codon in the uORF in a
suboptimal context and scan past it to initiate at a downstream ORF (leaky scanning); 3)
it may translate a short peptide (uORF) and then dissociate prematurely at the stop codon;
4) it may be stalled during the elongation or termination phase to block the additional
ribosomal scanning, which is mainly mediated by the peptide produced from the uORF
through its interaction with some part of the translation machinery (Morris DR et al.
2000). Overall, all these actions that uORFs take will end up inhibiting the translational
rate of the mRNA. Additionally, the uORF may also be involved in the destabilization of
its own mRNA by a nonsense-mediated mRNA decay (NMD) pathway to affect its gene
expression, as evidenced by the uORF in CPA1 mRNA (encoding the small subunit of
the arginine pathway carbamoylphosphate synthetase), which is critical for the sensitivity
to NMD (Ruiz-Echevarría MJ et al. 2000). So far, it is still unclear which mechanism is
responsible for the uORF-dependent regulation in Wnt13C; however, we can propose that
the uORFs of Wnt13C 5’-UTR employ to control the mRNA translation possibly through
one (or more) of above choices (re-initiation, leaky scanning, ribosomal dissociation,
ribosomal stalling) in the fate of mRNA with uORFs during its translation.
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7.3 Insights form the increased apoptosis by Wnt13 forms
7.3.1 Possible mechanisms of increased apoptosis by the nuclear Wnt13 forms
In our study, Wnt13 forms, especially the nuclear M1L-Wnt13B,

increase

caspase-3 like activity and cleavage of caspase-3 and 7 possibly through 1) increased
expression of executioner caspase 3 and 7; 2) upregulated expression of the pro-apoptotic
Bcl-2 member Bim, suggesting the involvement of the intrinsic apoptotic pathway.
7.3.1.1 Caspase-3 and -7
How the nuclear Wnt13 forms upregulate the expression of pro-caspases has yet
to be investigated. The regulation of caspase expression can take place at the
transcriptional levels. One factor that influences pro-caspase gene expression is interferon
regulatory factor (IRF)-1. Ectopic overexpression of IRF-1 was shown to transactivate
the endogenous ICE/CED 3 gene (former name for inflammatory caspase-1) in
lymphocytes (Tamura T et al. 1995). The same results were also seen in human U937
cells which were treated by γ-interferon resulting in the induction of ICE expression
(Tamura T et al. 1996). In addition, γ-interferon was found to induce the upregulation of
caspase 1, 2, 3, 6, 8, and 9 in human erythroid progenitor cells (Dai C et al. 1999). The
up-regulation of caspases is associated with cell differentiation in all these models.
Besides IRF-1, another transcription factor STAT1 is also required for constitutive
caspase expression. In human fibroblasts, STAT1 deficiency (U3A cells) resulted in 10
times lower levels of caspase-1, 2, and 3 at mRNA expression than control cells, and reintroduction of STAT1 into U3A cells were able to restore the expression of caspase-1
mRNA (Kumar A et al. 1997).
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The promoter of caspases were also cloned and characterized for further study of
the transcriptional regulation of caspases. The rat caspase-3 promoter lacks TATA box
but contains a cluster of Sp1 sites, and an Ets-1 binding site is found between -1646 and 1632, which is critical for sustained promoter activity, revealing that Est-1 like
transcription factors may regulate the transcription of rat caspase-3 (Liu W et al. 2002).
Hypoxia-inducible factor (HIF)-1 was shown to be increased with the same pattern as
pro-caspase-3 in vivo after ischemia, and gel shift assay demonstrated a specific HIF-1
binding activity to the promoter of caspase-3, suggesting that HIF-1 may regulate
caspase-3 expression at the transcriptional levels (Van Hoecke M et al. 2007). The
sequence of human caspase-3 promoter shares 60% homology with that of rat promoter:
the similarity is the absence of TATA box and the presence of Sp-1 like sequences;
however, the human caspase-3 promoter is shown to be activated by not only Sp1, but
also p73 isoforms instead of p53, both (Sp1 and p73) mediated by Sp-1 like sequences
(Sudhakar C et al. 2008). The murine caspase-3 promoter was also cloned and identified,
with the finding of putative transcription factor binding sites, including elements of
NFAT, E2F1, Myc, and p53 (Sabbagh L et al. 2006), but more studies are needed to
confirm which transcription factor is involved in the regulation of murine caspase-3
transcription. FOXO1 was found to activate caspase-3 transcription using mouse caspase3 promoter, which is mediated by direct binding of FOXO1 to the upstream regulatory
sequences (Bois PR et al. 2005). As for the nuclear Wnt13 forms, increased caspase-3
expression include both mRNA levels and protein levels, so it is more likely that the
upregulation of caspase-3 expression by the nuclear Wnt13 forms occurs at the
transcriptional levels. It is still possible that the nuclear Wnt13 increased caspase-3
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expression through FOXOs, which needs to be confirmed in caspase-3 promoter assay.
Otherwise, other mediators, such HIF-1, STAT-1 and p73, might be responsive for
increased transcription of caspase-3 by nuclear Wnt13 forms.
For caspase-7, its protein levels were induced in response to statin treatment in
dose-dependent manner, and CHIP assay demonstrated that SREBP-1 and -2 could bind
to the proximal promoter region of caspase-7 gene, whose expression was suppressed by
silencing SREBP-1 or -2 (Gibot L et al. 2009). In addition, another study showed that
human caspase-7 promoter contained a putative p53-binding site and its activity could be
induced by p53 (Joshi B et al. 2007). Therefore, the upregulated caspase-7 expression by
nuclear Wnt13 forms might be mediated by one of these transcription factors, and this
hypothesis needs to be tested in further experiments.
7.3.1.2 Bim
Besides FOXOs, the transcription of Bim can be regulated by other factors. The
mRNA levels of Bim was shown to be induced by cerebral ischemia in mice, while this
induction was suppressed in RelA (a subunit of NF-κB)

CNSKO

mice; and a putative NF-

κB site was then found in Bim promoter, which could be responsive to RelA; gel shift
assay also confirmed the RelA binds to Bim promoter to stimulate transcription (Inta I et
al. 2006). In hepatic cells, TGFβ was found to activate Bim transcription by increasing
the expression of Runx1 via the mechanism of IRES, which then binds FOXO3a as a coactivator leading to the transcriptional up-regulation of Bim through FOXO binding site,
revealing that both Runx1 and FOXO3a can regulate the activation of Bim transcription
(Wildey GM et al. 2009). Unlike Runx1 which regulate Bim through FOXO site, Runx3
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was shown to be responsible for transcriptional activation of Bim in gastric epithelial cell
apoptosis induced by TGFβ by interacting with three Runx sites in human Bim promoter;
one Smad site was identified from Bim promoter, which was also responsive to TGFβinduced Bim expression (Yano T et al. 2006). Moreover, the expression of Bim was able
to be induced by nerve growth factor (NGF) withdrawal in neuronal cells, because the
activation of cyclin-dependent kinase (cdk) 4 de-repressed transcription factor E2
promoter binding factor (E2F), which targeted C-myb gene to induce Bim transcription
via myb binding sites, so the Bim expression could be regulated during any step of cdk4E2F-myb pathway in response to NGF withdrawal (Biswas SC et al. 2005). Besides myb,
c-Jun and FOXO were found to be required for transcriptional induction of Bim in
response to NGF deprivation through interacting with AP-1 site and FOXO-binding site,
respectively (Biswas SC et al. 2007). The human Bim promoter was also shown to be
activated by E2F factor through the interaction with a putative E2F-binding site,
indicating a direct regulation of E2F in Bim transcription (Gaviraghi M et al. 2008).
Since the upreuglation of Bim expression occurred at the mRNA levels more
prominently, the induction of Bim took place more possibly at transcriptional levels.
Therefore, the Bim promoter is needed to define whether nuclear Wnt13 forms
upregulated Bim expression through FOXO factors. If the effect of nuclear Wnt13 is in
FOXO-independent manner, other factors that regulate Bim transcription, such as NF-κB,
Runx family, E2F, could be considered as potential mediators for the action of nuclear
Wnt13 forms.
Also, Bim and caspase-3 can be regulated post-transcriptionally. Mitogenactivated protein kinase kinase kinase kinase (MAP4K) 3 is a member of the Ste20
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family of protein kinases and can be activated by UV radiation and the pro-inflammatory
cytokine TNF-α, which was shown to modulate Bim expression at the posttranscriptional
level dependent of its kinase activity (Lam D et al. 2009). In murine B lymphoma cell
lines, anti-IgM induced prolonged activation of JNK which upregulated Bim expression
posttranscriptionally, resulting in cell apoptosis (Takada E et al. 2006). Moreover,
caspase-3 has been shown to undergo a unique post-transcriptionally regulation in mouse
and rat during development of skeletal muscle, but not other tissues (Ruest LB et al.
2002). However, which factor is responsible for the post-transcriptional regulation of
caspase-3 is still to be investigated. Thus, it is possible that the expression of caspase-3
and Bim is upregulated by Wnt13 forms at post-transcriptional levels.

7.3.2 Insights from other Wnt13 forms
Our data showed that mitochondrial Wnt13 forms had a moderate effect on
increasing endothelial cell apoptosis and the expression of apoptotic factors including
caspase-3, 7 and Bim, and this effect did not appear to be mediated by FOXOs, as the
nuclear localization and the transcriptional activity of FOXOs in any luciferase constructs
were unchanged by mitochondrial forms. One possibility is the mitochondrial forms
might relay the signal from mitochondria to those nuclear transcription factors who are
able to regulate caspase-3, 7 and Bim directly or indirectly. For example, under some
circumstances like stress, p53 can translocate to mitochondria where it possibly interacts
with mitochondrial Wnt13 forms, which might result in the activated or stabilized p53
translocating to nucleus to 1) induce caspase-7 transcription; 2) induce apoptosis through
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other pro-apoptotic factors such as Noxa, Bid. Another possibility is that due to the
importance of mitochondrial permeability as well as a large scale of pro-apoptotic factors
located in mitochondria, the mitochondria Wnt13 forms might exert certain positive
effects on 1) MOMP formation by promoting Bax translocation to mitochondria or the
opening of channels like VDAC; or 2) accelerating the release of pro-apoptotic factors
like cytochrome c to cytoplasm. In addition, since the amount of ROS (mainly
superoxide) was increased significantly by the mitochondrial Wnt13 forms as evidenced
by DHE staining, the mitochondria Wnt13 forms might affect MOMP and apoptosis
through regulate ROS production. All theses proposed mechanisms need to be testified in
further experiments.
However, Wnt13A showed a weak effect on EC apoptosis and a moderate
increasing effect on the expression of caspase-3, 7 and Bim. Wnt13A reduced FOXO3a
phosphorylation at Ser253 (an Akt/SGK site), and Wnt13A did not affect Akt
phosphorylation at Ser473, suggesting that other kinases like SGK may be responsible for
the decreased FOXO3a phosphorylation at Ser253. Wnt13A also increased the nuclear
localization of endogenous FOXO3a; however, Wnt13A did not appear to increase
FOXO activity in either FHRE-luc or SOD2 promoter –luc. Instead, it seems that the P7
fragment is more likely to be involved in the increased SOD2 transcription. The P7
fragment is featured by multiple Sp1 and AP-2 binding sites, so Wnt13A might regulate
the luciferase activity of P7 through Sp1 or AP-2 factors. In addition, Wnt13A has been
demonstrated to be the ligand for Fz7 receptor in BAECs (Struewing IT et al. 2007). Fz7
was also proved to interact with Wnt11 to control cell contact persistence at the plasma
membrane, suggesting the cross-talk between Wnt/PCP pathway and cell-cell adhension
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(Witzel S et al. 2006). Hence, it is possible that Fz7 affect JNK signaling which is a key
pathway in Wnt/PCP signaling. So we propose that Wnt13A might stimulate JNK
signaling through Fz7 receptor and then activate c-Jun to upregulate MnSOD expression
via AP-1 site located between -1.6K and 3K of SOD2 gene.

7.4 Clinical implications
The vascular endothelium is an active, dynamic tissue controlling many important
functions, including regulation of vascular tone and maintenance of blood circulation,
fluidity, coagulation, and responses to leukocytes and inflammatory factors (Gonzalez
MA et al. 2003). Neovascularization and vessel regression are determined by the balance
between proliferation and apoptosis of ECs, which is tightly controlled to maintain vessel
homeostasis (Mallat Z et al. 2000).
During normal vessel development and remodeling, EC apoptosis have been
shown to be required for vessel regression. Failure of EC apoptosis in vessel regression
can cause severe pathological change. Familial exudative vitreoretinopathy (FEVR) is a
hereditary ocular disorder characterized by supernumerous vascular branching due to
failure of vessel regression, retina detachments and leaky vasculature (Miyakubo H et al.
1982; Masckauchán TN et al. 2006). Another human disorder, called persistent
hyperplastic primary vitreous (PHPV), is caused by defective regressing of hyaloid
vascular system, resulting in the persistence of structures of the primary vitreous and the
development of a fibro-vascular retrolental plaque. Indeed, some components in Wnt
signaling have been shown to be correlated with such diseases. For example, Fz4
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mutations was found in association with familial exudative vitreoretinopathy (FEVR)
(Robitaille J et al. 2002; Omoto S et al. 2004); and Fz5 retina-specific knockout mice
developed a phonotype similar to PHPV, characterized by accumulation of retrolental
tissue, failure of vessel regression, and abnormal retina morphogenesis (Zhang J et al.
2008). Wnt13 isoforms, especially the nuclear forms, increased the sensitivity of EC to
apoptosis both at basal levels and after challenged by stimulus (LPS treatment).
Moreover, the expression of Wnt13 is tightly controlled during the development of
chicken eye, and Wnt13 has been shown to function in control cell fate in retina, and play
critical role in the formation of laminar structure, ciliary marginal zone (CMZ) and
iris/ciliary epithelium in the retina (Kubo F et al. 2003; Kubo F et al. 2009). Thus, all this
information gives a hint that Wnt13 forms might play a role in vessel regression, and
defects in Wnt13 forms might be involved in the pathogenesis of vascular disorders such
as PHPV and FEVR.
Besides, endothelial cell apoptosis appears to be involved in other vascular
disorders such as atherosclerosis and angiogenesis (Mallat Z et al. 2000; Dimmeler S et
al. 2000).
Atherosclerosis is a multifactorial disorder which develops in the arterial wall in
response to numerous pathological insults and results in excessive inflammatory injury
and fibro-proliferative plaque (Sima AV et al.2009). An increasing size of evidence
shows increased EC apoptosis in atherosclerotic plaques compared with normal tissues
(Choy JC et al. 2001). In the early stage of atherosclerosis, EC apoptosis induces loss of
EC number and EC integrity, leading to enhanced vascular permeability, SMC migration
and increased blood coagulation (Choy JC et al. 2001). EC apoptosis may be induced by
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oxLDL, CTL, cytokines, ROS or local inflammatory mediators (Sima AV et al.2009). In
our research, we used pro-inflammatory LPS to challenge BAECs and EC induce
apoptosis, and the nuclear Wnt13 forms further potentiate LPS-induced apoptosis by
upregulating pro-apoptotic factors. Thus, two possible scenarios would be generated by
Wnt13 forms: 1) more EC apoptosis in atherosclerotic lesion by Wnt13 forms might
promote EC dysfunction and vascular permeability, resulting in aggravating lesion at
vessel wall; 2) increased susceptibility to stimuli might help the injured cell to complete
apoptosis and self-removal in a quicker pace, possibly leading to the reduction of
inflammation. Therefore, whether Wnt13 is good guy or bad guy during pathogenesis of
atherosclerosis needs to be confirmed in atherosclerotic models.
Angiogenesis is the process of postnatal neovasuclarization, mediated by
proliferation, migration and remodeling of differentiated endothelial cells. Unlike being
mainly deleterious in atherosclerosis, EC apoptosis, counteracting proliferation, has an
inhibitory function in tumor angiogenesis (Dimmeler S et al. 2000), endothelial cell
apoptosis is believed to be a target to interfere tumor angiogenesis. In this case, the
increasing effect of Wnt13 on ECs may imply that Wnt13 forms might have inhibitory
action on tumor angiogenesis. However, this hypothesis is in need of more experiments
performed in endothelial cells from smaller vessels.

7.5 Future directions
Our findings reveal that the nuclear Wnt13C is regulated at translational levels
during apoptosis, and the nuclear Wnt13 forms increase EC sensitivity to apoptosis by
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upregulating pro-apoptotic factors such as caspase-3, 7 and Bim; also, the nuclear Wnt13
forms increase SOD2 transcription through intron 2 element of SOD2 gene, which is
possibly mediated by FOXOs. Hence, further studies include: 1) how nuclear Wnt13C
undergo regulation through uORFs; 2) whether FOXOs are responsible for the
upregulation of caspase-3, 7 and Bim by the nuclear Wnt13, which can be confirmed by
using promoters of caspase-3/7 and Bim; 3) whether other factors are responsible for the
upregulation of caspase-3, 7 and Bim by the nuclear Wnt13 (the possible candidate
regulators were described above); 4) whether the increased apoptosis by the nuclear
Wnt13 is correlated in the development of diseases, which needs to be defined in disease
models.
Moreover, Wnt13A and mitochondrial Wnt13 forms show less increase in EC
apoptosis and the expression of apoptosis-related factors, and they do not seem to
function through FOXOs. Therefore, more studies can be centered on: 1) which pathway
that mitochondria forms of Wnt13 signal from mitochondria to nucleus; 2) whether
Wnt13A function through Fz-7- JNK – AP-1- SOD2 pathway.
In conclusion, the findings of this research point to the interplay between Wnt13
forms and cell apoptosis. Specifically, the nuclear Wnt13C is induced at translational
levels during EC apoptosis; and the nuclear Wnt13 forms increase EC susceptibility to
apoptosis by upregulating the expression of pro-apoptotic factors, which suggests that the
expression and functions of the nuclear Wnt13 may form a positive feedback during
apoptosis, resulting in accelerating the completion of the apoptosis process (Figure 7).
Therefore, the interplay between the expression and functions of Wnt13 forms, especially
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nuclear forms, is important for EC homeostasis, which might also be involved in vessel
development and vessel pathogenesis.
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Figure 7 A possible model demonstrating the interplay between expression and functions
of Wnt13 forms during cell apoptosis. Specifically, the nuclear Wnt13C is induced at
translational levels during EC apoptosis. The nuclear Wnt13 forms increase FOXO
activity to upregulate SOD2 expression, as well as the expression of caspase-3 and Bim
leading to increased EC susceptibility to apoptosis. And this interplay between the
expression and functions of the nuclear Wnt13 may form a positive feedback during
apoptosis, resulting in accelerating the completion of the apoptotic program.
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